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HISTORY OF THE ETIOLOGICAL AGENT 
It’s 1908 when Nicolle and Manceux, two scientists of the laboratory of Charles Nicolle at the 
Pasteur Institute in Tunis, found a protozoan in spleen, liver and blood of a North-African 
rodent, the gundi (Ctenodactylus gundi), which was being used for leishmaniasis research.  
Even if they initially believed the parasite to be a piroplasm and then a Leishmania, soon they 
realized that they had been discovered a new organism. They named the parasite Toxoplasma 
gondii based on its morphology and the original host: toxon= bow or arc, plasma= life and 
gondii may have resulted from a misspelling of the original host, the gundi (Nicolle and 
Manceaux 2009). In the same year, Splendore discovered the same parasite in a rabbit in 
Brazil and erroneously identified it as Leishmania (Splendore 2009). 
For the next 30 years, T. gondii-like organisms were found in several other hosts, including 
humans.  
In 1937 Sabin and Olitsky showed that Toxoplasma was an obligate intracellular parasite that 
could be passaged in laboratory animals by intracranial, subcutaneous and intraperitoneal 
inoculation of brain homogenates (Sabin and Olitsky 1937).  In the same years, following a 
fatal case of T. gondii infection in a three-day old infant, it has been showed that Toxoplasma 
was a parasite capable of and associated with congenital transmission (Wolf et al. 1941). In 
the late 1940s and early 1950s Toxoplasma was shown to be involved in inflammatory 
diseases of the eye (Frenkel and Jacobs 1958). 
In 1948 the developing of “The Sabin-Feldman dye test”, the first serological technique to 
detected specific Toxoplasma antibodies, made it possible to find out that a high proportion of 
the human and domestic animal population was infected (Sabin and Feldman 1948). Due to 
this surprising data, Toxoplasma changed from being considered a rare exotic infection into 
one of more common human parasitic infections, but it was still unknown the mechanism  
whereby adults were infected.  
As the only parasites stages known at that time were tachyzoites and tissue cysts, numerous 
fruitless studies were performed to demonstrate the relation of Toxoplasma to Leishmania 
and to show the presence of an insect vector.  It’s when Jacobs et al. (1960) proved that that 
bradyzoites in tissue cysts could survive exposure to acid and trypsin that it was first 
suggested that carnivorism could be a possible mechanism of infection.  The role played by 
carnivorism was then confirmed in 1965 by Desmonts et al. in an epidemiological study in a 
tubercolosis hospital in Paris: it was observed that the incidence of T. gondii infection rose 
from 10% to 50% (and even to 100%) when raw or undercooked meat started to be given to 
patients for therapeutic purposes.  However, the observation that Toxoplasma could be 
transmitted through carnivorism did not explain the widespread infection in herbivores or 
strict vegetarians; indeed, a study in Bombay, India, found the prevalence of T. gondii in strict 
vegetarians to be similar to that in non-vegetarians (Rawal 1959). 
In 1965, Hutchinson first linked T. gondii infectivity with cat feaces. He fed tissue cysts to a cat 
infected with the nematode Toxocara cati, collected and floated faeces in a 33% zinc sulphate 
solution, stored this sample in tap water for 12 months to embryonate T. cati eggs and then 
fed these faeces to mice. The great discovery was that “something” in the faeces, that survived 
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for over a year in water, induced toxoplasmosis in mice (Hutchison 1965).  As neither the 
tachyzoites nor bradyzoites could survive this treatment, it was clear that it should be a new 
form of T. gondii; initially it was proposed that the parasite might be protected within the egg 
of the cat nematode, T. cati, similar to the transmission of the ﬂagellate Histomonas through 
Heterakis eggs (Hutchison 1967). The nematode egg theory of transmission was discarded 
when Toxoplasma infectivity was found in faeces of worm-free cats fed T. gondii (Frenkel et al. 
1969; Sheffield and Melton 1970). 
In 1970, almost simultaneously, scientific groups in the USA, UK, Germany and Netherlands 
resulted in the identification of the resistant form of Toxoplasma as a coccidian oocyst with 
typical coccidian asexual and sexual development occurring in the small intestine of the cat, 
recognized as the definitive host of the parasite (Hutchison et al. 1969; Dubey et al. 1970a; 
Hutchison et al. 1970; Overdulve 1970; Sheffield and Melton 1970; Weiland and Kuhn 1970; 
Witte and Piekarski 1970; Hutchison et al. 1971). 
Thus, knowledge on the life cycle of T. gondii was completed more than 60 years after its first 
description and still remains the only known member of the genus Toxoplasma (Dubey 2008). 
 
  
Table 1 Taxonomic classification of T. gondii 
Kingdom Protista 
Subkingdom Protozoa 
Phylum Apicomplexa 
Class Sporozoasida 
Order Eucoccidiorida 
Famliy Sarcocystidae 
Genus Toxoplasma 
Species gondii 
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LIFE CYCLE AND ROUTES OF INFECTION 
Toxoplasma gondii is an obligate intracellular parasite that occurs in most areas of the world, 
capable of infecting virtually all warm-blooded species, including humans.  
The life cycle of T. gondii is facultatively heteroxenous (intermediate host is not essential for 
the completion of the life cycle) and includes both sexual and asexual multiplication; the 
sexual phase takes place only felids, including the domestic cat, and makes them the definitive 
hosts of the parasite. A large range of vertebrates, including domestic and wild mammals, 
birds, and humans, are intermediate hosts. 
Like other protozoa, its life cycle requires switching between distinct developmental stages.  
In the case of T. gondii, the stages are :  
 the rapidly replicating tachyzoite,  
 the slower growing bradyzoites within tissue cysts; 
 the sporozoites within oocysts. 
The tachyzoite 
The term “tachyzoite” (tachos=speed in Greek), coined by Frenkel, describes the stage of the 
parasite that rapidly multiply in any cell of the intermediate host and in nonintestinal 
epithelial cells of the definitive host; it has also been called the proliferative form and the 
endozoite (Frenkel 1973).  It is the stage that Nicolle and Manceaux  found in 1909 in the 
gundi (Dubey 2008).  The presence of fast-replicating tachyzoites is an indication of an initial 
infection and an acute disease. 
The tachyzoite is lunate, approximately 2 by 6 µm, with a pointed anterior (conoidal) end and 
a rounded posterior end. Ultrastructurally, the tachyzoite consists of various organelles, 
inclusion bodies and an outer covering called pellicle; the nucleus is usually situated toward 
the central area of the cell and contains clusters of chromatin and a centrally-located 
nucleolus.  Although tachyzoites can move by gliding, flexing, undulating, and rotating, they do 
not have visible means of locomotion such as cilia, flagella, or pseudopodia.  
Both sporozoites or bradyzoites differentiate into tachyzoites once that an intermediate or 
definitive host ingests a sporulated oocyst or a tissue cyst and this conversion takes place in 
the small intestinal lamina propria within 18 h post infection (Dubey 1998a). 
Tachyzoites enter host cells by actively penetrating through the host cell plasmalemma or by 
phagocytosis. After entering the host cell, the tachyzoite becomes ovoid and is surrounded by 
a parasitophorous vacuole (PV), which appears to be derived from both the parasite and the 
host cell (Silva et al. 1982; Werk 1985; Bonhomme et al. 1992; Morisaki et al. 1995). 
Tachyzoites multiply asexually within the host cell by repeated endodyogeny (Ferguson 
2009) (Fig.1); this is a specialized form of reproduction in which the two progenies form 
within the parent parasite, consuming it (Sheffield and Melton 1968). Tachyzoites continue to 
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divide until the host cell can no longer support their growth and ruptures. In this way, the 
parasite can disseminate and replicate within the new host: it is reported that T. gondii 
organisms circulate in the blood only 1 h after infection  (Chinchilla et al. 1993).  
Fig. 1 T.gondii endodyogeny (http://www.charite.de/sysbio/research/toxoplasma/) 
 
 
In the blood flow, the majority of parasites exist intracellularly, inside infected leukocytes 
which contribute to the dissemination of the parasite from the general circulation into the 
peripheral tissue by a “Trojan horse” mechanism (Unno et al. 2008).   This parasitemia in 
primarly infected pregnant hosts (both animal and humans) may results in the invasion of the 
placenta and eventually of the foetus, if some tachyzoites cross the placenta (Tenter et al. 
2000).  
Tachyzoites are rapidly killed outside the host; they are considered sensitive to proteolytic 
enzymes and they are usually destroyed by gastric digestion (Powell et al., 2001). However, a 
study showed that tachyzoites may occasionally survive for a short period of time (up to 2 h) 
in acid pepsin solutions, and that oral application of high doses of tachyzoites may cause an 
infection in mice and cats (Dubey 1998b). It has also been suggested that tachyzoites may 
enter the host by penetration of mucosal tissue and thereby gain access to the host's 
circulation or lymphatic system before reaching the stomach (Riemann et al. 1975; Sacks et al. 
1982). 
Bradyzoites and tissue cysts 
The term “bradyzoite” (brady= slow in Greek) was also coined by Frenkel (1973) to describe 
the organism multiplying slowly within a tissue cyst in the intermediate host; they are also 
called cystozoites. 
Tachyzoites differentiate into bradyzoites around 10-14 days post infection. It is still not 
completely clear what is the molecular environment that regulates development from 
tachyzoites to bradyzoites; it is likely that differentiation into bradyzoites during in vivo 
infection is multifactorial with contributions from host immunity (Lyons et al. 2002), . Data 
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from in vitro studies suggest that the bradyzoite differentiation program is genetically 
programmed after the brief period of rapid division as tachyzoites (Skariah et al. 2010).   
Bradyzoites differ structurally only slightly from tachyzoites: they are more slender, with a 
nucleus situated toward the posterior end and they contain several amylopectin granules 
which stain red with PAS (Dubey et al. 1998a).  Similar to tachyzoites, bradyzoites are 
approximately 7 by 1.5 µm in size (Mehlhorn and Frenkel 1980) and divide by endodyogeny 
(Ferguson and Hutchison 1987).  
In the past, the methods used to distinguish tachyzoites from bradyzoites were the resistance 
of bradyzoites to acid-pepsin digestion and bioassay in cats.  Cats fed tachyzoites may become 
infected and may shed oocysts with a long pre-patent period (>15 days), whereas cats fed 
bradyzoites shed oocysts with a short (<10 days) pre-patent period. Dubey (199.b) suggests 
that these cannot be the sole criterion to distinguish between the two stages and that, to 
accurately determine the cyst-like structures, the identification of molecular markers is 
required; in fact, stage conversion is associated with the expression of stage-specific surface 
antigens (Lyons et al. 2002). Several stage-specific surface antigens (SAG) have been 
identified and many of these fall into two distinct families: SAG1 and SAG2. The SAG1 family 
includes SAG3, bradyzoitespecific recombinant (BSR) 4 SAG-related sequences (SRS) 1–4 
proteins, SAG5, SAG5.1 and SAG5.2. Whereas SAG1 and SRS1–SRS3 are present only on 
tachyzoites, BSR4 is present only on bradyzoites and SAG3 is present on both stages. This 
family of proteins is likely to play a role in the attachment process before parasite invasion, as 
proven for SAG1 and SAG3. The SAG2 family comprises four related proteins designated 
SAG2A (previously SAG2) and SAG2B–SAG2D. Whereas SAG2A and SAG2B are expressed by 
tachyzoites exclusively, SAG2C and SAG2D are expressed by bradyzoites exclusively (Lyons et 
al. 2002). 
The conversion to bradyzoites takes place within the parasitophorous vacuole (PV), which 
converts itself into a cyst. In this way, tissue cysts remain intracellular with an elastic and thin 
wall (<0.5µm), composed either of host cell and parasite materials (Ferguson and Hutchison 
1987). Their size is dependent on cyst age and the type of host cell parasitized; young tissue 
cysts may be as small as 5 mm in diameter and contain only two bradyzoites, while older ones 
may contain hundreds of organisms.  
Although tissue cysts may develop in virtually any cell type in vitro, in infected animals they 
are more prevalent in the neural and muscular tissues, including the brain, eyes, and skeletal 
and cardiac muscles; they can be also detected in visceral organs as lungs, liver, and kidneys 
(Dubey 1998a). The ones in the brain are often spheroidal and rarely reach a diameter of 70 
µm, whereas intramuscular cysts are elongated and may be 100 µm long.   
Tissue cysts are the terminal life-cycle stage in the intermediate host and their finding 
represent the establishment of a chronic infection; the species of intermediate host may also 
affect the ability of tachyzoites to convert to bradyzoites and to persist as tissue cysts. In some 
intermediate host species, such as sheep and goats, they may persist for the life of the host. 
The mechanism of this persistence is unknown. However, many investigators believe that 
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tissue cysts break down periodically, with bradyzoites transforming to tachyzoites that 
reinvade host cells and again transform to bradyzoites within new tissue cysts.  This 
reactivation can results in clinical symptoms and is a serious and life-threatening condition in 
immune-compromised individuals (Skariah et al. 2010).  
Fig. 2 On the left: tissue cyst with many bradyzoites within the brain of an infected mouse (scanning 
electron micrograph (http://cmgm.stanford.edu/micro/boothroyd/test.html). On the right: tachyzoites in a 
human foreskin fibroblast (HFF) grown in culture (Giemsa stain) 
(http://cmgm.stanford.edu/micro/boothroyd/test.html). 
 
 
 
 
 
Enteroepithelial asexual and sexual stages 
The sexual development of T. gondii, also called the coccidian stage, takes part only in the gut 
of the definitive hosts, the felines, when an uninfected cat ingests one of the three infectious 
stages of the parasite, tachyzoites, bradyzoites or sporozoites.  Felidae excrete T. gondii 
oocysts in faeces 3 to 10 days after ingesting bradyzoites, ≥ 18 days after ingesting of 
sporulated oocysts and ≥ 13 days after ingesting tachyzoites.  Under experimental conditions, 
it has been demonstrated that the bradyzoite induced cycle in cats is the most efficient since 
nearly all experimentally infected cats fed tissue cysts shed oocysts, whereas < 30 % of cats 
fed tachyzoites or oocysts shed oocysts (Dubey 1998a). 
Only the bradyzoite induced cycle in cats has been studied in detail (Dubey and Frenkel 
1972). After the ingestion of tissue cysts, contained in a prey animal or in meat, the cyst wall is 
dissolved by gastrical or intestinal proteolytic enzymes and the bradyzoites released in the 
gut’s lumen; once they penetrate the epithelial cells of the small intestine, they start  to 
replicate asexually by a process called Toxoplasma endopolygeny. This development 
represents an asexual proliferative phase with repeated nuclear divisions followed by the 
formation of between 8-20 daughters’ cells within the mother cell (Ferguson 2009). After five 
asexual stages of this multiplication, the mature merozoites are released, invade new 
enterocytes and undergo a repeated cycle of asexual development or differentiate into a 
sexual stage, either macrogametocyte (female gamete) or microgametocyte (male gamete).  
The factors involved in deciding the fate of a merozoite are unknown. The initial asexual 
cycles are required to increase parasite density for two reasons: firstly because the male and 
female gametes have to be able to find each other; secondly, since each macrogamete only 
produces a single oocyst, there requires being literally millions of merozoites available to 
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develop into macrogametes to produce the large number (millions) of oocysts seen in the 
faeces (Ferguson 2009).  
The sexual development starts 2 days after tissue cysts are ingested by the cat (Dubey et al. 
1998a) and gametes are found throughout the small intestine, more commonly in the ileum, 
above the nucleus of the host epithelial cell, near the tips of the villi.  The female gamete or 
macrogametocyte, is sub spherical and has two very important functions. Firstly, it has to 
synthesize and store all the nutritional requirements to allow sporulation in the external 
environment and sustain the viability of the sporozoites over long periods (in excess of 1 
year); secondly, it has to synthesize the specific components necessary to form the oocyst wall 
(Ferguson 2009).  Microgametes are elongated, consist mainly of nuclear material and present 
two long, free flagella projected posteriorly. Microgametes use their flagella to swim, to 
penetrate and fertilize mature macrogametes in order to form zygotes; after fertilization, an 
oocyst wall is formed around the parasite.  
Finally infected epithelial cells rupture discharging unsporulated oocysts into the intestinal 
lumen of the cat (Dubey et al. 1998a) which will eventually shed them into the environment 
or cat litter box.   
Sporozoites 
Unsporulated oocysts (zygote) are subspherical to spherical with a diameter of 10 by 12 µm. 
The cytoplasm of the unsporulated oocyst has a large nucleus with amorphous nucleoplasm 
and a distinct nucleolus (Fig. 3).  
Sporulation occurs outside the cat within 1 to 5 days of excretion depending on oxygenation 
and temperature. Firstly, the nucleus divides twice and two spherical sporoblasts are formed, 
each with two nuclei. As the sporulation continues, the sporoblasts elongate and sporocysts 
are formed, each nucleus divides into two and four sporozoites are formed in each sporocyst; 
a prominent residual body is left after sporozoites are formed and it is enclosed in a single-
unit membrane (Ferguson et al. 1979). Sporulated oocysts are subspherical to ellipsoidal and 
are 11 by 13 µm in diameter. Each oocyst contains two ellipsoidal sporocysts that measure 6 
by 8 µm; sporozoites are 2 by 6 to 8 µm in size with a subterminal nucleus and, 
ultrastructurally, they are similar to tachyzoites.  
Cats can shed upward of 360 million oocysts in their feces in a single day and the shedding 
period lasts for a median of 8 days, although it may be as long as 3 weeks (Dabritz and Conrad 
2010).  Sporulated oocysts can survive for long periods in moist soil, under most ordinary 
environmental conditions, and in water (Dubey and Beattie 1988).  
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Fig. 3 Multiple oocysts and a single Isospora oocyst (arrow): comparison of the relative size of Isospora 
felis to the Toxoplasma oocysts 
 
 
 
Fig. 4  Life cycle of T. gondii ( http://www.nzg.ac.za/) 
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ROUTES OF TRANSMISSION OF T. gondii  
Tachyzoites, bradyzoites contained in tissue cysts, and sporozoites inside of sporulated 
oocysts are the three infectious stages in the life cycle of T. gondii.  All the stages are infectious 
for both intermediate and definitive hosts which may acquire T. gondii infection mainly via 
one of the following routes:  
1. horizontally by oral ingestion of infectious oocysts from the environment (soil or 
water), i.e. faecal-oral route;  
2. horizontally via carnivorism by oral ingestion of tissue cysts contained in raw or 
undercooked meat or primary offal (viscera) of intermediate hosts, i.e. carnivorism; 
3. vertically by transplacental transmission of tachyzoites to the foetus, i.e. congenital. 
 
Faecal-oral route. As reported above, primary infected cats shed into their litter box or in the 
environment (soil, water) millions of unsporulated oocysts which become  infected within 1 
to 5 days after excretion.  Experimental studies demonstrated that in soil, sporulated oocysts 
remain infectious over a period of 18 months depending on humidity, temperature and 
exposure to direct sunlight (Yilmaz and Hopkins 1972; Frenkel et al. 1975). In water  (Dubey 
1998c) and seawater (Lindsay and Dubey 2009) sporulated oocysts  remain infective  for 6 up 
to 54 months at temperatures between 4 and 25 °C; oocysts resulted also resistant to 
experimental  freezing, surviving up to 28 days at -21°C  (Frenkel and Dubey 1973). As they 
are highly impermeable, they are very resistant to disinfectants (Kuticic and Wikerhauser 
1996; Jones and Dubey 2010).  Oocysts are distributed in the environment through wind, rain 
and surface water, or harvested feeds and they can be distributed mechanically by vectors and 
transported to water by runoff.  Intermediate hosts, especially humans and herbivores, as well 
as definitive host (Dubey 1998a), can be infected by the ingestion of food or water 
contaminated with sporulated oocysts. 
Carnivorism. Tissue cysts are contained in tissues, especially muscles and nervous system, of 
chronically infected intermediate hosts. Studies have indicated that T. gondii tissue cysts in 
meat are susceptible to various physical procedures such as heat treatment, freezing and 
salting (depending on the salt concentration and duration (Kijlstra and Jongert 2008)): e.g. 
freezing to -12 degrees °C for at least 2 days and cooking to an internal temperature of 67 
degrees kill tissue cysts in meat (Dubey 1996a).  Ingestion of tissue cysts is the main 
mechanism involved in transmission of the infection in carnivores, including humans.  It is 
clear that in humans, as omnivores, both mechanisms described above play a role in T. gondii 
transmission and it is likely that the lifestyle of the individual plays the most important role in 
how the parasite is transmitted; the possible sources of acquired infections in humans will be 
discussed ahead.  
Congenital. Transmission of T. gondii via tachyzoites can occur in hosts which contract 
primary T. gondii infection during pregnancy: in this case tachyzoites may be transmitted 
transplacentally to the foetus.  Congenital transmission has been documented in various 
intermediate hosts, as mice, sheep, goats and, most important, in humans.  
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In addition, tachyzoites have been found in the milk of several hosts, including cats, sheep, 
goats, cows, camels and mice (Powell et al. 2001; Dehkordi et al. 2013). Thus now, the report 
of acute toxoplamosis following the consumption of raw milk has been documented only for 
caprine milk. In addition to blood and milk, tachyzoites have been detected in other body 
fluids, including saliva, sputum, urine, tears, and semen but there is currently no evidence of 
horizontal transmission of T. gondii to humans via any of these routes. 
In conclusion, T. gondii may be transmitted from definitive to intermediate hosts, from 
intermediate to definitive hosts, as well as between definitive and between intermediate 
hosts. It is currently not known which of the various routes of transmission is more important 
from an epidemiological point of view. T. gondii life cycle may continue indefinitely by 
transmission of tissue cysts between intermediate hosts (even in the absence of definitive 
hosts) and also by transmission of oocysts between definitive hosts (even in the absence of 
intermediate hosts) (Tenter et al. 2000) (Fig. 5).  
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Fig. 5 Routes of transmission of T. gondii  
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CHARACTERISTICS OF T. gondii 
POPULATION 
It has been long known that different strains of T. gondii vary in virulence for mice. With the 
development of the molecular typing techniques, it has been possible to associate differences 
in virulence to genetic diversity and to investigate the correlation between T. gondii genotype 
and disease manifestation in animals and also in humans (Saeij et al. 2005). Several studies 
have been conducted by multilocus enzyme electrophoresis (MLEE) and restriction fragment 
length polymorphism (RFLP) on a large set of isolates collected from animals and humans 
from North America and Europe. Such studies revealed that T. gondii population is an unusual 
striking clonal population, highly structured and dominated by three clonal lineages, type I, II 
and III. These lineages differ genetically by 1% or less and have been derived from few genetic 
crosses among closely related parents (Howe and Sibley 1995). Highly similar or identical 
genotypes were sampled from different hosts in different geographic regions of North 
America and Europe revealing that there are no strong geographic differences between the 
two continents' isolated and that similar genotypes can be found in both animals and human 
infections (Sibley and Ajioka 2008).  
Clonality is usually described in protozoan parasites which lack a defined sexual phases in 
their life cycles, precluding the genetic exchange by meiosis. Although T. gondii is one of the 
few parasitic protozoa with a well-deﬁned sexual cycle, this mode of propagation evidently 
occurs only rarely. There are few possible explanations for this striking pattern: 
1. it is known that intermediate hosts develop strong immunity to primary infection, 
limiting the chances for simultaneous infection and developing  tissue cysts  related 
to one specific strain (Reikvam and Lorentzen-Styr 1976);  
2. cats are rarely simultaneously infected with multiple strains,  limiting the chances of 
genetic exchange;  
3. the parasite can be transmitted by direct oral infection between intermediate hosts 
without the necessity of the sexual phase in cats (Sibley and Ajioka 2008).  
 
A proper definition of T. gondii virulence is still incomplete because the susceptibility to the 
infection and to acute disease in different hosts is extremely variable: e.g. mice can die in one 
day and rats may be full refractory to the infection. As rodents are natural hosts for T. gondii, 
laboratory mice have provided a reasonable model to study the virulence factors associated 
with different T. gondii genotypes. The three lineages, i.e. type I, II and III, differ markedly in 
virulence in the mouse model; however, little is known about the correlation between T. 
gondii virulence in mice compared with other species. 
Type I strains are reported to be uniformly lethal with an infectious dose of a single viable 
organism in mice; the first human strain of T .gondii, called RH strain, was classified into 
lineage I. Type I virulent strains are found rarely in animals and in humans; in literature they 
have been associated with acquired ocular toxoplasmosis, congenital infection and cerebral 
toxoplasmosis in immunocompromised patients (Khan et al. 2005; Hunter and Sibley 2012).  
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Due to their rare isolation, scientists recently called the existence of type I strains into 
question. Some research groups reported that during genotyping analysis, the use of 
additional markers transformed a “type I strain” into a non-type I or atypical one. This 
suggests that the identification of type I strains by monolocus typing, as it was done in the 
past, needs to be confirmed by additional multilocus typing (Ajzenberg 2010).  
Type II strains are commonly isolated in both animal and human cases in North America and 
Europe (Darde et al. 1992; Howe et al. 1997) and have an intermediate virulence that varies 
with mouse strain. As the genotype of Toxoplasma strains is strongly linked to the 
geographical origin of infection, the French Toxoplasma Biological Resource Center (Toxo 
BRC, France) reported that in France type II strains are predominant in cases of congenital 
toxoplasmosis and in immunocompromised persons, whatever the clinical presentation 
(Ajzenberg 2010).     
Type III are considered completely avirulent in mice and are characterized by low tissue cysts 
burdens and limited ability to cause infection and human disease (Sibley and Ajioka 2008; 
Hunter and Sibley 2012).  
The analysis of acute virulence of type I strain, performed by classical genetics and by genetic 
crosses between virulent type I and avirulent type III, revealed that the high virulence of type 
I is largely due (90%) to a single allele at the ROP18 locus, a gene encoding a rhoptry protein 
(ROP). Rhoptries proteins (ROP) are discharged by rhoptries (secretory organelles involved in 
the formation of the parasite-containing vacuole) during the parasite cell invasion. ROP have 
different destination in the host cell, e.g trafficking to the host cell nucleus, but their specific 
roles in the parasite biology have not been exactly defined (Sibley and Ajioka 2008). The 
analysis of features of ROP18 in different T. gondii types evidenced that the ROP18 allele is 
remarkably polymorphic in type I strain whereas its expression level is reduced by more than 
100 fold in the type III lineages. Transfection of ROP18 typeI allele in type III strain resulted in 
a 4-fold increase in lethality in mice (Saeij et al. 2005; Sibley and Ajioka 2008). This ﬁndings 
provides evidence that virulence of the type I strains is strongly related to this speciﬁc allele 
unique to this lineage.  
A successful T.gondii infection depends on the ability of the parasite to cross biological 
barriers, such as gut epithelia, blood-brain barrier and placenta and access to 
immunoprivileged sites as the nervous system. Different migration capacities are related to 
strain-specific differences in parasite dissemination and parasite motility. In vitro studies 
evidenced that subpopulations of type I strain parasites display a higher migration capacity 
both in long-distance and across the extracellular matrix than type II and III strains (Saeji et 
al. 2005). Furthermore, in vivo type I parasites migrate more effectively to spleen than the 
other strains.  Genetic analysis supports that the association of migratory capacity and 
virulence is linked to the same chromosome region related to acute virulence (Barragan and 
Sibley 2002; Saeij et al. 2005).  
Growth rate is a common virulence feature in protozoan parasites. T. gondii burden is the 
major contributor to Toxoplasma pathogenesis in mice and it is related to an overstimulation 
of the immune system leading to high levels of T helper cell type 1 (Th1) cytokines, increased 
apoptosis and organ damage.  Several studies have noted that type I strains grow faster than 
the other strains and that one tachyzoite of type I strain is sufficient to generate high parasite 
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loads and high levels of Th1 cytokines. This high growth rate might be linked to a higher 
reinvasion rate of type I parasites compared with the type II or III strains; in fact, type I 
parasites remain infectious for a longer time in extracellular matrix so are able to disseminate 
more efficiently than type II and III (Saeij et al. 2005).  Furthermore, the doubling time (Td) of 
a strain seems to be related to the appearance of bradyzoites antigen (BAG1) and to the 
following conversion to the slower growing bradyzoite form. It has been seen that tachyzoites 
emerged from cells experimentally infected with virulent strains remained firmly on the 
tachyzoite phase not expressing BAG1 antigen at any time (Jerome et al. 1998; Saeij et al. 
2005).  Thus, there seems to be an inverse correlation between the virulence of Toxoplasma 
strains and the expression of bradyzoite genes (‘bradyzoiteness’) under normal culture 
conditions. 
As reported above, the major parts of the typing investigations were and are performed on 
strains isolated from North America and Europe, resulting in an overrepresentation by strains 
isolated in these areas. Recent typing studies are focusing on isolates from animals and 
humans collected from more remote areas of the world with the purpose to extend the 
knowledge on T. gondii population structure.  Surprisingly, strains from South America have 
been identified as natural recombinant, genetically different from those in North America and 
Europe; furthermore, in Brazil, T. gondii populations resulted to be distinct among different 
locations and some atypical genotypes have been shown to be highly pathogenic to humans, 
causing severe cases of ocular toxoplasmosis (Ferreira Ade et al. 2006; Khan et al. 2006; 
Dubey et al. 2007; Pena et al. 2008). More worringly, severe and fatal cases of toxoplasmosis 
in immunocompetent individuals were linked to one atypical strain in French Guiana (Carme 
et al. 2002; Demar et al. 2007). Genetic data on T. gondii isolates from Africa are scarce and 
not sufficient to elucidate the population structure in this continent. To date, studies of 
isolates collected in several African countries showed a predominance of classical lineages, 
type I and II in Uganda and predominantly type III in samples from Western and Middle Africa 
(Lindstrom et al. 2008; Velmurugan et al. 2008).  However, Mercier and colleagues (Mercier et 
al. 2010), identified, new haplogroups, called Africa 1 and 3, from isolates of Gabon area and 
proposed them as being major lineages in the continent, encouraging further studies with 
genotype analysis.    
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TOXOPLASMOSIS IN ANIMALS 
The capability of T. gondii to infect all warm blooded animals makes it the most successful 
parasite worldwide.  Among the different animal species, there is a wide variety of clinical 
responses, ranging from unapparent infection to fatal disease with many intermediate 
situations, such as behavioural changes and congenital diseases. Factors that may influence 
the outcome of T. gondii infection in animals include:  
 the parasite strain,  
 if the infected species has evolved alongside the cat and  
 how the immune system of the host responds to the infection (Innes 1997).  
Table 2 Severity of reaction to Toxoplasma gondii in intermediate hosts (Innes et al. 1997). 
Very Severe Intermediate Resistant 
Marsupials Human Cattle 
New World Monkeys Sheep Horses 
Old World Monkeys Goats Pigs 
 
Toxoplasma infection in felids 
Felids are the only known definitive hosts for T. gondii, with domestic cats and a large range of 
wild felids shown to be capable of shedding oocysts (Dubey 2008).  
Cats shed between 3 and 810 million of oocysts per infection in a period of 8 days on average, 
although this can be extended up to three weeks (Dabritz and Conrad 2010). After the first 
infection, cats are generally protected against re-shedding, although re-shedding has been 
observed experimentally upon challenge infection six years after the primary infection, upon 
administration of high doses of corticosteroids, and after superinfection with the related 
parasite Isospora felis (Dubey 1995).  Re-shedding was not observed in Feline 
Immunodeficiency Virus infected cats challenged with T. gondii 66 weeks post primary 
infection (Lappin et al. 1996), therefore it is unclear how the parasite may persist in cats 
following primary infection.  
As definitive hosts, cats are essential in the epidemiology of T. gondii, which is demonstrated 
by the low prevalence of infection in other animal species on cat free islands (Wallace et al. 
1972; Dubey et al 1997). Cats mainly become infected by ingestion of tissue cysts. Kittens can 
be infected by transplacental passage of the parasite and can possibly also be infected by their 
mother’s milk (Powell et al. 2001). Infection through ingestion of oocysts is another 
possibility, but cats are not very susceptible to oocysts compared to intermediate hosts 
(Dubey 1996b).  Prevalence of infection in cats varies with hunting behavior or other factors 
such as outdoor access and feeding on raw meat, this latter factor being associated with 
hunting behavior. In addition, the prevalence of infection increases with age, as T. gondii 
infection persists in the form of tissue cysts. Seroprevalences of up to 74% have been 
reported. These are generally higher in stray and feral cats compared to pet cats (Tenter et al. 
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2000).  Importantly, it has been recently shown that owning a pet cat is not a strong risk 
factor for human infection. In a review of 14 case-control studies for toxoplasmosis, only one 
indeed identified a slightly increased risk of infection in cat-owners (Petersen et al. 2010). 
Petting cats is probably not a risk, as no infectious oocysts could be detected on fur clippings 
collected 7 days after cats had shed millions of oocysts upon experimental infection (Dubey 
1995). The risk of accidental ingestion of oocysts while cleaning the cat litter box can be 
reduced by proper hand hygiene and by eliminating cat feces daily, before oocysts  have had 
the opportunity to sporulate. In addition, cat litter has been shown to reduce oocyst viability 
(Dubey et al. 2011). Accidental ingestion of oocysts is more probable during gardening, 
playing in a contaminated sandbox, or when eating raw and unwashed vegetables or fruits 
(Petersen et al. 2010). 
Felids are thought not to be severely affected by the T. gondii infection. About 10 to 20% of 
cats develop self-limiting, small-bowel diarrhea in the first 2 weeks after experimental 
inoculate (Lappin 2010). Disseminated toxoplasmosis with uncontrolled replication of 
tachyzoites in hepatic, pulmonary, CNS, and pancreatic tissues can develop after acute 
infection or in cats concurrently infected with feline leukemia, feline immunodeficiency, or 
feline infectious peritonitis viruses, as well as after cyclosporine administration or after renal 
transplantation (Lappin 2010). In a recent study from Finland, 6 out of 193 cats submitted to  
post-mortem examination were diagnosed with general toxoplasmosis, demonstrating that T. 
gondii may be more of a health issue for cats than previously thought (Jokelainen et al. 2012).  
There are other feline species that are more susceptible than domestic cats: female Pallas cats 
can transmit T. gondii to their offspring when persistently infected, which often leads to fatal 
toxoplasmosis in kittens, and is a common cause for failure of captive breeding programs 
(Kenny et al. 2002).  
As cats are generally not affected by the clinical disease, prevention should focus on cats as a 
source of environmental contamination with T. gondii.  Although cats are not necessarily a 
direct risk for human infection, all human infections can be traced back to cat-shed oocysts, 
either as a direct source of human infection or via infection of food animals causing meat-
borne infection in humans. Therefore, reducing the number of oocysts shed in the 
environment could significantly reduce T. gondii infections in both food animals and humans. 
At the moment only a limited set of control options are available. The first option is to reduce 
the cat population. This includes timely neutering of owned cats, and a control strategy for 
stray cats. The second option is to prevent oocysts from ending up in the environment. Cat 
owners should thus encourage their cats to use the litter box, and dispose of cat litter with 
household wastes rather than, for example, flushing it down the toilet. The third option is to 
prevent cats from becoming infected by limiting their hunting behavior, e.g. by keeping them 
indoors (Woods et al. 2003). In addition, cats should not be fed with raw meat.  All these 
options involve changes in the behavior of cat owners or of their cats, which implies that it 
may not be feasible to achieve a large reduction of the number of oocysts shed into the 
environment using these methods. Focusing only on high risk locations, by keeping cats away 
from food animals, vegetable gardens and sandpits may be more feasible.  
A vaccine for cats to prevent or reduce oocyst shedding would greatly enhance the 
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possibilities of T. gondii infection control, and should be considered a research priority. An 
experimental cat live vaccine using oral administration of the T-263 strain, derived from the 
RH strain, prevented oocyst shedding in 84% of kittens (Frenkel et al. 1991) and has been 
shown to decrease the exposure of pigs to T. gondii in a farm-based experiment (Mateus-
Pinilla et al. 1999). However, this vaccine strain needs to be maintained in mice, limiting the 
scale of production. Moreover, the vaccine requires frozen storage, and importantly, as a live 
vaccine, it may be hazardous to the people administering it (Innes et al. 2009). A different 
type of vaccine should thus be favored but, so far, studies are limited. The use of recombinant 
feline herpesvirus-1 expressing the T. gondii rhoptry protein ROP2 did not reduce oocysts 
shedding (Mishima et al. 2002). Intranasal administration of crude native rhoptry proteins 
reduced oocysts shedding by 87.4% compared to an adjuvant-control group (Zulpo et al. 
2012), and prevented 2 out of 3 vaccinated cats from shedding oocysts (Garcia  et al. 2007).  
Toxoplasma infection in livestock  
In most countries, epidemiological data on T. gondii infection in livestock are not regularly 
monitored and information on its diffusion is mainly obtained from local surveys.   
From the review of the seroepidemiological studies published in literature until 2000 (Tenter 
et al. 2000), it has been possible to note that prevalence of antibodies against T. gondii vary 
widely among different animal species with the highest levels of seropositivity reported in 
sheep and goats and the lowest values in horses and poultry.   
Among livestock, sheep and goats are susceptible to congenital toxoplasmosis, which 
represents one of the main causes of abortion and stillbirth; in other species (pigs, cattle, 
horses, chickens), the infection usually remains asymptomatic (Dubey and Jones 2008). 
Despite the clinical manifestation, the importance of T. gondii primary infection in livestock is 
related to the ability of the parasite to produce tissue cysts in infected animals, which may 
represent important sources of infection for humans.   The organotropism of Toxoplasma and 
the number of tissue cysts produced in a certain organ vary with the intermediate host 
species: tissue cysts are most frequently observed in various tissues of infected pigs, sheep 
and goats, less frequently in poultry and horses and only rarely in cattle (Tenter et al. 2000; 
EFSA 2007).    Even if the seropositivity of meat-producing animals does not necessarily 
reflect the risk that those animals pose for their consumers (Tenter 2009),  it has been 
recently demonstrated that in sheep, the antibody concentration was strongly related to the 
probability of the presence of tissue cysts in meat samples (Opsteegh et al. 2010a).  
Using intensive farm management together with adequate measures of hygiene, confinement, 
and prevention, it has been economically possible to produce pigs and poultry free of T. gondii 
infection, although this has been achieved in only a few countries, i.e. in the Netherlands and 
Denmark (van Knapen et al. 1995; Shirley 1997). 
These measures include: 
a) to keep meat-producing animals indoors throughout their life-time; 
b) to keep the sheds free of rodents, birds, and insects; 
c) to feed meat-producing animals on sterilized food, and  
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d) to control access to sheds and feed stores, i.e. no pet animals should be allowed inside 
them (Tenter et al. 2000) 
By contrast, production of free-ranging livestock will inevitably be associated with T. gondii 
infection. Animals kept on pastures with an increased pressure of infection due to 
contamination of the environment with oocysts, such as sheep and goats, show high 
seroprevalences in many areas of the world, i.e. up to 92 and 75%, respectively (Tenter et al. 
2000). 
Toxoplasma infection in sheep 
Toxoplasma gondii antibodies have been found in sheep worldwide; global seroprevalence 
values have been recently reviewed by Dubey (2009b) revealing that values vary widely 
among different locations, from 4% to 92%. Since then, seroprevalences of 44.1% (90/204) 
have been reported in sheep from Grenada and Carriacou, West-Indies (Chikweto et al. 2011), 
18.6% (71/382) in Sao Paulo, Brazil (Langoni et al. 2011), using MAT and 49.3% (248/503) in 
Spain using a commercial ELISA (Garcia-Bocanegra et al. 2013). In a serological survey of T. 
gondii infection in adult breeding sheep in Great Britain, of the 3539 sera collected from 227 
flocks, 74% were found to be positive for T. gondii specific antibody using latex agglutination 
(Hutchinson et al. 2011).  
In relation to different serological tests used, different cut-off and different animal 
investigated, their comparison should be done with extreme care (Dubey 2009b). However, it 
is clear that the infection is widely diffused among the global sheep population.  
Seroprevalence has been shown to increase with the age of the animals, indicating that the 
major part of sheep acquire infection post-natally; differences in seroprevalence between 
young and adult sheep are probably related to the oral route of transmission, with the older 
animals being exposed for longer time (Dubey and Kirkbride 1989; Lunden et al. 1994; Dubey 
2009b; Katzer et al. 2011).  Antibody levels are expected to stay elevated for the lifetime of the 
animal, because the immune response of infected animals does not completely clear the 
parasite and animals stay persistently infected (Katzer et al. 2011).  
As sheep are herbivores, the most likely source of infection is represented by oocysts shed by 
infected cat and contaminating the environment, i.e. pastures, feed stock or water.  The 
importance of ingestion of sporulated oocysts has been supported by risk assessment studies 
showing a statistically significant association between infection and:  
 the presence of cats in the farms (Vesco et al. 2007; Abu-Dalbouh et al. 2012; Cenci-
Goga et al. 2013; Guimaraes et al. 2013; Mendonca et al. 2013).; 
 the management (Dubey 2009b; Gebremedhin et al. 2013); 
 the use of superficial or stagnant water for drinking animals (Vesco et al. 2007; Cenci-
Goga et al. 2013; Gebremedhin et al. 2013); 
 the age of investigated animals (Vesco et al. 2007; Katzer et al 2011; Hutchinson et al. 
2011;)  
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With regard to sheep farming, animals kept on pastures and raised under estensive or semi-
estensive conditions are generally believed to be more likely exposed to Toxoplasma oocysts 
(Tenter et al. 2000); however some authors found an increased risk of infection for sheep kept 
under intensive conditions as farm facilities may provide shelter to various hosts of T.gondii 
(such as cats and rodents) which might be involved in the spread of the infection (Tzanidakis 
et al. 2012).  
Also flock size was found to be a significant risk factor for the infection but in relation to the 
farming conditions under which animals were kept (Cenci-Goga et al. 2013).  
Once ingested, oocysts excyst in the small intestine, releasing sporozoites which quickly 
invade and multiply within the cells of the gut differentiating into tachyzoites (Innes et al. 
2009). A common clinical sign of toxoplasmosis during the early stages of infection is an 
elevated temperature which may last for a further week, during which time tachyzoites may 
be detected in the circulation and find their way to the placenta (Dubey and Sharma 1980; 
Wastling et al. 1993).  Important observations from several studies have shown that ewes 
infected during one pregnancy are unlikely to suffer from a recrudescence of the infection in a 
subsequent pregnancy, suggesting that they are able to develop effective protective immunity 
against the disease (Buxton et al. 2006; Buxton et al. 2007; Innes et al. 2009). However, the 
protection is not to consider absolute (Innes et al. 2009; Edwards and Dubey 2013): recent 
studies reported the finding of T. gondii DNA in fetuses from persistent infected ewes 
suggesting a recrudescence of congenital transmission of T. gondii but this data require 
confirmation by other techniques, i.e. bioassay in mice for determining the viability of the 
parasite (Morley et al. 2005; Morley et al. 2008). 
Congenital transmission from ewes primarily infected during pregnancy to the foetus 
represents an important cause of abortion and economic losses to sheep industry, reported in 
New Zeland, Australia, UK and Europe (Dubey and Beattie 1988).  The stage of pregnancy 
when transplacental transmission of T. gondii takes place is important in determining the 
clinical outcome. If the infection occurs early in gestation, when the foetal immune system is 
relatively immature, foetal death is likely to occur. Infection at mid-gestation can result in 
birth of a stillborn or weak lamb which may have an accompanying small mummified foetus, 
whereas infection in later gestation may result in birth of a live, clinically normal, but infected 
lamb.  Characteristic white spot lesions may be observed on placentas from sheep that have 
aborted their lambs and these areas of necrosis may compromise the function of the placenta 
to support the fetus during gestation (Buxton 1990).  The average annual incidence rates of 
clinical toxoplasmosis was estimated to range between 1% and 2% (Blewett and Trees 1987) 
but, according to Dubey (2009b), “actual losses in lambs due to toxoplasmosis are difficult to 
estimate because the disease is sporadic, only a small number of aborted lambs are submitted 
for diagnosis and, most importantly, toxoplasmosis does not produce clinical disease in the 
ewe, not alarming the farmer”. In the UK the estimate of the annual cost of toxoplasmosis to 
the sheep industry has been calculated to be £12.4 million (Gutierrez et al. 2012). 
In the last decade the scientific community shown  increased interest in determining the role 
played by T. gondii in ovine abortion and numerous studies have been conducted worldwide 
with the aim to investigate the presence of the parasite in placentae or aborted foetuses.  The 
results of these studies are summarized in Table 3. 
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Table 3 Summary of the T. gondii-abortion cases reported in literature. 
 
 
COUNTRY 
DIAGNOSTIC  
METHOD USED 
TISSUE 
OVERALL 
PREVALENCE 
(n° pos samples 
/total tested) 
REFERENCE 
SPAIN 
B1 nested PCR 
 
IFAT-ELISA 
 
Hystology 
 
Fetal brain 
serum or fetal 
thoracic fluids 
sections of fetal 
brain, heart, liver 
and placental 
cotyledons 
23.1%  
(40/173) 
Pereira-Bueno et al. 
(2004) 
ITS1 nested PCR Fetal brain 
5%  
(4/74) 
Moreno et al. (2012) 
HUNGARY 
Hymmuno 
histochemistry 
Fetal membranes 
8%  
(5/65) 
(Szeredi and Bacsadi 
2002) 
IRAN IFAT 
Fetal 
abdominal/thoracic 
fluids 
5.2 %  
(17/352) 
(Razmi et al. 2010) 
IRELAND 
Duplex real-time PCR 
based on 529 bp 
repeated element 
Placenta 
Fetal brain, fetal 
tissues, fetal stomach 
contents, fetal pleura 
fluid, fetal hair coat 
swabs, and vaginal 
swabs. 
10% 
 (51/489) 
(Gutierrez et al. 2012) 
JORDANY 
PCR kit 
(VeTeK™TOXO 
Detection Kit for the 
detection of T. 
gondii by one-step 
PCR) 
Fetal blood and pool 
of tissues 
29.8 %  
(76/255) 
(Abu-Dalbouh et al. 
2012) 
ITALY 
ITS1 nested PCR 
Fetal brain, skeletal 
muscle, liver, spleen, 
abomasum 
placenta 
11.1% 
(271/2421) 
(Masala et al. 2003) 
ITS1 nested PCR 
Fetal brain, skeletal 
muscle, liver, spleen, 
abomasum 
Placenta 
17.1%  
(63/366) 
(Masala et al. 2007) 
SWITZERLAND Himmunohystology 
Various fetal tissues 
sections 
19% 
(16/86) 
(Chanton-
Greutmann et al. 
2002) 
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These results confirm once more how T. gondi represents a common cause of abortion in  
sheep. In global sheep farming a more strictly application of proper prophylactic measures is 
urgently needed for the prevention of the infection and the economic losses due to missed 
lactation and lambs.   
For reducing losses to the sheep industry, a life vaccine (Toxovax ™) is available in New 
Zealand and Europe to help prevent ovine congenital toxoplasmosis; this vaccine, initially 
developed in New Zealand and further studied in Scotland, consists of a modified S48 strain of 
T. gondii that has lost the ability to differentiate into bradyzoites (O'Connell et al. 1988) but 
that can induce protective cell-mediated immune responses in sheep (Buxton and Innes 
1995).  Toxovax™ is advised to be administered at least 3 weeks prior to mating by 
subcutaneous inoculation and it induces a protective immunity for at least 18 months with a 
meat and milk withdrawal period of six weeks following vaccination (Buxton and Innes 
1995); care should be taken by those administering it as it is a zoonotic pathogen (Innes and 
Vermeulen 2006). 
Together with the vaccination, other prophylactic measures are fundamental for reducing the 
environmental contamination and the infection rate of the animals, i.e. the control of the cat 
population (both stray and pets) in the farm, especially for the 2 months before the lamb 
season (Dubey et al. 1990b), the cover of the feed stock at all times to prevent contamination 
(Buxton 1990) and, when possible, prevent the  access of cats to water sources used for 
drinking animals.  Moreover, strict sanitation measures are necessary during an abortion 
outbreak, e.g. the separation of aborting ewes or the ones with vaginal discharges and the 
dispose of aborted fetuses and placentae (Masala et al. 2007). 
The control of T. gondii infection in sheep is also important from a public health point of view 
since tissue cysts may persist in organs of infected sheep for several months and perhaps for 
life, representing a source of infection for humans (Uggla and Buxton 1990; EFSA 2013). It has 
been demonstrated, indeed, that T. gondii was still detectable after more than five months p.i 
in tissues of asymptomatic sheep experimentally infected (Dubey 1984).  Regarding the 
distribution of the cysts, two experimental studies, which examined by PCR and histological 
techniques the distribution of T. gondii in various tissues of experimentally infected sheep, 
found that the parasite was more frequently detected in the brain, in the heart and in muscle 
samples (Esteban-Redondo and Innes 1998; Esteban-Redondo et al. 1999). According to 
European Food Safety Authority, the consumption of raw or undercooked mutton represent 
the main source of infected meat in Southern European countries (EFSA 2007; Kijlstra and 
Jongert 2008). 
 
Little genetic typing has been performed on T. gondii isolates from sheep and published data 
indicated that Type II is the predominant lineage of the strains isolated. Interestingly, no Type 
I isolate of T. gondii has been found in sheep to date (Dubey 2009b). 
Several studies have shown the presence of T. gondii DNA in ovine milk samples. Fusco et al. 
(2007) detected T. gondii DNA in 3.4% (4/117) of the milk samples (10 samples pooled from 
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each farm) collected from 117 farms of the Campania region in Italy; additionally, they tested 
milk samples for anti-Toxoplasma antibodies founding 91 positive out of the 117 samples 
tested.  Similarly, in Brazil, T. gondii DNA was detected in the milk of 5 (3%) naturally infected 
sheep, out of the 70 seropositive tested animals (Camossi et al. 2011).  In a recent study 
performed in Iran, milk samples from different animal species, including sheep, have been 
tested for T. gondii by cell line culture, ELISA and PCR; using the culture method, the 7.02% 
(13/315) of ovine milk samples were found to be contaminated, with the positivity confirmed 
by bioassay in cats too (Dehkordi et al. 2013). Thus far, acute toxoplasmosis has not been 
associated with the consumption of unpasteurized ovine milk; however these results, in 
particular the positivity in bioassay, suggest that the consumption of raw ovine milk, or dairy 
products made with raw milk, might be considered a source of infection for humans (Tenter et 
al. 2000). 
Toxoplasma infection in goats 
Similarly to sheep, T. gondii infection in goats has been reported worlwide with seropositivity 
values varying widely among different countries (from 4% to 77%) depending on the 
serological techniques used, the cut off values, the animals investigated and management 
conditions (Tenter et al. 2000). Though these differences, it is clear that the infection is 
widespread among global goats population.  
Similarly to sheep, goats are supposed to acquire the infection mainly by the ingestion of 
oocysts from contaminated pastures or water (Mancianti et al. 2013); various studies 
demonstrated that risk factors associated with T. gondii infection in goats are similar to the 
ones described above for sheep (Tzanidakis et al. 2012; Garcia-Bocanegra et al. 2013; 
Kantzoura et al. 2013; Lopes et al. 2013). Furthermore, goats are thought to more susceptible 
to toxoplasmosis than sheep as a result of their higher activity and movement compared with 
sheep, which increases the probability of contact with contaminated sources (Abu-Dalbouh et 
al. 2012). 
Congenital transmission from goats primarily infected during pregnancy to their foetuses is 
similar to that seen in sheep representing a likewise important cause of abortion and neonatal 
mortality. The stage of pregnancy when transplacental transmission of T. gondii takes place is 
important in determining the clinical outcome. Infection early in gestation can result in foetal 
death and resorption/abortion while infection in the latter part of the pregnancy may have no 
clinical effect, with the offspring born normal but infected and immune (Buxton 1998). In 
experimentally infected goats, doses as low as 10 sporulated oocysts may produce abortion 
(Dubey 1982).  An experimental study showed that infected goats experimentally re-infected 
with oocysts had a repeat transplacental transmission of the parasite (Dubey 1982).  On the 
contrary, an experiment using 11 pregnant goats, infected and re-infected with high doses of 
oocysts showed that none of the young born to the previously-exposed goats had congenital 
toxoplasmosis (Obendorf et al. 1990).  More studies are required to improve the 
understanding of the pathogenesis of congenital toxoplasmosis in goats and if the infected 
animals develop protective immune response. Although abortion and neonatal mortality are 
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the main clinical signs, adult goats can develop clinical toxoplasmosis involving liver, kidneys 
and brain (Dubey and Beattie, 1988) 
 
As previously reported for sheep farming (Dubey 2009b), also actual data on the impact T. 
gondii abortion in caprine farming are difficult to obtain and they can only be deduced from 
the scientific press. An 8-year period diagnostic assessment of caprine abortion cases 
conducted by immunohistochemical procedures in California, USA, identified T. gondii as the 
causative agent in the 3% (7/211) of cases (Moeller 2001). Recently, an investigation on 
caprine aborted foetuses, sent to a diagnostic service in Spain, revealed the presence of 
T.gondii DNA in 3.8% (1/6) of the examined samples  whereas previously the parasite was 
detected in 8.3% of goat abortion (Moreno et al. 2012). Investigations on abortion during two 
lambing seasons in Switzerland showed that  T. gondii was the responsible agent of caprine 
abortion in the 15% of cases (22/144) (Chanton-Greutmann et al. 2002); in Egypt, the rate of 
abortion due to T. gondii reported in a flock of goats was 43.7% (Ahmed et al. 2008).  
Although these rates of detection are noteworthy, the burden of T.gondii abortion in goats is 
not truly assessed as the disease is still under-detected and underreported in relation to the 
absence of a proper surveillance system.  
Regarding the distribution of tissue cysts, early studies on distribution of Toxoplasma in 
tissues of goats experimentally and naturally infected demonstrated that tissue cysts 
frequently develop in liver and kidneys but that persist longer in skeletal muscle than in brain 
(Dubey 1980b; Dubey et al. 1980).  
Recently, parasites have been be detected by a quantitative PCR in various tissues of 
experimentally infected goats, with the highest concentration of tissue cysts found in lung and 
brain tissue (Jurankova et al. 2013). Furthermore, the parasite has been isolated by bioassay 
in mice from goats' hearts destined to human consumption in USA; the isolates were 
subsequently grown in cell culture for genotyping studies, revealing a dominance of Type II 
and Type III and also the presence of atypical genotypes (Dubey et al. 2011).  Genotyping data 
on T. gondii strains from goats worldwide is very limited. Dubey (1980a) isolated a mouse 
virulent strain (GT1) from muscles of a goat from Ohio, USA. Ragozo et al. (2009) isolated 
viable T. gondii from tissues of 12 out of 26 seropositive goats from Brazil:  these 12 isolates 
were grouped into five atypical genotypes and clonal Types II and III were absent. Recently, 
Mercier et al. (2011) isolated T. gondii from 10 seropositive goats from Dienga, Gabon, Africa; 
all 10 isolates were avirulent for mice and Type III by T. gondii microsatellite markers.  
Regardless of genotypes identified, all of these studies suggest that goats can be important 
hosts for T. gondii transmission to humans. 
The control of toxoplasmosis is similar to that in sheep and biosecurity measures should be 
conducted in farms to prevent contact between cats, rodents and feed bins.  
ToxovaxTM vaccine is not licensed for use in goats; however, when it has been tested, 
protection was observed against abortion but the 25% of the vaccinated group had stillbirths 
after challenge with sporulated oocysts (Chartier and Mallereau 2001). 
The excretion of T.gondii tachyzoites in caprine milk was studied for the first time in 1980 by 
inoculation of mice with milk collected from experimentally and naturally infected goats 
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(Dubey 1980b; Dubey et al. 1980): the parasite was successfully isolated from milk sampled 
from experimentally infected animals (Dubey et al. 1980) whereas no isolation was achieved 
from naturally infected goats (Dubey 1980b).  In Iran milk's samples collected from healthy 
naturally infected goats have been recently tested for Toxoplasma infection by cell line culture 
and the positive ones confirmed by bioassay in cats: 18% (10/180) of the samples tested 
positive by the culture method and had positive bioassay too (Dehkordi et al. 2013). Other 
studies documented the presence of T.gondii DNA in the milk of naturally infected goats 
(Bezerra et al. 2013; Mancianti et al. 2013).  These findings, in particular the positivity in 
bioassay, together with the reports of acute human toxoplasmosis following the consumption 
of milk of naturally infected goats (Sacks et al. 1982; Chiari Cde and Neves 1984; Skinner et al. 
1990), highlight the importance of caprine milk as a source of infection for human.   Moreover, 
a recent case-control study of adults infected with T. gondii in USA identified drinking 
unpasteurized goats' milk as a risk factor for recently-acquired toxoplasmosis (Jones et al. 
2009).  Nevertheless feeding of goat whey was also identified as a source of T. gondii infection 
in pigs in the Netherlands (Meersburg et al., 2006). 
 
Toxoplasma infection in sheep and goats in Italy 
According to the National Institute of Statistics (ISTAT), in Italy there are 7.5 million small 
ruminants, in particular about 6.8 million of sheep and 861,000 of goats (http://www.istat.it). 
Small ruminants are predominantly reared in Central-Southern Italy: Sardinia is the Italian 
region with the highest percentage of heads of small ruminants, owning approximately half of 
the total Italian sheep stock and more than 20% of the total heads of goats. Following 
Sardinia, Sicily, Lazio and Tuscany own respectively 10.4%, 9.4% and 8.1% of the total sheep 
stock whereas Calabria, Sicily and Basilicata own 15.1%, 13.2% and 10.7% of the total goats 
population, respectively (http://www.izs.it/IZS 2013). 
In Southern Italy, the traditional handling sheep methods are represented by transhumance 
and by permanent handling system.  Transhumance, or "big transhumance" in relation to the 
high number of animals (1000-3000) present in each flock, is a seasonal migration between 
winter and summer pastures which was very practised in the past but less common 
nowadays, with the exception of Sardinia. Under this system, sheep are grazed on the plains 
during the falling-winter season whereas they are kept on mountain pastures during the 
summer. In relation to the high number of heads in each flock and to the nomadic 
characteristic of the system, animals are unlikely to be closely supervised by the shepherd and 
can be uncontrolled for long-short periods (Idda et al. 2010).  Under the permanent handling 
system, flocks of 500-1000 heads are permanently kept outside on fenced pastures, almost 
exclusively living on graze, receiving very little food supplement and drinking water coming 
from surface sources (local streams or lakes)  or ground waters, like springs and wells (Vesco 
et al. 2007).    
Throughout Italy, goats are predominantly reared under extensive conditions, using natural 
pastures; furthermore in relation to their capacity for adaptation to very different 
environments, they can be reared also under extreme conditions, as barren lands, in 
particular in Southern Italy (De Luca, 2004).  
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In Northern Italian regions, sheep and goats farming is not as widespread as in Southern 
because these species are not very important in the livestock industry.  The only exception is 
represented by the Alps, where small ruminants’ husbandry is a productive livestock sector, 
in particular for local cheese-making (De Luca, 2004). 
In Table 4 are summarized data on T. gondii seroprevalence in sheep and goats published in 
Italy over the last 3 decades and reviewed by Rinaldi and Scala (2008). The prevalence values 
are highly heterogeneous and difficult to compare since various assays have been used and 
animals sampled were of different ages and reared under different farming conditions. 
Considering that almost all the studies have been performed in the Central-Southern regions 
where sheep farming is more concentrated, it might be interesting to investigate the presence 
of T. gondii antibodies also in animals rose under different conditions in other parts of Italy.  
The role played by T. gondii in ovine and/or caprine abortion has only been documented in 
Sardinia by Masala et al. (2003; 2007): in two consecutive surveys, the authors analysed by 
PCR aborted foetuses collected throughout the region. In the first study (1999–2002), T. 
gondii DNA was found in the 11.1% (271/2471) of tissues from ovine aborted foetuses, with 
placenta tested positive in 31.5% of cases; among caprine tissues, DNA was found in the 6.4% 
(23/356) of samples with the placenta found positive with the highest frequency again (50%; 
6/12).  In the second survey (2003–2005), authors examined again abortion specimen 
collected from 107 farms (98 ovine and 9 caprine) in northern Sardinia: T. gondii DNA was 
found in 18.1% (53/292) ovine foetuses and in 13% (3/23) of caprine samples. Few years 
later, Zedda et al. (2010) monitored by serology an outbreak of toxoplasmosis occurred in a 
Sardinian farm where abortion event involved 7.2% of 430 pregnant sheep; authors found a 
very high serological positivity (45.99%) in the animals and also anti-toxoplasma IgG in the 
sera of one of the farmers, in addition to T. gondii DNA in aliquots of grain and pellets taken 
from feed stocks. 
All these data clearly indicate that in Sardinia clinical toxoplasmosis plays an important role in 
the economic losses due to lamb mortality and to missed lactation, that are estimated about 
10 million Euro/year (Masala et al. 2003). However, according to the authors, the application 
of prophylactic measures for reducing environmental contamination, like reducing the 
number of stray cats and/or keep covered sheep feed and/or isolate aborting ewes and 
dispose aborted foetuses and/or placenta, is almost impossible as the breeding conditions are 
still linked to primitive and nomadic herding practices (transhumance) with animals 
remaining out of individual control for as long as 24h and sometimes even longer without any 
chance of control  (Masala et al. 2003; Masala et al. 2007; Zedda et al. 2010).  
Vesco et al. (2007) and Cenci-Goga et al. (2013) assessed risk factors for T. gondii infection in 
sheep flocks raised in Sicily and Tuscany, respectively. Either the presence of cats in the farms 
(Vesco et al. 2007) and their access to water used by sheep were found positively associated 
with farm-level seroprevalence (Cenci-Goga et al. 2013); furthermore, in both studies the use 
of stagnant or surface water for drinking animals resulted to significantly increase the risk for 
a sheep to be seropositive, confirming that contamination of water (and feed) with oocysts is 
fundamental in the epidemiology of the disease. In Sicily, the seroprevalence increased with 
age from 39.7% in animals less than 1 months to 57.5% in adult sheep; all the lambs were 
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found to be IgM negative, indicating that in these animals IgG were the maternal transmitted 
one through colostrum and confirming the low frequency of congenital infection (Innes et al. 
2009). However it is noteworthy that no fall in seroprevalence was observed after the first 
month of life, thus indicating that the infection happens soon after weaning due to a very high 
pressure of infection in pastures (Vesco et al. 2010). 
 
With regard to the use of the vaccine (Toxovax TM), currently registered as a prophylactic 
measure against abortion in sheep, as far as we know, such procedure is not practiced in Italy 
(Cenci-Goga et al. 2013).  
Risk factors for Toxoplasma infection in goats have not been assessed in none of the published 
study; however Mancianti et al. (2013) hypothesized a high environmental pressure in the 
pasture and a probably presence of a stray cats population as possible explanation of the 
noteworthy seroprevalence value (60.6%) found in goats  raised in Tuscany.  
Although the consumption of dairy products made from raw ovine and/or caprine milk is a 
common eating habit in Italy, the role of ovine and, more important, caprine milk as a 
potential source of infection for human has not been exhaustively studied yet. Only two 
studies (Fusco et al. 2007; Mancianti et al. 2013) detected the presence of T. gondii DNA in 
Italian ovine and caprine milk samples, respectively: T. gondii DNA was found in the 3.4% 
(4/117) of examined ovine samples and in the 13% (10/77) of caprine milk. Even if a positive 
PCR does not demonstrate the presence of viable tachyzoites, these findings can hypothesize 
the possibility of transmission of Toxoplasma to humans through consumption of raw milk.  
 
As far as we know, genetic typing from T.gondii isolates in Italy has been performed in goats 
by Mancianti et al. (2013) and in sheep abortion by Chessa et al. (2014). In the first study, 
conducted in Tuscnay, genetic characterization revealed the presence of classical clonal type 
isolates (III and I)  from most samples (8/10) but also the presence of atypical genotypes from 
2 samples. This is difficult to explain as the animals were born and lived uniquely in the Italian 
farm; the only possible explanation of the presence of atypical strains might be the occurrence 
of a recombination event in cats sharing the same area with the examined goats. In the second 
study, conducted in the Sardinia region, T. gondii DNA was found in 5 placentas, 14 brains, and 
2 livers by PCR analysis and all isolates displayed Type II alleles, indicating that the Type II T. 
gondii may be associated with ovine abortion. 
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Table 4 Seroepidemiological studies on T. gondii prevalence in Italy 
 
SPECIES REGION 
N° 
EXAMINED 
ANIMALS 
SEROPREVALENCE 
(%) 
DIAGNOSTIC 
METHOD 
REFERENCES 
SHEEP 
 
SICILY 1,876 49.9 ELISA IgG 
(Vesco et al. 
2007) 
SARDINIA 
7,149 
28.4 IFAT IgG (Masala et al. 
2003) 9.9 IFAT IgM 
29,886 
19.2 IFAT IgG (Tola et al. 
2006) 5.4 IFAT IgM 
1,043 51.3 ELISA 
(Natale et al. 
2006) 
524 45.99 IFAT (IgM+IgG) 
(Zedda et al. 
2010) 
CAMPANIA 1170 28.5 IFAT IgG 
(Fusco et al. 
2007) 
TUSCANY 630 33.3 IFAT IgG 
(Cenci-Goga et 
al. 2013) 
GOATS 
LAZIO 198 95 MAT 
(De Capraris 
and Gravino 
1981) 
APULIA AND 
BASILICATA 
244 68.9 IFAT 
Puccini et al 
1983 
SARDINIA 
2,445 
12.3 IFAT IgG (Masala et al. 
2003) 5.6 IFAT IgM 
4,562 
11.7 IFAT IgG (Tola et al. 
2006) 4 IFAT IgM 
TUSCANY 127 60.6 MAT 
(Mancianti et al. 
2013) 
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Toxoplasma infection in pigs 
Similarly to what reported for small ruminants, the prevalence of the infection in pigs varies 
either globally and among the classes surveyed (market pigs versus sows, indoor pigs from 
biosecure housing systems versus free-range) as the prevalence of infection in pigs is also 
influenced by management systems. Dubey (2009a), reviewing worldwide information on 
prevalence since 1988,  reported that in the USA the application of good management 
measures in pigs farming leaded to a drastic decline of the prevalence of infection in the last 
decade, e.g. in breeder pigs seroprevalence dropped from 42% in 1983-1984 to 20.8% in 
1992. Since the review published by Dubey (2009a), the seroprevalence of T. gondii in 
slaughter pigs from Ireland has been recently observed at 4.7% (15/317) (Halova et al. 2013).  
In Mexico a prevalence of 12.7% (136/1,074) has been observed (Alvarado-Esquivel et al. 
2011) and between 2.7% (162/6238) and 12.5% (38/305) in North America and Brazil, 
respectively (Hill et al. 2010; Samico Fernandes et al. 2012).  A study across ten regions of 
China noted an overall seroprevalence of 53.4% (434/813) (Yu et al. 2011). 
Signs of severe clinical symptoms following natural T. gondii infection are uncommon and 
disease reports in the literature are generally described as sporadic outbreaks.  One of the 
first identified cases occurred in the US in 1951 where fifty percent of the infected pigs died 
showing cough, diarrhea, weakness, lack of coordination and tremors (Farrell et al. 1952).   
More recently a lethal outbreak of T. gondii was reported in fattening pigs from China with 
morbidity and a mortality rate of 57% (549/960) and 2% (19/960), respectively (Li et al. 
2010): further investigations linked this outbreak to ingestion of contaminated feed as cats 
were found to reside within the feed warehouse. Clinical disease in fattening pigs has also 
been reported in two regions of Northern Italy, Lombardia and Emilia-Romagna with death 
occurred 2-4 days after initial symptoms (Gelmetti et al. 1999).   
Porcine abortion caused by T. gondii infection has also been reported, although again with a 
rare occurrence in this livestock species.  Although a number of other outbreaks of porcine 
abortion and severe clinical disease in naturally infected pigs have been reported, disease is 
generally subclinical.  A more commonly observed symptom is a slight increase in rectal 
temperature during the initial stages of infection, which may persist for 1-2 days.   More acute 
clinical symptoms, although rare, are likely to be linked to the age, the immune status, and 
even the breed of the infected animal (Dubey 2009a). Pigs generally go onto develop efficient 
protective immunity and quickly recover from infection without any obvious clinical signs. 
Clinical symptoms in pigs which have been experimentally infected with T. gondii are similar 
to those described above.  
The source of infection in pigs can be via either oocyst contamination from soil or feed, or 
from consumption of tissue cysts from infected rodents or other small mammals harboring 
tissue cysts: contamination of feed or soil with oocysts is thought to be the main source of 
infection anyway (Lehmann et al. 2003).  Transmission of T. gondii to pigs from the 
consumption of infected rodents has also shown to be a direct source of infection, particularly 
in animals reared outdoors (Kijlstra et al. 2004), which have generally been shown to have a 
higher prevalence of the parasite.  A study by Dubey and collaborators  have  shown the 
prevalence of T. gondii in an outdoor reared  pig farm from  Northern USA to be 90.9% 
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(30/33), which is significantly higher than the figures reported for pigs raised in conventional 
indoor housing (Dubey et al. 2012). A similar trend was also showed in a study examining the 
prevalence of T. gondii in Argentinean sows (Venturini et al. 2004) and in Dutch ones; in 
particular, van der Giessen et al. (2007) found the prevalence of T. gondii in conventionally 
raised pigs in the Netherlands to be 0.38% (1/265), while the animals which were reared 
outdoors had a prevalence of 5.62% (10/178).  It should also be noted that the age of the 
animal is important as an increase in age is linked to an increase in T. gondii seropositivity 
(Berger-Schoch et al. 2011; Halova et al. 2013) and that industrial pigs are more likely to have 
a short life. 
As clinical toxoplasmosis is not considered a problem in pigs, the main reason to implement a 
control strategy to prevent exposure to T. gondii in this species is to reduce the number of 
parasites entering the human food chain and their subsequent transmission.  
Together with sheep and goats, pigs are known to harbor a greater number of tissue cysts 
compared to other animals such as cattle and horses (Tenter et al. 2000), therefore 
undercooked or raw pork from infected animals is potentially a great source of infection for 
foodborne toxoplasmosis in humans.   
To our knowledge, there is no identification system for individual pigs destined for human 
consumption neither in the USA nor in Europe, since pigs are not tested for T. gondii infection 
at slaughter in any country (Dubey 2009a). Currently, the most successful control measures 
are those which involve good on-farm management, such as ensuring that cats are not allowed 
to enter feed and  grain stores and that they have limited access to pig farms (Gamble et al. 
1999).  The important role of cats in transmission of the parasite to pigs has been 
demonstrated in an experimental vaccination trial in cats in Illinois, USA (Mateus-Pinilla et al. 
1999).  The authors demonstrated that a decreased number of infected pigs was observed 
when cats living around the farms under investigation had been vaccinated against 
Toxoplasma, using live bradyzoites of the attenuated mutant T-263 strain, derived by 
mutagenesis from the RH strain, capable of preventing oocyst shedding by cats.   
Effective rodent control is also vital as pigs are omnivores and can consume rodents or rodent 
cadavers if they are present within their housing.  A study examining a 4 month rodent 
control program in three organic pig farms, followed by longitudinal analysis over seven 
months, showed that the levels of T. gondii infection in pigs fell from 10.9% (10/92) to 3.3% 
(4/122) and that the prevalence of infected pigs rose again after the control campaign had 
stopped (Kijlstra et al. 2008).  Therefore any on-farm control strategies must concentrate on 
cat and rodent control, both within the farm and the area used for food storage.    
Another control strategy consists of vaccinating the pigs against the parasite to prevent tissue 
cyst formation, hence reducing the transmission of T. gondii from infected pigs into the food 
chain.  Although a licensed vaccine for this purpose is currently unavailable, research has 
shown that vaccination using live strains of the parasite has had more success than a killed 
vaccine approach (Innes et al. 2011). 
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Toxoplasma infection in pigs in Italy 
The Italian pig sector counts about 9.000.000 of heads with more than 80% of animals that is 
concentrated in Northern Italy.  
Lombardy is considered the leader region owning 45.5% of the total pigs’ population, 
followed by Emilia-Romagna and Piedmont owning 17.6% and 10.6%, respectively. In these 
regions, animals are predominantly reared under intensive methods: 74% of the pigs’ herds 
raise more than 2000 animals and the density of animals can reach 3000 pigs/km2.  On the 
contrary, pigs herds of Central and Southern of Italy are predominantly "back yard" holdings, 
with an average of 27 and 13 animals raised in each farm, respectively (Bellini et al. 2010).  
Little information is available on T. gondii infection in Italian pigs as in the last decade only 
four serological studies have been conducted on pigs from farms located in different parts of 
Italy.  
In Sardinia, Sicily and Umbria, respectively regions of Southern and Central Italy, different 
groups of researchers, using different serological methods and investigating animals raised 
under different conditions, found a similar seroprevalence value of 16% (Scala et al. 2008; 
Villari et al. 2009; Veronesi et al. 2011).  
Despite the economic importance of the swine breeding in Northern Italy, only one study 
analysed the serological status of pigs intensive reared in this area (Giacomini et al. 2013): the 
seroprevalence value found was 4.4%, that is low if compared to the 16% found in Centre and 
South Italy, but is noteworthy if compared to the value found in the Netherlands, where the 
prevalence of Toxoplasma in intensive farming raised swine was 0% (Kijlstra et al. 2004). 
However no data were reported by Giacomini et al. (2013) on management conditions of the 
investigated farms and it is therefore not possible to further analyse the differences between 
Italian and Dutch intensive breeding conditions.  
Villari et al. (2009) and Veronesi et al. (2011) performed risk assessment studies on T. gondii 
in pigs farms located in Sicily and Umbria, respectively. In both studies the presence of cats 
had no influence on the serological status of the animal; authors supposed that other factors, 
such as the presence of infected rodents and the absence of use of coveralls or boots or 
footbaths before entering the stables, could have masked the influence of exposure to cats as 
risk factors.  Moreover, the access to carcasses of dead animals, the lack of application of all-
in-all-out housing (Veronesi et al.2011), the absence of rodent control and the use of water 
drawn from wells for drinking animals (Villari et al. 2009) resulted to significantly increase 
the risk for a pig to be seropositive. These findings clearly indicate that, in these regions, in 
addition to the presence of high levels of environmental contamination, the swine production 
systems lacks of proper hygienic conditions and management systems. The high level of 
environmental contamination in Sicily was also confirmed by the difference in seroprevalence 
found between imported and locally reared animals: animals from France and Spain showed 
an overall seroprevalence of 0.7% whereas locally raised pigs revealed a seroprevalence value 
of 16.4% (Villari et al. 2009). 
The high risk of exposure to T. gondii in pigs is a consequent public health risk as raw or 
undercooked pork meat may represents an important source of human toxoplasmosis.  As 
pigs are not tested for T. gondii infection at slaughter in Italy, the only available method for 
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decrease the risk for humans infection is to improve management systems and introduce 
modern intensive farming systems (Kijlstra and Jongert 2008). 
With regard to clinical toxoplasmosis, in October 1994 Gelmetti et al. (1999) reported 4 
outbreaks of disease with high morbidity (50-60%) and mortality (10-42%) in 2 different pig 
herds located in Northern Italy. The origin of infection still remains unknown as the 4 farms 
did not have any common feed sources or exchange of animals. Considering that either the 
presence of cats (3/4), poor hygienic conditions of the husbandry (2/4) and the absence of a 
program of rodents control (3/4) have been reported by the authors, the high rate of 
morbidity and mortality could have been due to the ingestion of a very high number of tissue 
cysts (infected rodents) or oocysts (high environmental contamination) or, eventually, to the 
circulation of a highly pathogen strain of T. gondii.   
As far as we know, no studies have documented T. gondii genotypes circulating in pigs reared 
in Italy.  
Toxoplasma infection in cattle, horses and chickens  
Being mammalian, also cattle and horses can act as intermediate hosts of T. gondii; as 
herbivores, they become infected only by the ingestion of food or water contaminated with 
sporulated oocysts or by congenital transmission.  
In cattle, seroprevalence values are generally high (up to 92%) but in infected animals tissue 
cysts are found rarely as they are unlikely to persist for long time; furthermore, only few 
positive bioassay results have been reported for naturally infected cattle (Dubey 1986) or 
beef samples (Aspinall et al. 2002; Dubey et al. 2005). On the contrary, PCR based detection of 
T. gondii in bovine samples is relatively common (e.g. More et al. 2008; Santos et al. 2010; 
Opsteegh et al. 2011b) but, as already reported, the detection of T. gondii DNA does not 
necessarily mean the presence of viable parasites and a risk for human infection.  
In cattle, natural T. gondii infection does not appear to cause clinical disease or abortion 
(Dubey 1986); however, in a recent study, 16 out of 60 gravid dairy cows tested positive for T. 
gondii by bioassay of their foetuses, showing the occurrence of transplacental transmission of 
the parasite (de Macedo et al. 2012). 
Beef is usually considered of low risk for human infection (Dubey and Thulliez 1993; Tenter et 
al. 2000; Kijlstra and Jongert 2008) even if a recent quantitative microbial risk assessment 
conducted in the Netherlands demonstrated that, when consumed raw, beef can contribute to 
67.6% of predicted meat-borne infections (Opsteegh et al. 2011a).  
Milk from infected cows has always been considered of negligible importance in the 
transmission of the infection (Dubey 1986); however a recent Iranian study detected T. gondii 
also in bovine milk's samples by cell line cultures and, more importantly, by bioassay in cats, 
calling into question the role played by bovine raw milk in the transmission of the infection 
(Dehkordi et al. 2013).  
Under natural conditions, the prevalence of T. gondii antibodies in horses is generally low, 
with variations related to the serological methods used and animals investigated; recent 
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serological studies conducted in Greece, Mexico and Spain found seroprevalence values 
ranging from 1.8% to 13.3% with higher prevalence in animal kept in rural environment 
compared to animals kept indoors in urban settings (Kouam et al. 2010; Alvarado-Esquivel et 
al. 2012; Garcia-Bocanegra et al. 2012).  
Currently, there is no evidence that T. gondii infection causes clinical disease in either 
naturally or experimentally exposed horses. This animal species is thus considered resistant 
to toxoplasmosis (Dubey and Jones 2008). Transplacental infection of the fetus with T. gondii 
and resulting abortions are considered possible but rare, with only one documented case 
(Aleandri et al. 1978). 
Few successful attempts of isolation of viable T. gondii parasites from naturally or 
experimentally infected horses have been performed in the past (Zardi et al. 1964; Al-Khalidi 
and Dubey 1979); more recently, two groups of researchers isolated the parasite from pooled 
samples of muscles and brain using bioassay in mice, in Egypt and Brazil respectively, 
(Shaapan and Ghazy 2007; Evers et al. 2013).  These findings suggest that also horsemeat can 
be considered a source of T. gondii infection for humans, mainly in countries where horsemeat 
is part of the culinary tradition and where people eat it rare or undercooked. 
Chickens are susceptible to T. gondii infection but are generally considered to be resistant to 
clinical toxoplasmosis (Dubey et al. 2005; Hill and Dubey 2013). Free ranging chickens, 
feeding from the ground, are frequently exposed to the parasite oocysts present in soil (Hill 
and Dubey 2013); this risk is further enhanced by the location where free range chicken are 
kept, which is often in close proximity to human habitation, increasing the likelihood that cats 
and oocysts are present. Seroprevalence data for T. gondii infection in back yard and free 
range chicken is widely available and has been summarized  in a recent review, which 
describes international seroprevalence data ranging from 30% to 100% (Dubey 2010). On the 
contrary, prevalence data for chickens reared indoors are rare (Dubey et al. 2005). In the 
United States T. gondii has been isolated frequently from the tissues of backyard chickens but 
no viable T. gondii was recovered from chicken meat samples obtained from shops using 
bioassays (Dubey et al. 2005). This findings highlights the zoonotic potential of free range 
chickens if consumed undercooked and also when handling their raw meat. Thus, free ranging 
chickens are a relevant and excellent epidemiological target for studies of the prevalence of T. 
gondii oocysts in the environment (Dubey et al. 2007). Furthermore in relation to their 
resistance to toxoplasmosis, to their feeding habits and to the fact that they are an invaluable 
source of viable parasites, samples from chickens have been collected all over the world and 
have been used for broadening the knowledge on T. gondii genotypic diversity (Lehmann et al. 
2006). Analysis of these samples revealed a far greater diversity within T. gondii population 
than that previously expected: Type II confirmed to be the prominent type encountered in 
North America and Europe but to be either absent or very rare in South and Central America, 
where a greater diversity in the form of atypical strains was observed (Lehmann et al. 2006; 
Dubey and Su 2009; Rajendran et al. 2012) .   
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Toxoplasma infection in wildlife species 
Although infection is common in wildlife, descriptions of symptomatic diseases are rare and 
infection is often discovered following post-mortem examinations. Exceptions concern animal 
species that have evolved in environments where there are no cats. As a result, many of these 
species are very susceptible to T. gondii infection and exhibit clinical symptoms of 
toxoplasmosis, which are often fatal (Innes et al. 1997). Wildlife species infected with T. gondii 
are important as a source of infection for humans. They are also studied for epidemiological 
reasons. The consumption of raw or undercooked venison and game meat (wild boars, hares, 
bears and grouse) containing tissue cysts has been demonstrated as a source of infection for 
humans (Tenter et al. 2000; Ross et al. 2001); moreover, handling and evisceration of game 
may also present a risk for human infection, especially for hunters and their families (Dubey 
1994).   
In cervids (roe deer, red deer, fallow deer) the seroprevalence has been found to vary 
considerably depending on the serological technique used, the host species and the 
geographical location: it ranges from 14 to 60% in wild roe deer, from 1.6 to 24% in fallow 
deer and is around 15 % in red deer (Aubert et al. 2010; De Craeye et al, 2011). Toxoplasma 
gondii infection is common in wild boars and seroprevalence in different European areas 
ranged from 23% to 55% (Beral et al.2012). These high prevalence percentages are difficult to 
compare because they were obtained using different serological methods. However, these 
studies do confirm the high frequency of T. gondii infections in wild boars and stress that 
eating raw or undercooked wild boar meat is a real risk for acquiring infection. This is of 
particular importance in countries where traditional raw and salted pork products are 
consumed, especially if they contain wild boar meat (Richomme et al. 2010).  
Foxes are used frequently as a sentinel species to give an indication of how frequently T. 
gondii occurs in a geographical area, due to the predicted frequent exposure of the host to the 
parasite based on their carnivorous nature (Burrells et al. 2013). Seroprevalence of T. gondii 
in foxes ranged considerably between European countries: two independent studies found a 
seroprevalence of 20% in British foxes (Buxton et al. 1997; Hamilton et al. 2005), while 64% 
of foxes in France (Aubert et al. 2010), 68% in Hungary (Jakubek et al. 2007), 79% in 
Germany (Herrmann et al. 2012) and 98% in Belgium (De Craeye et al. 2010) tested positive. 
The variability in the seroprevalence in the different wildlife species is likely to be influenced 
by their diet and habitats. Wild foxes and boars are exposed to tissue cysts because of their 
feeding habits, which may include small mammals, such as rodents and carrion or birds, all of 
which can be T. gondii carriers in their tissues. In addition to this, foxes and boars may also be 
exposed to oocysts contaminating soil or water (Herrmann et al. 2012). Cervids, that feed 
mainly on grass, leaves, young shoots and berries, are therefore less likely to be exposed to 
and ingest tissue cysts however they can be infected by drinking contaminated water or 
eating grass contaminated with oocysts (De Craeye et al. 2010). Therefore, wildlife species 
with different feeding habits are good indicators of different sources of T. gondii 
contamination. The geographical differences in T. gondii prevalence within wildlife host 
species may vary according to their habitat, the presence or absence of domestic or wild felids 
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and the climate. The contact between wildlife and domestic animals increases the opportunity 
of parasite exchange between the sylvatic and domestic transmission cycle (De Craeye et al. 
2010; Beral et al. 2012).   
Animal species that have evolved in isolation of T. gondii or had only very limited contact with 
the parasite are particularly susceptible to T. gondii infection and can exhibit clinical 
symptoms of toxoplasmosis, which are often fatal.  This is well documented for marine 
mammals, in particular for Southern sea otters, macropods from Australia, New World 
monkeys and lemurs from Madagascar (Conrad et al. 2005; de Camps et al. 2008).  
Encephalitis caused by T. gondii is one of the major causes of death of sea otters, often found 
associated with shark attacks as the infection makes them less able to evade attacks. In the 
same way, T. gondii infection in Australian marsupials may make them more prone to 
predation causing declines in the population in the wild (Parameswaran et al. 2009); this is a 
particular threat when the infection causes declines and die-offs in endangered species, like 
the eastern barred bandicoot (Obendorf et al. 1996) or the brush-tailed rock-wallaby (Barnes 
et al. 2010).  
Nevertheless, as T. gondii infection in marsupials is not always fatal but can be long-term 
latent and reactivated during time of stress, like captivity, toxoplasmosis has been associated 
with widespread pathology and death in several collections of captive marsupials in zoos 
worldwide (Canfield et al. 1990; de Camps et al. 2008; Parameswaran et al. 2009).  
The description of severe and fatal toxoplasmosis in lemurs and New World monkeys is 
mainly based on zoo animals where animals were thought to be infected following exposure 
to oocysts brought in their enclosures or following the ingestion of undercooked infected 
meat, respectively (Dubey et al. 1985; Innes 1997; de Camps et al. 2008). 
Toxoplasma infection in rodents 
Natural T. gondii infections in wild rodents are common and these prey species are likely to 
play a substantial role in the transmission of the parasite to the definitive host, ie. felids, 
resulting in the amplification of the parasite and shedding of millions of environmentally 
stable oocysts that are infectious  to all warm blooded animals. 
There are numerous studies that report behavioral changes in rodents infected by T. gondii; 
these changes are predicted to aid predation by cats and to increase transmission rates of the 
parasite. Behavioral alterations that are described include deleterious memory and learning 
effects (Witting 1979), increases in time spent in the open (Hay et al. 1984), being less 
neophobic (fear of novelty) (Berdoy et al. 1995) and inhibition of fear of cats and cat 
kairomones (Berdoy et al. 2000; Vyas et al. 2007). Immuno-histochemistry studies in mice 
showed that Toxoplasma proteins may directly interfere with neuronal function which may 
significantly contribute to altered behavior of the host (Haroon et al. 2012). A recent study 
also showed that T. gondii induces a significant increase in dopamine metabolism in neural 
cells which may help to provide a mechanism for parasite induced behavioural changes 
(Prandovszky et al. 2011). Although these behavioral changes have been observed, they are 
not consistently seen in all infected animals, which raise the question whether these behavior 
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changes are chance events rather than adaptive manipulations of the host by the parasite 
(Worth et al. 2013). Studies are continuing to investigate how these behavior changes are 
achieved: whether this is due to uneven brain colonization (Berenreiterova et al. 2011) and 
how parasite infection can inhibit neuronal function (Haroon et al. 2012)
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TOXOPLASMOSIS IN HUMANS 
The acknowledgment of T. gondii as a human pathogen is dated 1939, when Wolf and 
colleagues identified Toxoplasma as the causative agent of encephalomyelitis in a three day 
old infant (Wolf et al. 1939). In the wake of this detection, during the next decade other 
scientists discovered new pathological aspects of the parasite:  Toxoplasma was demonstrated 
to be capable of and associated with congenital transmission (Wolf et al. 1941) and it was 
shown to be involved in inflammatory diseases of the eye, e.g. adult retinochoroiditis (Wilder 
1952; Frenkel and Jacobs 1958). 
In the same periods, Sabin and Feldman introduced the methylene blue dye test, i.e. Sabin-
Feldman test (Sabin and Feldman 1948), a serological technique that opened the door for 
extensive epidemiological studies on the frequency of infection in both animals and, more 
important, in humans. Since then, it has been estimated that up to one third of the world 
human population has been exposed to the parasite (Tenter et al. 2000).  
The European Food Safety Authority (EFSA) in "The Community Summary Report on Trends 
and Sources of Zoonoses, Zoonotic Agents, Antimicrobial Resistance and Foodborne 
Outbreaks in the European Union in 2005" reported that toxoplasmosis has the highest 
human incidence among zoonotic parasitic diseases. Despite that, it is considered an under-
detected and underreported disease as very few European States have a routine surveillance 
system for toxoplasmosis and the only data available are laboratory-confirmed clinical cases 
that are not sufficient to assess the true disease burden (EFSA 2007).   
From the review of the scientific literature on human toxoplasmosis, it is possible to obtain 
seroprevalence estimates of infection in various parts of the world; however, as different 
serological techniques have been used to obtain this information, they are difficult to compare 
and may not reflect nationwide prevalences differing from the true prevalence of infection.  
Nevertheless, these data can be useful if interpreted as estimates, reflecting the different 
levels of prevalence among similar populations in different region of the world.  In the UK and 
US estimates vary between 9.1% - 11% of the population are predicted to be infected, in South 
America figures range from 6.1% - 77.5%, in Europe from 8.2% - 63.2% , and in Asia and 
Oceania 0.8% - 63.9% (Pappas et al., 2009).  A steady decrease in the incidence of human 
toxoplasmosis assessed by antibody levels has been reported among adults over the past two 
decades in the United States and Northern Europe (Jones et al. 2007). This observed decline in 
Toxoplasma seroprevalence has been attributed to the introduction of modern farming 
systems resulting in a lower prevalence of Toxoplasma cysts in meat in combination with an 
increased use of frozen meat by consumers (Tenter et al., 2000; Diza et al., 2005; Kijlstra and 
Jongert 2008; Torrey and Yolken 2013). 
CLINICAL ASPECTS OF Toxoplasma INFECTION IN HUMANS 
For an opportunistic parasite such as Toxoplasma, expression of the disease is mainly 
dependant of host immunity and genetic background. It is usual to consider that in 
immunocompetent individuals the infection is mild symptomatic or totally asymptomatic and 
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that clinical sever manifestation occurs only in immunocompromised patients or congenitally 
infected children. However, a part of the variation in disease manifestation, even in 
immunocompetent humans, may be related to the parasite itself: inoculum dose, infecting 
stage, route of infection, and parasite genotype. 
Immunocompetent individuals  
T. gondii primary infection in children and adults is asymptomatic in most patients: the most 
typical clinical manifestation is isolated cervical or occipital lymphadenopathy that may 
persist for  weeks or months; severe manifestation as encephalitis, myocarditis, polymiositis, 
pneuomonitis and hepatitis are very rare and infrequent (Montoya and Liesenfeld 2004). 
However, fatal cases due T. gondii infection have been reported in immunocompetent 
individuals from South America (French-Guiana) and have been associated with one atypical 
highly virulent strain (Carme et al. 2002; Demar et al. 2007). Recently other 2 cases of severe 
toxoplasmosis in immunocompetent individuals caused by atypical strains have been 
described in France; for both patients the ingestion of infected meat imported from Brazil and 
Canada resulted to be the more likely cause of infection (Pomares et al. 2011).  Furthermore, 
in the last years it has been recognized the possibility that ocular toxoplasmosis in 
immunocompetent individuals may be a consequence of postnatally acquired infection (Khan 
et al. 2006). 
Immunocompromised individuals 
The majority of Toxoplasma infection in immunocompromised hosts, such as individuals 
receiving cortocosteroids or cytoxic drugs, patients with hematological malignancies, 
transplants or AIDS, can be life-threatening and happens almost always as reactivations of 
previous infections or reactivation of tissue cysts in transplanted organs and in bone marrow 
transplants; primary infection is thought to be a rare event (Mele et al. 2002). The most 
affected site is the Central Nervous System (CNS) with clinical presentation that ranges from 
asymptomatic reactivation to severe disseminated disease with encephalitis, 
meningoencephalitis or, more commonly, tumor lesions with a mass effect. Motor syndrome, 
consciousness disturbances, seizures and focal signs are common manifestations that are 
clinically indistinguishable from other CNS complications; infection can also involve lungs and 
eyes.  In AIDS patients Toxoplasma-encephalitis was an important cause of death (10-30% of 
cases) but thanks to the introduction of highly active antiretroviral therapy (HAART) and 
immune reconstitution the incidence of disease in AIDS patients is declining in developed 
countries (EFSA 2007).   
For patients receiving a transplant of a solid organ, especially heart (a predilection site for T. 
gondii) the risk of toxoplasmosis can be reduced by serological screening of the donor and the 
recipient and if necessary by a prophylactic treatment (EFSA 2007) with cotrimazole. 
Prenatal Toxoplasma infection and congenital toxoplasmosis (CT) 
Immunocompetent women that contract T. gondii during pregnancy can transmit the infection 
to the foetus. The most likely mechanism of the vertical transmission is that tachyzoites may 
invade placenta during temporary parasitemia of the mother, replicate within cells and some 
of these may cross the placenta and enter the foetal circulation or foetal tissues (Remington 
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and Desmonts 1990). While the risk of intrauterine infection of the foetus increases during 
pregnancy, the effects on the foetus are more severe if transmission occurs at an early stage of 
pregnancy. According to the "Systematic Review on Congenital Toxoplasmosis" study group 
(Thiebaut et al. 2007), the transmission occurs in about 15% of women infected at 13 weeks 
of pregnancy, 44% at 26 weeks and 71% at 36 weeks; overall, about a third of infected 
mothers give birth to an infant with toxoplasmosis. At early stages of pregnancy, about 10% of 
prenatal infections result in abortion or neonatal death due to encephalomyelitis (Remington 
and Desmonts 1990); up to 10%  of congenitally infected newborns show the classical triad of 
symptoms, i.e. retinochoroiditis, intracranial calcifications and hydrocephalus. About 12-16% 
of these newborns die from the disease and the surviving ones can suffer from mental 
retardation to other neurological deficiencies (Tenter et al. 2000).  On the contrary, infants 
infected during late stages of pregnancy are asymptomatic at birth but they may develop 
clinical symptoms later in life, e.g. eye (retinochoroiditis, strabismus and blindness), CNS 
(convulsion, mental retardation) or ear (deafness) deficiencies. 
In immunocompetent women that acquire primary T. gondii infection 4-6 months before 
conception or earlier, protective immunity usually prevent vertical transmission to the foetus; 
on the contrary, immunocompromised pregnant women previously infected can transmit 
congenitally the parasite.  
Ocular toxoplasmosis (OT) 
Chorioretinitis is the most common clinical manifestation of ocular toxoplasmosis: the classic 
signs of infection are retinal scars and white-appearing lesions often associated with vitritis 
(Pfaff et al. 2013). The presence of T. gondii in eye tissues was not considered to be a threat to 
health in immunocompetent individuals as ocular toxoplasmosis (OT) was commonly 
supposed to affect exclusively congenitally infected patients. In the last decade, OT following 
acquired infections has been frequently documented; interestingly  multi-center and 
retrospective studies of clinical cases of ocular toxoplasmosis revealed that ocular 
toxoplasmosis was the result of postnatal infection in at least two thirds of patients, when it 
was possible to determine the origin of the infection, (Gilbert and Stanford 2000; Delair et al. 
2008).  Due to the difficulty to differentiate with absolute certainty between congenital and 
acquired infection in case of clinical OT, the percentage of acquired cases is probably 
underestimated.   
Ocular toxoplasmosis (OT) is reported to be more common in South and Central America, the 
Caribbean and parts of tropical Africa compared with Europe and Northern America. Ocular 
disease in South America is more severe than in other continents with lesions that are larger, 
more numerous, more recurrent and more likely to damage vision due to the presence of 
extremely virulent atypical genotypes of the parasite. OT in South America is a leading cause 
of blindness in the population, both in children and in adults (Ajzenberg 2011; Petersen et al. 
2012). 
Further research on the role of Toxoplasma strains as well as basic studies on parasite 
virulence is needed to explain why OT is so severe in some countries, such as Brazil. With the 
availability of ocular fluid specimens obtained for diagnostic purposes and the development 
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of advanced proteomic techniques, a biomarker fingerprint that is unique for an eye 
with toxoplasmosis may become available; it is hoped that such a biomarker analysis may also 
be able to distinguish between acquired versus congenital disease (Kijlstra and Petersen 
2013).  
Latent toxoplasmosis  
One of the most important scientific finding of the past 20 years has been the evidence of an 
association between latent toxoplasmosis and severe psychiatric and neurological diseases, in 
particular schizophrenia; the increased prevalence of toxoplasmosis in schizophrenics has 
been reported in more than 50 studies and/reviews (Torrey et al. 2007; Torrey et al. 2012).   
A strong proof of the causative role played by T. gondii comes from a recent magnetic 
resonance imaging (MRI) study showing that in a subpopulation of Toxoplasma infected 
patients was present a decreased density of grey matter in particular parts of the brain which 
was not present in Toxoplasma-free schizophrenics (Horacek et al. 2012). Additional 
confirmation of this relation comes from a recent study which proved that having antibodies 
against T. gondii resulted a risk factor for the development of schizophrenia (odds ratio=2.73) 
(Torrey et al. 2012). The major responsible for the association between toxoplasmosis and 
schizophrenia seems to be dopamine, a neurotransmitter which is usually found at high levels 
in schizophrenic patients.  In brains of Toxoplasma-infected patients, dopamine seems to be 
produced by brain cells responding to interleukins produced as a consequence of T. gondii 
infection; furthermore, other studies showed that Toxoplasma can produce and express in 
tissue cysts the key enzyme for the synthesis of dopamine, releasing it into surrounding 
tissues (Gaskell et al. 2009; Prandovszky et al. 2011; Flegr 2013).  
Latent toxoplasmosis has been demonstrated to cause a wide range of behavioral changes in 
humans and animals, in particular rodents. These alterations are named “parasite 
manipulation” in animals or “parasite constraint” in humans (Webster 2001); particularly in 
rodents which are  intermediate hosts predated by cats,  Toxoplasma alter host behavior for 
its benefit, prolonging their reaction times and changing their native fear of the odor of cats 
into an attraction. In various independent studies involving infected humans, the same 
behavioral changes, such as the prolongation of reaction times, have been reported also in 
humans and thought to increase the probability of traffic or work accidents in this patients 
(Flegr et al. 2002; Yereli et al. 2006; Flegr et al. 2009).    Significant high levels of anti-T.gondii 
antibodies have been also reported in individuals with obsessive-compulsive disorders, 
depression and anxiety (Dalimi and Abdoli 2012); in particular depression is likely to be 
responsible for the increased risk of suicides in psychiatric patients with high levels of anti-
Toxoplasma antibodies (Okusaga et al. 2011). Nevertheless, a correlation study showed that 
the incidence of suicide in Europe correlates with prevalence of toxoplasmosis in any 
particular country (Flegr 2013). 
In the end, results of many other studies suggest that latent toxoplasmosis could play an 
important role also in bipolar disorders (Pearce et al. 2012), personality disorders (Hinze-
Selch et al. 2010), Parkinson’s disease (Miman et al. 2010a), Alzheimer’s disease (Kusbeci et 
al. 2011), obsessive-compulsive disorders (Miman et al. 2010b), cryptic epilepsy (Yazar et al. 
2003), autism and even brain tumors (Flegr 2013).  
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POSSIBLE SOURCES OF ACQUIRED INFECTION 
Humans can act as intermediate hosts of T.gondii; being omnivores, they can acquire the 
infection by the ingestion of either tissue cysts present in meat or sporulated oocysts 
contaminating food or water. Other routes of infection are reported in literature, but they are 
considered less common, such as the inhalation or inoculation of tachyzoites and the 
accidental ingestion of tachyzoites eliminated in secretions and excreta of infected animals, 
e.g. placentas from infected abortions (Jones et al. 2009).  Since acquired infection with T. 
gondii is increasingly being recognized as a severe cause of acute ocular toxoplasmosis in 
immunocompetent adults, the focus of education for the prevention of the infection must be 
expanded to human infections in general (Peterson et al. 2010).   
Meatborne infection 
In Europe, three large case-control studies have pinpointed uncooked meat as the most 
important risk factor for pregnant women (Kapperud et al., 1996; Baril et al., 1999; Cook et al., 
2000). The largest study conducted by Cook et al. (2000) estimated that consumption of not-
well-cooked meat was the cause of infection in 30–60% of pregnant women with acute 
toxoplasmosis.  
Due to the varying organotropism of T. gondii in different animal species, the number of tissue 
cysts produced in a certain organ varies greatly among food producing animals (Dubey and 
Jones 2008); however, tissue cysts are generally more prevalent in muscle and nervous 
system compared to internal organs, thus the consumption of e.g. livers and kydneys are 
considered less likely sources of infection (Tenter et al 2000). In response to natural infection, 
most farm animals that are seropositive for T. gondii have been shown to harbor infectious 
parasites in their meat, with the exception of beef (Tenter et al., 2000; Kijlstra and Jongert 
2008); viable tissue cysts have been detected in especially sheep, pigs and various wild 
animals, and are considered very rare in cattle (Tenter et al. 2000).  
All the case control studies cited above (Kapperud et al., 1996; Baril et al., 1999; Cook et al., 
2000) have identified the consumption of mutton/lamb meat as a highly significant risk factor 
for contracting T. gondii in pregnant women. Sheep are considered particularly vulnerable to 
T. gondii infection as they are usually kept on pastures contaminated with sporulated oocysts; 
in relation to the environmental burden of oocysts, seroprevalence in sheep can exceed 90% 
(Tenter et al. 2000).  A recent PCR based study on sheep meat demonstrated that serological 
screening can be used to estimate the number of animals that harbor tissue cysts and that, 
therefore, seropositive sheep can pose a risk to their consumers (Opsteegh et al. 2010a). Raw 
or undercooked lamb meat is considered a delicacy in certain countries such as France and it 
is considered an important source of infection in that country (AFSSA, 2005); the 
consumption of raw/undercooked lamb was identified as a statistically significant risk factor 
(OR 3.13) in the European multicentre study conducted in 2000 by Cook and colleagues. A 
recent study by Dubey and colleagues (2008) found 77.9% (53/68) lamb hearts positive in 
bioassay in mice. However, as the probability of acquiring the infection increases with the age 
of the animals, adult sheep are more likely to be seropositive than lambs (Dubey et al. 2009b); 
however, mutton probably poses a smaller risk of infection  to the consumer than lamb meat 
as it is often consumed well cooked (Kijlstra and Jongert 2008).   
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One outbreak of acute toxoplasmosis has been described following the consumption of 
undercooked pork (Choi et al. 1997). Pork meat from breeder pigs is no longer considered as 
the major source of acquired toxoplasmosis since, with the introduction of intensive farming, 
the infection has been practically eliminated in many countries (Kijlstra et al., 2004; van der 
Giessen et al., 2007; Jones and Dubey 2012). However, the animal friendly production systems 
is becoming more and more popular and this may cause a re-emergence of pork meat as an 
infectious meat source (Kijlstra et al., 2004; van der Giessen et al., 2007; Hill et al. 2010).  In 
fact, in a recent study viable T. gondii has been isolated from 17 of 33 organically raised pigs 
from Michigan (Dubey et al. 2012).  
The ingestion of beef has not been considered important in the epidemiology of T. gondii 
because cattle are not a good host for this parasite (Dubey and Beattie 1988). However, only 
relatively small amounts of beef have been tested for viable T. gondii parasites with negative 
results. Multi-center epidemiologic studies have demonstrated that the consumption of 
undercooked beef can be considered a risk factor for T. gondii infection in humans (Baril et al. 
1999; Cook et al. 2000) because beef is often mixed with other types of meat in minced meat 
preparations that are consumed raw or undercooked (Kijlstra and Jongert 2008). 
Similarly to pigs, meat from indoor raised chicken has been demonstrated not to pose risk for 
the consumers, as viable T. gondii has not been isolated by bioassay from any of the 2094 
chicken meat samples tested from retail stores in the United States (Dubey et al. 2005). On the 
contrary, the prevalence of T. gondii in free-range chickens is very high (United States, 17%–
100%) and the recent trend of consumers demanding meat from organically grown free range 
poultry will probably increase the risk of acquiring infection from poultry (Jones and Dubey 
2012). 
The presence of cysts in edible tissues from horses has been demonstrated (Al-Kjalidi and 
Dubey 1979). The role of horses as a source of T. gondii infection depends on regional 
preferences for horse meat, the preparation method and the seroprevalence of horses used 
for consumption (Gill, 2005; Kijlstra and Jongert 2008). Raw or undercooked horse meat is 
frequently consumed in countries such as Belgium, Italy, France and Japan (Gill, 2005). In 
France, severe human toxoplasmosis has been epidemiologically linked to ingestion of horse 
meat imported from Canada and Brazil (Pomares et al. 2011) and viable T. gondii has been 
isolated from US horses slaughtered for export (Al-Khalidi and Dubey 1979). 
The consumption of goat's meat is very popular in developing countries. In a recent study, the 
seroprevalence of T. gondii antibodies in goat meat destined for human consumption in the 
United States was found to be 53.4% (Dubey et al. 2005).  
An emerging risk is the increasing popularity of game meat such as roe deer, wild boar or 
kangaroo, as a study from the European Food Safety Authority has recently estimated that 
approximately half of the game produced in Europe may be seropositive for T. gondii (EFSA, 
2007). Epidemiological studies and several outbreaks have identified the handling and 
consumption of raw or undercooked game as a source of toxoplasmosis (Cook et al., 2000; 
Ross et al., 2001; Carme et al., 2002; Dubey and Jones, 2008). Due to high demand in certain 
countries there is an intense trade of both farmed and natural game, partly via frozen import 
or, more risky for acquiring the infection, fresh meat imports (Reinken, 1998). Earlier studies 
have indicated that kangaroos are highly susceptible to T. gondii infection and kangaroo meat 
 
 
42 
 
was implicated as the cause of an outbreak of toxoplasmosis in Australia in 1994 (Kijlstra and 
Jongert 2008).  
The relative importance of risk factors and the type of meat associated with it varied among 
different countries (Cook et al. 2000).  For example, in France consumption of undercooked 
beef was a stronger risk factor than consumption of undercooked lamb (Baril et al. 1999), in 
Norway consumption of undercooked lamb was a stronger risk factor than consumption of 
undercooked pork (Kapperud et al. 1996), whereas in Poland consumption of undercooked 
pork was the principle risk factor identified in the study (Paul 1998). These findings may 
reflect differences in eating habits of consumers or different prevalences of infection in meat-
producing animals in these regions. 
Production of Toxoplasma free meat is thus directly related to the application of specific 
actions both on farms and animal's level, i.e.  the adoption of proper hygienic condition and 
prophilactic measures for the prevention of infection in food-producing animals (e.g. rodents 
controls, application of intensive production system, storage of feed stock, use of tank waters, 
animal vaccination) together with an effective control of  the cat population (keep cats indoor, 
neuterization, vaccination) (Tenter et al. 2000; Kijlstra and Jongert 2008).  Since such 
measures might require in some cases the eradication of breeding habits or the total 
renovation of the farms, they are difficulty accepted by farmers in absence of a National 
Eradication program of toxoplasmosis. At the same time, the monitoring of the meat at the 
slaughterhouse is likewise difficult, as there is no general agreement among the tests to be 
used; no standardized reference sera or other reference materials are available and there is 
no laboratory certification program (Kijlstra and Jongert 2008).  Therefore, the most reliable 
method to assure non-infectivity of meat is represented by pre-kitchen procedures involving a 
combination of treatments (Lopez et al. 2000; Leroy et al. 2005). Freezing for 2 days at -20 °C 
is sufficient to inactivate the parasite (Kijlstra and Jongert 2008). In general, freezing can 
inactivate the T. gondii tissue cysts, but proper timing and temperature are necessary for a 
100% parasite killing efficiency, as for example tissue cysts remain viable up to 22 days at -1 
and -3.9 °C and 11 days at -6.7 °C (Kotula et al., 1991). Also heating could inactivate tissue 
cysts. At 50 °C it takes 1 h to inactivate tissue cysts whereas immediate destruction takes 
place when the internal temperature of meat reaches a temperature of 67 °C (Dubey et al., 
1990a). Cooking infected meat in a microwave does not guarantee killing of the parasite, most 
probably due to uneven heating (Lunden and Uggla, 1992). Numerous studies have addressed 
the effect of curing procedures such as salting, smoking or fermentation on tissue cyst 
survival. Curing of lamb meat with salt and sugar for 64 h at 4 °C or smoking salt-injected 
meat at temperatures not exceeding 50 °C for 24–28 h were effective in killing T. gondii 
(Lunden and Uggla, 1992). Studies by Dubey have shown that 6% NaCl can kill the isolated 
tissue cyst, independent of the temperature used (Dubey, 1997a). Isolated tissue cysts can 
survive for 56 days in a solution of 0.85% salt, 49 days at 2% and 21 days at 3.3% (Dubey, 
1997). More recent data have shown that injection of >2% NaCl and/or >1.4% lactate salt 
solutions into experimentally infected pig meat could kill the parasite whereas a 1% NaCl 
solution provided variable results and the addition of tripolyphosphate salts had no effect on 
parasite viability (Hill et al., 2004, 2006). PCR studies have demonstrated the presence of T. 
gondii DNA in commercially available swine sausages but bio-assays did not detect the 
 
 
43 
 
presence of viable tissue cysts in these samples (de Oliveira Mendonca et al., 2004). However, 
there is too much variability in these procedures to make a safety recommendation on salts, 
cured or smoked meat preparation (Jones and Dubey 2012). Also irradiation at 0.4–0.7 kGy or 
high-pressure processing at 300–400 MPa can inactivate T. gondii tissue cysts in meat; 
however, the effects of irradiation and of high pressure treatment on color and texture have 
limited consumer acceptance (Kijlstra and Jongert 2008; Jones and Dubey 2012). 
Water and contaminated food and soil  
The percentage of T. gondii infections acquired by tissue cysts versus oocysts is not known; 
however, humans may frequently become infected by ingesting or inhaling the T. gondii 
oocysts directly. Recently Hill and colleagues (2011) have recognized the oocyst-specific 
antigen and Boyer and colleagues (20011) have used it for testing serum samples of mothers 
of congenitally infected infants in the US in order to differentiate oocyst- versus tissue cyst– 
induced infection. The study demonstrated that 78% of these women (59/76) had oocysts-
acquired infections.  
The oocysts burden in the terrestrial and aquatic environments is influenced by 3 factors: the 
oocysts loading, the oocysts survival and their transport overland and in waterways 
(VanWormer et al. 2013). The oocyst loading depends on the felid distribution, availability of 
prey or other food resources and duration and quantity of oocysts shedding (VanWormer et 
al. 2013). Studies have reported that approximately 1% of cats are shedding oocysts at any 
given time and that they excrete oocysts for a median of 8 days with a total of up to 55 million 
oocysts per day (Dabritz and Conrad 2010). The total number of oocysts shed by a single cat 
varies widely from 3 to 810 million; in USA the annual quantity of oocysts deposited on soil 
was estimated at 779-1328 oocysts/m2 (Dabritz and Conrad 2010). The oocysts are 
remarkably stable, especially if they are deposited in shady, moist, and temperate conditions. 
Oocysts maintained experimentally at 48°C in seawater or freshwater remained viable for 24 
and 54 months, respectively (Dubey 1998c; Lindsay and Dubey 2009); oocysts also survived 
for over a year in vials of 2% sulfuric acid at 48°C (Frenkel and Dubey 1972) and up to 28 
days of freezing at -21°C (Frenkel and Dubey 1973). Transport and potential accumulation of 
T. gondii in soil and water is determined by the combination of felid defecation behavior, 
environmental characteristics and surface properties of oocysts. With felid defecation 
behavior it is intended the habits or not to bury the feces and the location of defecation; in fact 
if feces are buried under the soil, fewer are mobilized in the environment whereas if feces are 
left exposed, as it is reported in feral cat colonies, they are more likely to be transported (Ruiz 
and Frenkel 1980). Location of defecation can enhance oocysts transport and the likelihood 
for humans to acquire the infection from the environment; felids, in particular feral and wild, 
have been reported to defecate near waterways, running streams and/or shallow ponds, 
enhancing the transport of oocysts into aquatic environments (VanWormer et al. 2013). In 
1979, an outbreak occurred in US Army soldiers during a 3-week training exercise in Panama 
(Benenson et al., 1982) and the source of infection was recognized to be unfiltered, iodine 
treated water from streams contaminated by jungle cats. Furthermore, cats select places with 
loose soil in order to better cover their feces, as gardens or children's play areas (sandboxes 
or sandpiles) (Torrey and Yolken 2013). A Japanese study quantified the frequency of cat 
defecations in three uncovered urban sandboxes by monitoring the places for almost 5 
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months with night lights and camcorders and identified a total of 961 cat defecations (Uga et 
al. 1996). Using this number, Torrey and colleagues (2013) estimated that the hypothetical 
accumulation of T. gondii oocysts per square foot in each sandbox was between 55.184-
1.677.852 oocysts. The substrate, the vegetation and the climate at the defecation sites also 
affect oocyts transport: while permeable soils facilitate vertical percolation with a reduced 
number of oocysts mobilized, asphalt and concrete surfaces can lead to increased 
mobilization of pathogens (VanWormer et al. 2013).  
The transport of oocysts into aquatic systems is also directly influenced by precipitation 
patterns, in terms of duration, intensity and frequency. The role played in oocysts transport 
by excessive rainfall and runoff into water reservoir was demonstrated in a large 
toxoplasmosis outbreak in the Victoria area of British Columbia in 1995 (Bowie et al., 1997; 
Burnett et al., 1998); 100 persons reported acute toxoplasmosis after drinking unfiltered 
water from a reservoir of the Greater Victoria area that had been contaminated by T. gondii 
oocysts following high precipitations. Similarly, in Santa Isabel do Ivai, Brazil, waterborne T. 
gondii was thought to be responsible for an outbreak involving 155 persons served by an 
underground tank reservoir delivering unfiltered water (de Moura et al., 2006). It was 
supposed that runoff contaminated with T. gondii oocysts entered the reservoir because a cat 
with a litter of kittens lived on top of the underground tank reservoir that was not adequately 
sealed.    
The oocysts burden in both terrestrial and aquatic environment is also influenced by the way 
of disposal of the cat litter boxes by cat owners; Dabritz and colleagues (2006) reported that 
among Californian cat owners it was a common habit to dump the contents of cat litter boxes 
on the property or to flush it down the toilet. This last practice was recognized later as one of 
the causes of T. gondii oocysts contamination of the Morro Bay region that was causing death 
among sea otters. In order to prevent soil or water contamination, cat feces should not be 
flushed into the municipal sanitation system, but rather bagged and disposed in trash. 
Furthermore, feces should not be left for more than one day in the litter box in order to 
prevent their sporulation (Kapperud et al. 1996).  
To reduce the risk of infection from soil some hygienic measures should be adopted by 
pregnant women and humans in general, i.e. wearing gloves during gardening, (Torrey et al. 
2013) or avoid eating unwashed fruits or vegetables (Kapperud et al. 1996). A recent study 
investigated the effectiveness of two soaking solutions in inactivating oocysts from 
experimentally contaminated lettuce samples (El-Tras et al. 2011). Either soaking the 
vegetables in water at 65°C or in vinegar solutions at 45°C for 1 minute was efficient to 
inactivate T. gondi sporulated oocysts. The acid pH of the vinegar solution (pH 4.2) neutralizes 
oocysts charge and lead to flocculation and subsequent accumulation of T. gondiii oocysts.  
Studies have shown that also cockroaches and flies may carry oocysts from cat feces to 
unprotected food (Wallace 1971, 1972) and that T. gondii oocysts may even infect humans 
who pet dogs that have rolled in cat feces (Frenkel and Parker 1996). In that cases cover the 
food and wash accurately hands are hygienic measures of fundamental importance.   
With regard to water, as the level of contamination is not usually known, it should be avoided 
drinking unfiltered water. Toxoplasmosis outbreaks due to the consumption of unfiltered 
water occurred in many areas of the world, in particular where surface water was used for 
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human consumption without any purification, including Brazil (Heukelbach et al., 2007; 
Cavalcante et al., 2006; Boia et al., 2008),  India (Palanisamy et al., 2006; Hall et al., 1999), 
Poland (Jones and Dubey 2010), Turkey (Ertug et al., 2005), Granada (Asthana et al., 2006), 
Taiwan (Hung et al., 2007), and China (Lin et al., 2008). Guidelines for prevention of T. gondii 
infection (Lopez et al. 2000; Leroy et al. 2005) suggest that, if untreated surface water 
represents the main source of drinking water, filtering (absolute 1 lm filter) or boiling will 
help eliminate T. gondii oocysts. Chlorine treatment will not inactivate T. gondii, but a long 
exposure (3 hours) to tincture of iodine (2%) will be effective. It is also possible that ingestion 
of inadequately treated water or inadvertent ingestion of recreational water from streams, 
lakes, or ponds may be involved in some human infections (Jones and Dubey 2010). Shellfish 
and other filter feeders consumed raw can be considered another potential source of infection 
as they have been experimentally shown capable of retain and filtrate oocysts from water 
(Arkush et al. 2003; Lindsay et al. 2004). Travelers should also avoid drinking untreated or 
inadequately treated water and be aware that in some areas of the world municipal water in 
not adequately treated or filtered. When possible, access of cats to the areas around drinking 
water tanks or reservoirs should be limited.  
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HUMANS TOXOPLASMOSIS IN ITALY 
Italy lacks a nationwide epidemiological surveillance system for toxoplasmosis (Bénard et al. 
2008; Mosti et al. 2013); serological tests for toxoplasmosis are performed as a routine 
prenatal screening during pregnancy, with a first evaluation at the 13th week, followed by 
monthly testing of pregnant women who are seronegative for toxoplasmosis (total 5–7 tests), 
as indicated by Italian legislation (Pinto et al. 2012). Surveillance on congenital toxoplasmosis 
(CT) is only confined to a regional programme in the Campania region, which has been 
running since 1997 with the aim to monitor the burden of CT through the monitoring of IgG 
levels in living newborn babies (Stagni et al. 2009). Therefore, epidemiological data about the 
seroprevalence of T. gondii in the general Italian population are not available whereas data 
about seroprevalence in pregnant women are sparse and limited to the area where the results 
of the routine screening have been statistically analyzed (Buffolano et al. 1996; De Paschale et 
al. 2008; Thaller et al. 2011; Mosti et al. 2013).  
Recently, a retrospective studies conducted in the Tuscany region (Carrara and Lucca district) 
investigated the seroprevalence for T. gondii in individuals referring to two hospitals for 
serological tests; all the serum samples considered have been tested for both IgG and IgM 
anti-Toxoplasma antibodies (Pinto et al. 2012). The total sample size was 10,352, with the 
majority (92.6%) of individuals that were female, mostly (95.2%) of childbearing age. The 
high rate of women that underwent to serological analysis indicates both a good awareness of 
the risk posed to pregnant women by toxoplasmosis and an easy access to prenatal screening 
for women resident in that area. Overall, a total of 2,216 subjects, corresponding to 21.4% of 
the sample, were found to be positive for IgG antibodies and among women in reproductive 
age (9,132), the prevalence detected was 19.4% (1,766).  The Toxoplasma IgG seropositivity 
showed a significant positive correlation (p<0.0001) with age: the very low prevalence was 
observed in younger age groups and markedly increased in older people. The rising trend 
with age reflects the continuing risk of exposure and infection in adult life. 
Another retrospective study, conducted in the same area estimated the seroprevalence of T. 
gondii infection in both general population and women of reproductive age (13 177 subjects) 
over a 4-year period (2007-2010) in order to evaluate the trend of exposure to the parasite 
(Mosti et al. 2013). The data showed a decline in IgG prevalence from 31% in 2007 to 24.2% 
in 2010. More interestingly, a significant (p < 0.0001) reduction over time of IgG 
seroprevalence was also observed in females of the 16-45 years age group, i.e. from 30.2% in 
2007 to 23.6%  in 2010. This decline in women of reproductive age has become evident in 
Italy since 2001: seroprevalence shifted from 48.5% in 1995 (Valcavi et al. 1995) to 31.4% in 
2001 (Vezzo et al. 2001) and to 21.4% in 2005 (De Paschale et al. 2006). This finding is also in 
agreement with the decreasing trend reported in several EU countries (Berger et al. 2009; 
Stricker et al. 2009; Hofhuis et al. 2010) as well as in the USA (Jones et al. 2007). The decline 
has been attributed to lower prevalence of Toxoplasma cysts in meat, as a result of modern 
farming systems, in combination with an increased use of frozen meat by consumers (Tenter 
et al., 2000; Diza et al., 2005; Kijlstra and Jongert 2008; Torrey and Yolken 2013). 
Risk factors for toxoplasmosis during pregnancy have been assessed in two studies conducted 
in two hospitals of Naples and Rome (Buffolano et al. 1996; Thaller et al. 2011). In the first 
study, the 12% (42/3518) of investigated women resulted recently infected (IgM+IgG 
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positive) and the 39% (380/3518) previously infected (IgG positive and IgM negative). Eating 
cured pork, raw meat and gardening resulted significantly associated with IgM positivity.  
Tissue cysts are reported to be inactivated after curing meat with more than 10% added salt 
and sucrose and at a temperature of conservation between 18°C and 22°C (Lunden and Uggla 
1992); however homemade cured pork products prepared following traditional recipes 
usually contain low concentrated salt solutions (<1%), are stored at less than 12°C and are 
often eaten within 10 days of slaughter (Buffolano et al. 1996). These conditions do not assure 
the inactivation of tissue cysts in the meat. Furthermore, these products are often prepared 
with meat from farm animals kept outdoors together with internal organs, as livers or kidney, 
which contain tissue cysts. The consumption of homemade cured pork preparation, together 
with gardening and eating raw meat,  resulted to be the most likely source of infection for 
primarily infected (4.8%; 113/2356) pregnant women also in the study conducted in the 
Rome district (Thaller et al. 2011). These findings clearly suggest that if susceptible pregnant 
women avoid eating cured pork or raw meat, the risk of primary infection could be reduced. It 
is, however, concerning that these habits are still well-established among Italian pregnant 
women as they reflect an inappropriate divulgation of the epidemiology of the disease and of 
the hygienic measures necessary for the prevention of infection. Guidelines for prevention of 
infection with T. gondii have been developed by the Centers for Disease Control and 
Prevention in the USA (Lopez et al. 2000) and by the EUROTOXO project (Leroy et al. 2005).  
In relation to the serious consequences of both congenital and acquired toxoplamosis, a 
widespread diffusion of this information should be provided by the National Health System 
throughout the Country, with particular attention to the rural areas and to women in 
reproductive age. Furthermore, extension of the CT monitoring system, which is solely 
running in the Campania Region, across the country, could help to define a future strategy for 
the prevention of CT (Stagni et al. 2009). 
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LABORATORY DIAGNOSTIC 
In relation to the peculiarity of its life cycle, T. gondii can be detected by direct and indirect 
methods in almost all warm blooded animals (including humans), in tissues destined to 
human consumption and in environmental samples.  The substrates of detection vary from 
serum samples, cat feces, fluids present in the thoracic cavity of aborted fetuses, tissues from 
aborted fetuses, milk, extracts of infected tissues, liquid drained from muscles after cycles of 
freezing and thawing and samples of soil or water.   
DIAGNOSIS OF TOXOPLASMOSIS IN ANIMALS 
T gondii infection in animals can be diagnosed directly by Polymerase Chain Reaction (PCR), 
mice or cell culture isolation, histology and indirectly by serological methods. Direct methods 
are considered too expensive and inadequate for routine application, as they are time 
consuming and they do not often lead to a rapid and sensitive diagnosis. Indirect serological 
tests are considered more feasible and they are largely used for surveillance and monitoring 
of Toxoplasma in animals, though standardized methods are still not available. 
DIRECT METHODS 
Isolation of the agent 
Direct isolation of live parasites is still considered the "gold standard" method for diagnosis of 
toxoplasmosis. Attempts of isolation of T. gondii are usually performed from aborted ovine 
and caprine fetuses and fetal membranes by inoculation of laboratory mice. Tissues samples 
are homogenized and then intraperitoneally inoculated in mice; in case of very virulent 
strains, tachyzoites can be detected in peritoneal fluids 3-4 day p.i, whereas the detection of 
cysts in mice brain by histological examination requires 40 days (Piergili-Fioretti 2004). 
Failure to demonstrate tissue cysts does not rule out a positive diagnosis, so serum from 
infected mice may be analyzed for the presence of antibodies against Toxoplasma; if this 
analysis is also negative, the infection is unlikely (OIE, 2008). Although mice bioassays are still 
considered the definitive method of diagnosis of T. gondii (Gutierrez et al. 2010), this method 
is labour intensive, time consuming, expensive, relies upon the submission of fresh material to 
the diagnostic laboratory and is generally impractical in diagnostic situations. 
Tissue sections 
Tachyzoites and tissue cysts can be found in tissue sections and organs fixed and stained with 
hematoxylin and eosin and immunohystochemistry. In animals that die with acute 
toxoplasmosis, focal mononuclear inflammation, with or without focal necrosis, may be seen 
in a number of tissues, including the liver, heart and lungs. In cases of abortion and stillbirth 
in sheep and goats, affected placental cotyledons typically contain large foci of coagulative 
necrosis that may have become mineralised with time (OIE, 2008). Any associated 
inflammation is characteristically slight and nonsuppurative. Well preserved samples of 
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placental cotyledons may show moderate edema of the mesenchyme of the fetal villi with a 
diffuse hypercellularity due to the presence of large mononuclear cells. Sometimes small 
numbers of intracellular and extracellular toxoplasms are visible, usually on the periphery of 
a necrotic area or in a villus that is in the early stages of infection. The Toxoplasma tachyzoites 
appear ovoid, 2–6 μm long, with nuclei that are moderately basophilic and located centrally or 
towards the posterior end; primary and secondary lesions may also develop in the fetal brain 
(OIE, 2008). Histological examinations of biological samples show a lack of reliability since the 
parasite is not evenly distributed in tissues and animals can be infected with few parasites 
(Piergili Fioretti, 2004; Cenci-Goga et al. 2011).  
PCR-based Methods 
Parasite DNA can be extracted and purified from several tissues, including tissues from 
aborted fetuses, placenta, the central nervous system, blood and fluids. The specificity of this 
test is almost 100%, but the difficulty to extract DNA and concentrate large sample quantities 
results in limited sensitivity (Alfonso et al., 2009). The main target regions are the B1 
repetitive sequence (Burg et al. 1989), the P30 (SAG1) gene (Savva et al. 1990), 18S ribosomal 
RNA (rRNA) (Ellis, 1998) and the 529 bp fragment (Homan et al. 2000). The sensitivity of the 
PCR is dependent on the copy number of the target sequence: P30 is present in 1 copy, B1 in 
35 copies, rRNA in 110 repeat units and the 529 bp fragment is repeated 200-300 fold. In 
order to improve the detection limit, both B1 gene and 18S ribosomal RNA are often amplified 
by nested PCR (Homan et al. 2000). Real time-PCR is a very sensitive and rapid technique that 
allows direct detection and quantification of the parasite in biological samples. Of the PCR 
targets described for T. gondii, the 35-copy number B1 gene and the 18S ribosomal RNA have 
been the most widely used for T. gondii diagnosis in ovine and caprine aborted fetuses and 
tissues and placenta has been identified as the main target organ of T. gondii (Hurtado et al. 
2001; Masala et al. 2003, 2007; Pereira-Bueno et al. 2004; Ahmed et al. 2008; de Moraes et al. 
2011; Moreno et al. 2012).  Recently, real-time PCRs have emerged as reliable methods of T. 
gondii diagnosis in animals (Switaj et al., 2005); this is a very sensitive and rapid technique 
that allows direct detection and quantification of the parasite in biological samples. Gutierrez 
and colleagues (2010) used a quantitative real time PCR based on 529 bp elements for 
detecting T. gondii DNA in aborted fetuses and placenta from experimentally infected sheep. 
This assay leaded to the identification of infected fetuses even when typical histological 
lesions were not detected or in cases where the fetal membranes were not available for 
submission to the laboratory. The placenta was confirmed to be the target sample, resulting 
positive from the earliest time points and having the highest levels of infection; fetal brain and 
lung resulted the samples of choice for detection of ovine toxoplasmosis when placenta was 
not available. That real-time PCR provided a valuable addition to the methods currently 
available for routine diagnosis of ovine abortions. 
Coprological Tests 
Coprological tests for the detection of oocysts in feces from naturally infected cats are of little 
significance because of the short patency (15 days). However, fecal samples from 
experimentally infected cats, e.g. following bioassay, can be processed by common flotation 
methods and by microscope examination of the oocysts (Mancianti et al. 2010).  
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INDIRECT METHODS 
In absence of a "gold standard" serological technique for detecting anti-T.gondii antibodies in 
animals, a broad range of serological methods can be used for testing animals' sera. The use of 
one technique rather than another is influenced by different factors, such as the animal 
species to be investigated, the number of samples to be tested, the experience of lab 
technicians and the availability of specific instruments. The major part of T. gondii serological 
screening published in literature involved sheep and pigs, as they are food producing animals 
where tissue cysts are most frequently observed (Tenter et al. 2000).  In particular for sheep, 
serological titre has been demonstrated strongly related to the probability of the presence of 
tissue cysts in meat samples (Opsteegh et al. 2010a); however, standardized validated 
serological tests are not currently available for correlating seropositivity to the presence of 
infective meat.  When performing a serological survey, the use of serological methods with 
high performance characteristics is of paramount importance in order to achieve a correct 
identification of infected and non infected animals.  
The Sabin-Feldman dye test (DT) is considered the most specific test for toxoplasmosis, but it 
is rarely used for the diagnosis of toxoplasmosis in animals in relation to its technical 
difficulty and to the use of live virulent tachyzoites  as antigen (Dubey 1997b).  Therefore, a 
modified agglutination test (MAT) was described by Dubey and Desmont (1987) using as 
antigen tachyzoites inactivated with formalin, instead of live ones. The limitation of MAT 
observed by Minho and colleagues in Brazil (2004) in serological screenings were the long 
incubation time (overnight) and the cost of the antigen, as MAT employs a large amount of 
formalin-treated whole tachyzoites. However, it should be considered that with MAT could be 
tested a great number of sera (96-wells plate) and the reading of the results can be performed 
directly by visual inspection without the need of specific instruments. When MAT has been 
compared to DT for detection of T. gondii infection in naturally infected sows, it resulted more 
sensitive (Se 82.9% vs 54.4%) than DT but equally specific (90.2% vs 90.8%)(Dubey et al. 
1995). Again, MAT has been evaluated, together with other serological methods, in 
comparison with DT for the diagnosis of T. gondii infection in sheep, revealing the highest Se 
(96%)(Shaapan et al. 2008). Since a commercial MAT kit is available (Toxo-Screen DA, 
bioMérieux, France), this is one of the most commonly test used today for pets and wild 
animals because it is easy, safe and does not require species-specific reagents (Cenci-Goga et 
al. 2011). The Se and Sp values claimed by the manufacturer and obtained by comparison 
with DT are 96.22% and 98.8%, respectively (Toxo-Screen DA manufacturer's instruction, 
bioMérieux, France).   
Indirect Immunofluorescence Test (IFAT) is a simple and widely used method. Whole killed 
Toxoplasma tachyzoites are first incubated with diluted test serum, then the specie-specific 
fluorescent- labeled antibodies is added and finally the results are viewed with a fluorescence 
microscope.  According to what reported in the OIE Terrestrial Manual (2008), a serum is 
defined positive when at least 80% of tachyzoites are surrounded by an unbroken band of 
green fluorescence; however, a non specific polar fluorescence in tachyzoites may affect the 
reading results. In IFAT sheep and swine sera are usually screened at 1/64 and 1/16 dilution.  
An advantage of IFAT is that not requires specific trained lab technicians, can be performed 
for several dilutions of sera in order to determine the end-point titre and can also detect IgM. 
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However, differences in the performances of the test (Se and Sp) may depend on the 
Toxoplasma strain used and on the subjectivity in interpreting the fluorescence reaction 
(EFSA, 2007; Cenci-Goga et al. 2011); furthermore, some species-specific conjugates may be 
difficult to find. Different commercial IFAT kits are available; for example, Mega Cor 
(Diagnostic, Horbranz, Austria) claims both Se and Sp > 99% for its product, but Cenci-Goga 
and colleagues (2013) could not find confirmation of this when they tested sera from 
naturally infected sheep.  Macri and colleagues (2009) compared the performances of a 
commercial MAT kit for the detection of Toxoplasma specific IgG antibodies in dog and cat 
sera using a commercial IFAT kit as reference method. MAT showed an “almost perfect” 
agreement with IFAT in detecting positive and negative results in cat sera, whereas only a 
“substantial” agreement was observed in dog sera due to false negative results. Minho and 
colleagues (2004) compared IFAT and MAT for detection of antibodies against T. gondii in 
experimentally infected pigs and these tests revealed excellent agreement in detecting 
antibodies during the infection period.  
The Enzyme-linked Immunosorbent assay (ELISA) is another test widely used for 
examination of animal sera. Ninety-six wells plates may be coated with antigens of various 
origins, e.g. soluble antigen preparation made from Toxoplasma RH strain tachyzoites (OIE, 
2008), purified tachyzoite surface antigen (SAG) (Hosseininejad et al. 2009; Tzanidakis et al. 
2012;), P-30 cuticular antigen (Berger-Schoch et al. 2011) and crude rhoptry Toxoplasma 
proteins (Garcia et al. 2006). Several ELISA kits are commercially available for detection of T. 
gondii antibodies (both IgG and IgM) in different animal species. ELISAs are suited for testing 
large numbers of samples, e.g. routine screening on farms or at slaughterhouse, but similarly 
to IFAT, require species-specific enzyme-labeled conjugate and a spectrophotometer for 
reading the results. Shaapan and colleagues (2008) evaluated the sensitivity and specificity of 
IFAT, MAT and in-house ELISA in detecting anti-Toxoplasma antibodies in sheep sera by 
comparing the results with these techniques with those of DT, considered as a reference test; 
MAT had the highest sensitivity (96%), followed by ELISA (90.1%) and IFAT, which 
demonstrated the lowest sensitivity (80.4%). On the other hand, IFAT had the highest 
specificity (91.4%), followed by MAT (88.9%) and ELISA (85.9%). Similarly, Garcia et al. 
(2006) evaluated performances of MAT and in-house rhoptry ELISA in experimentally 
infected pigs by comparison with IFAT: both tests resulted highly specific (100%) but ELISA 
was more sensitive (94.3%) than MAT (87%). Mainar-Jaime and Barbéran (2007) used MAT 
and ELISA for testing sheep sera, evidencing a very high degree of agreement between the two 
serological tests. 
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DIAGNOSIS OF HUMAN TOXOPLASMOSIS 
T gondii infection can be diagnosed indirectly with serological methods and directly by PCR, 
isolation (mouse inoculation or cell culture) and histology. Whereas indirect serological 
methods are widely used in immunocompetent patients, definitive diagnosis in 
immunocompromised people is mostly undertaken by direct detection of the parasite. Direct 
demonstration of the organism (mouse inoculation, cell culture, or PCR for T gondii DNA) 
from cerebrospinal fluid, blood, and urine, and ophthalmologic testing, radiological studies, 
and examination of cerebrospinal fluid could assist diagnosis of congenital disease (Montoya 
and Liesenfeld 2004). 
DIRECT METHODS 
PCR can be used for detection of T. gondii in body fluids and tissues. In particular PCR 
amplification of the 35-fold repetitive B1 gene has been successfully used to diagnose 
congenital (Grover et al. 1990) ocular (Montoya et al. 1999), cerebral and disseminated 
(Brezin et al. 1990; Dupouy-Camet et al. 1993; Mele et al. 2002) toxoplasmosis.  The use of 
molecular biology on amniotic fluid, fetal blood and peripheral maternal blood has 
revolutionized prenatal diagnosis of congenital toxoplasmosis by enabling early diagnosis 
(Piergili Fioretti 2004). Peripheral blood, cerebrospinal fluid, and urine should be considered 
for PCR examination in any newborn suspected to have congenital disease. In 
immunocompromised patients suspected to have localized or disseminated toxoplasmosis, 
performing PCR from blood (buffy coat), body fluids (including bronchoalveolar lavage or 
cerebrospinal, pleural, ascitic, peritoneal, or ocular fluids), bone-marrow aspirate, or tissues  
can be an important diagnostic aid (Montoya 2002). However, a positive result of brain tissue 
PCR may not differentiate between a patient with toxoplasmic encephalitis and an individual 
with different brain pathology but who is chronically infected (latent infection) with T gondii 
(Montoya and Liesenfeld 2004). 
Attempts of T. gondii isolation from blood or body fluids should be undertaken in case of 
suspected acute infection and for strain typing; viable parasites can be isolated by mice 
inoculation or cell cultures. Furthermore, tachyzoites can be demonstrated in tissues section 
or smears of body fluid, e.g. bronchoalveolar lavage or cerebrospinal fluid, during primary 
acute infection or reactivation of previously acquired latent infection (Montoya and Liesenfeld 
2004).   
INDIRECT METHODS 
The detection of IgM and IgG helps in differentiation of acute (IgM only or both IgM and IgG) 
or chronic infection (IgG only). In adults, IgM antibodies arise within the first week of 
infection, rapidly increase, and thereafter decline and disappear at highly variable rates. IgG 
arise within 1–2 weeks after infection and persist for the lifetime of an individual (Montoya 
and Liesenfeld 2004). Detection of IgG antibodies to T gondii should be done in pregnant 
women and immunocompromised patients in order to identify women at risk and patients at 
risk for reactivation of a latent infection, respectively.  The Sabin-Feldman dye test, 
immunofluorescent antibody test, ELISA, IgG avidity test, and agglutination and differential 
agglutination test can be used for detection of IgG antibodies (Montoya and Liesenfeld 2004).. 
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The Sabin-Feldman dye test is the so called "gold standard" serological test for detection of 
anti- T. gondii antibodies in humans (EFSA, 2007); it is based on the inability of tachyzoites to 
absorb the dye when, tested with anti-Toxoplasma anti-serum, the immunocomplex has been 
formed. Both sensitivity and specificity of the test are high, but the method requires live 
tachyzoites, is expensive and needs specialized laboratory and equipment (Cenci-Goga et al. 
2011). Immunoenzymatic methods (ELISA) are available for the detection of IgG and IgM and 
also for testing the avidity (functional affinity) of IgG antibodies in pregnant women in order 
to discriminate between recently acquired infection and those obtained in the more distant 
past (Hedman et al. 1989). Presence of high avidity antibodies essentially rules out a recently 
acquired infection (e.g. in the last past 3–4 months) whereas low avidity antibodies are 
indicative of an old acquired infection. For diagnosis of congenital infection in newborns, the 
IgM immunosorbent agglutination assay (ISAGA) is frequently used in relation to its high 
sensitivity and specificity (Desmonts et al. 1981). Detection of IgG antibodies in the newborn’s 
serum could be attributed to congenital infection as well as to the passage of mother’s 
antibodies through colostrum. Therefore, testing for IgM and IgA antibodies will help in 
identifying congenitally infected babies (Decoster et al. 1991). In babies resulted IgG positive 
but IgM and IgA negative, the use of IgG/IgM western blots of mother-infant pairs can prove 
useful (Pinon et al. 2001). In case of maternally transferred IgG, antibodies usually decline and 
disappear within 6–12 months.  
Access ® Toxo IgG and IgM (Beckman Coulter Inc., USA), Radim Toxo IgG and IgM (Radim, 
Pomezia, ROMA), Toxo IgG avidity (TechnoGenetic- Bouty company-Sesto San Giovanni, 
Milano BEIA) are serological kits that have been utilized in recent Italian epidemiological 
studies (Mosti et al. 2013; Thaller et al. 2011).  
METHODS OF Toxoplasma DETECTION IN FOOD AND WATER  
MEAT 
Risk-factor analysis indicats that 30 to 63% of human infections can be attributed to the 
consumption of undercooked meat (Cook et al. 2000). Besides pre-harvest food safety 
measure-s to apply for monitoring Toxoplasma infection in food-producing animals, post- 
harvest strategies at slaughter and during food processing have become more and more 
important in recent years. However, there is no general agreement among test to be used, no 
reference materials and no laboratory certification programs for monitoring the parasite 
burden in meat destined to human consumption (Kijlstra and Jongert 2008). Thus, the "gold 
standard method" for determining the infectivity of meat samples is still considered bioassays 
using either mice or cats (Kijlstra and Jongert 2008). As sentenced above, bioassays are 
laborious, time consuming and cannot be used for testing large numbers of samples. 
Therefore, PCR based methods to detect T. gondii in meat samples have been developed but 
they resulted to be less sensitivity in comparison to bioassays (da Silva and Langoni 2001; 
Garcia et al. 2006). This is mainly related to the inhomogeneous distribution of tissue cysts in 
combination with the small size of the sample analyzed; in fact for PCR analysis, DNA is 
usually isolated from 50mg of samples whereas in bioassays 50 to 500 g of meat samples are 
fed to a cat or inoculated into mice after artificial digestion. In 2010a, Opsteegh and colleagues 
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developed a PCR-based method that can be used as an alternative to the bioassay in 
quantitative screening of large number of meat samples; this method combines 
homogenization of a large sample with specific magnetic capture of T. gondii DNA. This 
magnetic capture real- time PCR resulted comparable in terms of sensitivity to bioassay for 
experimentally infected pigs' tissues. Furthermore, when PCR results of seropositive sheep 
meat samples have been compared to ELISA results, antibody concentration resulted strongly 
correlated to the probability of a positive PCR from meat and, consequently, to the presence of 
infective parasite. The correlation between the presence of tissue cysts and antibodies against 
T. gondii has been shown also by Dubey et al. (2008) in lambs.  
An innovative matrix that it is used at the slaughterhouse for the identification of T. gondii 
positive carcasses is muscle fluids or meat juice samples. Meat juice samples are obtained 
after a cycle of freezing and thawing from meat samples (usually 25 g of diaphragms or 
hearts) collected at the slaughterhouse. Monitoring programs based on muscle fluid serology 
have been successfully implemented for Salmonella (Mousing et al. 1997), Trichinella (Nockler 
et al. 2005) and Aujesky virus (Le Potier et al. 1998) diagnosis in slaughtered pigs. Numerous 
serological studies compared results obtained testing serum samples and meat juice collected 
from the same slaughtered sheep or pig in order to find out the reliability of muscle fluids for 
detecting anti-Toxoplasma antibodies and for identifying infected animals (Wingstrand et al. 
1997; Lunden et al.2002; Halos et al.2010; Berger-Schoch et al. 2011; Villena et al.2012; 
Ranucci et al. 2012). In Sweden, the correlation between the 2 types of samples tested by 
ELISA was found to be excellent in pigs (Wingstrand et al. 1997; Lunden et al.2002). In Italy, 
the average concordance between serum and meat juice from finishing pigs tested by IFAT 
was substantial (Ranucci et al. 2012). Also Villena et al. (2012) in France found a substantial 
agreement between ELISA results on diaphragm fluids and MAT on heart fluids from 
slaughter sheep, confirming that this matrix can be considered relevant for surveys of 
toxoplasmosis seroprevalence in meat. In order to improve the performance characteristics of 
serology methods when testing meat juice samples, Mecca and colleagues (2011) proposed to 
adjust fluids testing dilution in relation to their blood content.; this solution resulted indeed in 
a decreased number of false negative meat juice samples, demonstrating that reactivity of 
meat juice samples is dependent on the blood concentration of the tissue. Interestingly, 
Villena et al. (2012), in samples from slaughtered sheep, found a significant correlation 
between increasing MAT titres from muscle fluids and the probability of isolating live 
parasites from the heart. This finding is in accord to what reported by Dubey and colleagues 
(2008) in lambs and by Opsteegh and colleagues (2010a) in sheep, suggesting that consuming 
undercooked meat from seropositive sheep may pose a real risk to consumers.  
These results on muscle fluids are promising; however, further studies investigating the 
correlation of meat juice results and infectivity of the meat are needed in order to evaluate the 
future application of muscle fluids serology for the identification of "Toxoplasma free" meat 
products (Mecca et al. 2011).  
MILK 
The excretion of Toxoplasma in milk can be evidenced by a bioassay using cat and mice, by cell 
line cultivation, by capture ELISA and by PCR (Dehkordi et al. 2013). Similarly to what 
reported for meat, the "gold standard" methods for determining the infectivity of milk and 
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dairy products are still bioassays or cell line cultures. Detection of T. gondii DNA is only 
indicative of the presence of parasite without giving any certain information on infectivity and 
on the risk posed to consumers.   
WATER 
The directive 98/83/CE on the quality of water for human consumption does not contain 
specific regulatory measures for water in regard to contamination with Toxoplasma oocysts. 
Therefore, no standardized methods are available. The main difficulty is represented by the 
recovery of oocysts from large volumes of water. Methodologies published in literature are 
based on the experience gained from other coccidians such as Cryptosporidium and involve 
concentration of oocysts using filtration of large volumes, centrifugation or flocculation of the 
samples (Karanis et al. 2013). Direct identification of T. gondii by microscopy is not reliable 
due to a high resemblance with oocysts from other coccidian species. Therefore, PCR based 
methods are commonly used for detecting the presence of T. gondii DNA in concentrated 
water samples (Villena et al. 2004; Kourenti and Karanis 2006). To date, the only method able 
to show the presence of infective material in water samples is represented again by mouse 
bioassay; however, scientists are working on the development of a quantitative reverse 
transcription PCR method to differentiate between viable and nonviable oocysts detected in 
environmental samples (Karanis et al. 2013). 
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PREFACE 
Emilia-Romagna (E-R) region owns 1.17% and 1.13% of the Italian sheep and goat stock, 
respectively (www.istat.it), for a total of more than 86.000 heads kept in 3331 flocks 
(http://www.izs.it/IZS). Forli-Cesena and Bologna are the regional districts with the highest 
concentration of ovicaprine heads, owning, respectively, more than 23.000 and 13.000 
animals (http://www.izs.it/IZS). According to the number of animals reared, ovicaprine farms 
can be classified (Cortini, 1999) as: “in backyard” (1-20 animals), semi-professional (50-100 
animals) and professional (more than 100 animals); farms holding 1-5 animals are registered 
for self-consumption and don't have the permission to sell either meat or dairy products.  
From the analysis of the OviCaprine National Registry (http://www.izs.it/IZS), in E-R region 
backyard and semi-professional farms are the most widespread (94.5%; 3150/3331) with 
44% (1400/3150) that are registered for self-consumption; professional holdings represent 
only 4% of the total (5.4%; 181/3733). Forty-nine per cent (49.3%; 1643/3331) of the flocks 
are registered for meat production whereas dairy flocks are only the 4.6% (154/3331) of the 
total.  The 88.7% of meat producing ovicaprine farms are “in backyard” whereas the 55% 
(85/154) of milk producing flocks owns more than 100 animals. Throughout the region, 
intensive management (65%; 2161/3331) is more widespread than extensive and only 4 
flocks are transhumant ones (0.4%; 4/3331). 
In 2011 the E-R territory has been recognized as having an official ovicaprine brucellosis-free 
status (Deliberazione della Giunta Regionale 27/06/2011, n. 917); since then, according to 
European guidelines, the routine serological controls on the flocks are performed on a 
biennial frequency. The laboratory assigned to the regional serological screening is the 
Laboratory of Serology of the Istituto Zooprofilattico Sperimentale of the Lombardy and 
Emilia-Romagna (IZSLER), Bologna section. Thus, all the ovicaprine sera collected by 
Veterinary Officers from each flock of the regional territory are sent to this center; the only 
exception is represented by Piacenza district, which send samples to the central section of the 
IZSLER, in Brescia. Thanks to collaborations between the Laboratory of Parasitology of the 
Department of Veterinary Medical Sciences and the IZSLER, Bologna section, it has been 
possible to have access to the remainder of the ovicaprine serum samples after the serological 
screening for brucellosis.  
The aim of this collaboration was to collect sera from animals from all the regional districts 
and, among them, to select a statistically significant number of flocks to test for the presence 
of anti-T.gondii antibodies in order to have, for the first time, data on the prevalence of the 
infection in sheep and goats of the E-R region.  
Between October 2012 and January 2013, a total of 6026 ovicaprine sera representing 504 
flocks have been collected and stored at -20°C; from each flock 50% of sera have been 
sampled. Of the 504 flocks, 189 were from Forli-Cesena, 92 from Bologna, 52 from Modena, 44 
from Parma, 40 from Reggio-Emilia, 39 from Ravenna, 33 from Rimini and 17 from Ferrara 
district. Since previous information on T. gondii prevalence was not available for the 
calculation of a valid statistical sample set of flocks, we considered a 50% expected 
prevalence, a confidence level of 95% and an accepted error of 5%; using a web sample size 
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calculator (RaoSoft Inc.) the sample size was calculated as 345 flocks, from which all collected 
serum samples should be tested.  The sample size of flocks (345) to be tested was then 
stratified by districts, according to the proportion of flocks in each district, as reported in 
Table 1. 
 
Table 1 Summary of flocks present and number of flocks to be tested for each district 
DISTRICT 
N° OVICAPRINE 
FLOCKS PRESENT IN 
EACH DISTRICT 
(2012) 
RELATIVE 
PERCENTAGE (%) 
N° OVICAPRINE 
FLOCKS TO BE 
TESTED 
Forli-Cesena 725 23.3% 80.4 
Bologna 673 21.6% 74.5 
Modena 379 12.2% 42.1 
Reggio Emilia 339 10.9% 37.6 
Parma 315 10.1% 34.8 
Rimini 303 9.7% 33.5 
Ravenna 264 8.5% 29.3 
Ferrara 115 3.7% 12.8 
Total (w/o Piacenza) 3113 100 345 
 
Due to the high number of samples, we decided to use a rapid, easy and economic serological 
method for the screening. Thus, we firstly worked on the development of an in-house indirect 
ELISA for the detection of antibodies against T. gondii in sheep and goats sera. Even if 
serological seropositivity of meat-producing animals does not necessarily reflect the risk that 
those animals pose for their consumers, it has been recently demonstrated that in sheep, the 
antibody concentration was strongly related to the probability of the presence of tissue cysts 
in meat samples. This suggested that serological screening can be used as a tool for estimating 
the number of seropositive animals which are likely to harbor tissue cysts. In light of this, we 
used this in-house ELISA for testing a batch of sheep sera collected in the Forli-Cesena district, 
in order to evaluate not only of the distribution of infection in sheep flocks of the Emilia-
Romagna region, but also the risk for humans to acquire the infection by consumption of 
undercooked mutton.   
Fig.1 Concentration of ovicaprine herds in each district (%)
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MATERIALS AND METHODS 
DEVELOPMENT AND VALIDATION OF AN INDIRECT ENZYME-
LINKED IMMUNOSORBENT ASSAY FOR THE DETECTION OF T. 
gondii ANTIBODIES IN SHEEP AND GOATS' SERUM SAMPLES    
1. Reference sera 
Flock 1. In December 2011, 104 serum samples were collected from a sheep dairy flock 
located in Palesio, Bologna's district. All the animals were older than 6 months. This flock has 
been chosen as no prophylactic measures were adopted for preventing the transmission of 
the infection to sheep, i.e. a population of cats was steadily present on the farm and have free 
access to feed store and to pastures. Sheep were kept indoors during the winter season and on 
the pasture during spring-summer.   
Flock 2. In 2012, two-hundred and forty-four serum samples were collected from a dairy 
flock located in Forli-Cesena district. The flock was composed of more than 600 animals that 
were kept under intensive management conditions. No further information on the 
management conditions was available.  
All 348 reference sera were primarily tested by Indirect Immunofluroescence Antibody Assay 
(IFAT) and then used in different steps of the ELISA validation process. 
2. Indirect immunofluorescence antibody assay (IFAT) 
IFAT was performed using slides spotted with whole RH strain tachyzoites (Mega Cor 
Diagnostic, Horbranz, Austria) as antigen and fluorescein isothiocyanate-labelled rabbit anti-
sheep IgG (whole molecule, KPL, Gaithersburg, Maryland, USA) diluted 1:20 in PBS plus 1% 
Evan's blue, as conjugate.  Sera were screened at a dilution of 1:64 (cut-off) as recommended 
in guidelines of the OIE (2008); positive sera from Flock 1 were serially diluted two-fold to 
define the end-point titre, i.e. the highest dilution of serum that still gave a positive reaction. 
Positive and negative controls were included in each assay and the slides were examined 
under a fluorescence microscope at 400X magnification (Diaplan Microscope, Leitz, Milan, 
Italy). A non specific polar fluorescence (green fluorescent cap at the parasite pole) may be 
present, therefore only a bright, linear, peripheral fluorescence of the tachyzoites was 
considered as positive.  
Although the manufacturer claimed both Sensitivity (Se) and Specificity (Sp) to be >99%, we 
adopted a Se = 80.4% and Sp = 91.4%, according to what had been reported by other authors 
(Shaapan et al. 2008; Cenci-Goga et al. 2013) for calculation of the true prevalence (TP) from 
apparent prevalence (AP). The formula used was the following (Rogan and Gladen 1978): 
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3. In-house indirect enzyme-linked immunosorbent assay (ELISA) 
3.1 Process of assay validation 
According to Jacobson (1998), the development and validation of our in-house indirect ELISA 
assay followed these steps: 
 determination of the antigen;  
 determination of the control serum; 
 determination of the reagents; 
 optimization and standardization of reagents and protocols; 
 determination of the performance characteristics of the assays. 
 
3.1.1. Antigen. We used the water-soluble antigen fraction of T. gondii tachyzoites of the S48 
strain that was kindly provided by the Moredun Research Institute (Edinburgh, Scotland). The 
stock protein concentration was 2.6 mg/ml.  
3.1.2. Sheep and goats serum controls. Five sheep sera, selected among samples from Flock 
1, have been selected on the basis of IFAT results, i.e. three positive serum samples (2 with 
titer 512 and 1 with titer 256) and two negative samples. A T. gondii positive goat sera sample 
was kindly provided by Professor Francesca Mancianti from the Faculty of Veterinary of Pisa's 
University; the sample tested positive in Indirect Immnofluorescence Antibody test with an 
antibody titre ≥512. 
3.1.3. Reagents. Donkey anti-sheep IgG and rabbit anti-goat IgG labeled with horseradish 
peroxidase (HRP) were used as enzyme-antibody conjugate and the Sure Blue TMB was used 
as substrate (Table 1). Donkey anti-sheep conjugate have been tested against goat positive 
control in order to evidence cross reactivity with goat IgG.   The TMB substrate is a ready to 
use solution that develops a deep blue soluble product when reacts with horseradish 
peroxidase labeled conjugates. The substrate reaction was stopped by adding of 2M H2SO4.  
3.1.4. Optimization of reagents and protocol. Optimal dilutions for ELISAs were 
established using checkerboard titrations with different dilutions of antigen, sera and HRP-
conjugate (Fig.1). Antigen was diluted in bicarbonate buffer (Table 2) and tested at 1:500, 1: 
1000 and 1:2000 dilutions. Flat-bottom Greiner Medium binding 96-wells plates (cat n° 
655001) were coated with 100 µl/well of diluted antigen by overnight incubation at 4°C. 
Unoccupied hydrophobic sites on the coated wells were blocked by the addition of 250 
µl/well of blocking buffer (PBS/1%BSA, Table 2). Serum samples were tested at the dilution 
of 1:100 and 1:200 in PBS/0.05%Tween20/1%BSA (Table 2); 100 µl of diluted serum was 
added to each well in duplicates and incubated at 37°C for 1 hour. HRP-conjugate was tested 
at the dilution of 1:5000, 1:6000, 1:7000 and 1:8000 in PBS/0.05%Tween20/1%BSA and 
incubated at 37°C for 1 hour. In order to test nonspecific binding of enzyme conjugate and the 
stability of the substrate, two samples without serum, where the analyte only and where the 
analyte as well as the enzyme-conjugate were substituted with dilution buffer respectively, 
were included on each plate. The Sure Blue TMB substrate was added (100 µl per well) and its 
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incubation time was evaluated monitoring the OD values of the samples at 650nm using a 
microplate reader (Multiscan EX version 1.1, Labsystems, DASIT, Milan, IT). The substrate 
reaction was stopped by the addition of 100 µl of 2M H2SO4 when OD values of the positive 
controls were ≥ 0.60. At the end of each incubation step, with the exception of TMB 
incubation, the excess reactants were washed away by washing each plate 4 times with the 
wash buffer (PBS/1%BSA, Table 2) (Table 2). The wash buffer was dispensed as 250 µl per 
well by multichannel pipette and plates were allowed 2 minutes to soak with buffers for the 
disruption of low affinity nonspecific interactions. The excess buffer was tapped out by 
banging the plate upside down on dry paper towels.  The combination of dilutions that 
achieved the maximum spread in activity between negative and high positive samples, with a 
minimal background activity, was considered as optimal.  
 
Fig. 1 Checkerboard titrations' template 
 
 
 
 
 
Table 2 List of reagents used 
 
 
 
REAGENT  
Enzyme-antibody conjugate Horse Radish Peroxidase labeled Donkey 
anti-sheep IgG (Sigma Aldrich, A3415) 
Substrate Sure Blue TMB (KPL,  52-00-02) 
Stop solution 2M H2SO4 
Bovine Serum Albumine (BSA) Sigma Aldrich (A7906_10G) 
Tween 20 Sigma Aldrich (P1379-500) 
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Table 3 Composition of buffers and dilutors used 
 
3.1.5. Standardization of the protocol. Preliminary evidence of repeatability was obtained 
by evaluating results from four replicates of each control sample within each plate (intraplate 
variation) and between plates (interplate variation), on four different occasions. For the 
evaluation of both intraplates and interplates results, coefficients of variation (CV), i.e. 
standard deviation of replicates divided by mean of replicates, were calculated. Raw 
absorbance values were used at this stage of validation. CV with values less than 20% 
indicated adequate repeatability at this stage. If excessive variation (CV >30%) was evidenced 
for the majority of samples within and/or between runs, a backward step to the optimization 
of the conditions was performed.  
3.1.6. Validation of the ELISA for sheep sera 
The determination of ELISA's performance characteristics, i.e. the determination of cut-off 
and DSe/DSp, was performed by testing a panel of sheep sera and analyzing the results with 
two different statistical methods.  Thus, the indirect ELISA was evaluated first by comparison 
with IFAT, i.e. the cut-off point was calculated using IFAT results of the panel of reference sera 
of known reactivity; for this ELISA's DSe and DSp values were called relative values. Secondly, 
BUFFER/DILUTOR NAME COMPOSITION 
Coating Buffer Bicarbonate buffer 
Na2CO3                   1.59g 
NaHCO3                  2.93g 
deionized water  1000ml 
pH 9.6 
Blocking buffer 
PBS/1%BSA 
 
 
NaCl                         7.650 g 
Na2HPO4                 0.724 g 
KH2PO4                   0.210 g 
Deionized water 1000ml 
BSA                          1g 
Serum and conjugate diluents 
PBS/0.05%Tween20/ 
1%BSA 
 
NaCl                         7.650g 
Na2HPO4                 0.724g 
KH2PO4                   0.210g 
Deionized water 1000ml 
Tween 20               0.5 ml 
BSA                          1g 
Wash Buffer PBS/0.05%Tween 20 
NaCl                         7.650g 
Na2HPO4                 0.724g 
KH2PO4                   0.210g 
Deionized water 1000ml 
Tween 20               0.5 ml 
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the cut-off point was calculated on a statistical basis, i.e. fitting a binary mixture model based 
on the frequency distributions of the ELISA results. 
3.1.6.1 Comparative serology  
A panel of known infected and uninfected sera was necessary for validating the ELISA by 
comparison with IFAT. The number of sera has been calculated within statistically defined 
limits, using the following formula (Jacobson 1998): 
  
                                
  
 
n is the number of known infected and uninfected animals; DSe is the worst case assumption 
of ELISA diagnostic sensitivity (and DSp the worst case assumption of ELISA diagnostic 
specificity); c is the confidence interval for the estimate; e is the percentage of error, 
expressed as decimal.  
Estimating an 88% of DSe and a 90% of DSp with a 95% confidence interval and ±5% of error 
allowed the number of known infected and uninfected animals required was 162 and 138, 
respectively, for a total of 300 samples. A total of 318 sera were selected from Flock 1 and 
Flock 2 based on the IFAT results, i.e. 178 infected and 140 uninfected sera. ELISAs were 
performed following the optimized protocol; raw OD-values were corrected first for blank 
measurement, i.e. the average OD-value for blank controls on a plate was subtracted from the 
OD-values of the sera on that plate.  Then blank-corrected OD values were normalized 
calculating for each sample (ODx) a standardized blank corrected OD value using the formula 
proposed by Lind et al. (1997): 
    
   OD corr = [OD (x) - OD (N1)] x                 / OD (P1) +               
where OD (P1) and OD(N1) are the blank-corrected OD values obtained on the actual plate for 
serum P1 and N1 and                 and                are the means OD-values obtained  for the  P1 and 
N1 at the end of the experiment (16 plates), respectively.  A plate was retested if the CV of 
duplicates of control sera (P1 and N1) was >20%. Individual sera were retested if CV was 
above 20% (Opsteegh et al. 2010). Raw OD-values have been corrected by blank substraction 
and normalized as described above. Since antibody titers are usually lognormally distributed 
(Jacobson 1998; Thrusfield, 2005), ODc-values were log-transformed; then the frequency 
distribution of the log transformed ODc- values was calculated in order to test if the 
population was normally distributed, i.e. to confirm the presence of two components, one for 
seropositive and one for seronegative animals. To assess performance of the ELISA test, the 
cut-off point, and following DSe and DSp, have been calculated generating a ROC curve using 
IFAT test as criterion-reference standard (XLSTAT data analysis and statistical application for 
Microsoft Excel®; Addinsoft). In the ROC curve analysis, sensitivity and specificity are 
computed across all the possible threshold values and the optimal cut-off value is the logODc-
value at which the number of animals scored correctly is maximized (Greiner et al. 2000). For 
measuring the discriminatory power of the ELISA, the area under the curve (AUC) for the 
ROC-curve has been calculated. The closer the curve is located to upper-left hand corner, the 
larger is the area under the curve and the better the test can discriminate between diseased 
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and non-diseased (Greiner et al. 2000).  Since the AUC can have any value between 0 and 1, 
the relationship between the area under the ROC curve and the diagnostic accuracy was 
evaluated according to Swets (1988): AUC≤0.5 test non-informative; 0.5<AUC<0.7 less 
accurate tests; 0.7<AUC<0.9 moderately accurate tests; 0.9<AUC<1 highly accurate tests; 
AUC=1 perfect test.  The degree of agreement between the results from the 2 tests was 
quantified using κ statistic. The strength of the agreement for the kappa coefficient was 
evaluated as follows: ≤0 = poor; 0.01–0.20 = slight; 0.21–0.40 = fair; 0.41– 0.60 = moderate; 
0.61–0.80 = substantial; and 0.81–1.00 = almost perfect. The McNemar test was applied to the 
serological test results, and the p values were calculated. The test was considered as 
significantly different from the reference test when p < 0.05 (Dohoo et al. 2003). 
3.1.6.2 Analysis of mixture distributions: intrinsic cut-off calculation 
In order to obtain absolute values of sensitivity and specificity for the ELISA, the calculation of 
the cut-off point was based solely on the distribution analysis of the log ODc-values from the 
panel of standard sera (Jacobson, 1998). Under the assumption of a normal distribution of the 
sampled population, a binormal mixture model was fitted to the observed frequency 
distribution of the log-transformed ODc-values based on maximum likelihood in Mathematica 
(Wolfram Research, Champaign, IL, USA). The model estimated two means, two standard 
deviations and the prevalence; this estimated prevalence was equivalent to the area under the 
curve of the positive distribution divided by the total area under both curves. For the cut-off 
calculation, a ROC curve based on the distribution from the binormal mixture model was 
constructed. The optimal cut-off resulted as the log transformed ODc-value at which the DSe 
and DSp values were maximized; in addition the AUC was calculated. Standard sera were then 
classified as positive or negative based on the intrinsic cut-off. IFAT results were then deemed 
correct or incorrect relative to the ELISA, which were considered the new standard of 
comparison and IFAT performance characteristics were revaluated. McNemar's χ2-test and 
the Kappa statistic were used to test the level of agreement between the ELISA results 
obtained using the intrinsic cut-off and the IFAT. 
APPLICATION OF THE IN-HOUSE INDIRECT ELISA 
In this preliminary part of the serological survey, we focused on sheep flocks from Forli-
Cesena district.  Thus, 10 flocks were randomly selected among flocks holding more than 20 
animals, i.e. semi-professional (20-100 animals) and professional flocks (more than 100 
animals) (Cortini, 1999) and all the sera collected from each holding (50% of the total) were 
screened with the in-house indirect ELISA developed, for a total of 375 sera.  Table 4 
summarizes information on size, type of production and management system of each tested 
flock.  
Using the cut-off value determined by binormal mixture analysis, the overall and in-flock 
apparent prevalence (AP) of infection were calculated. The overall AP was calculated as the 
total of positive sera on the total of tested sera whereas the in-flock AP was calculated as 
positive sera on the total sera tested for each flock. Then, the AP was used for the estimation 
of the true prevalence (TP) using the following formula (Rogan and Gladen 1978): 
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For the statistical analysis, flocks were categorized into 3 groups according to the number of 
animals present in each: 20-50 animals, 50-100 animals, more than 100 animals. Proportions 
of positive animals were compared using the Chi-Square test (χ2); a p value of <0.05 was 
considered statistically significant. 
 
 
 
Table 4  Size, production and handling system of investigated flocks 
 
Total sheep 
present in the 
flock 
Production 
system 
Handling 
system 
N° tested sera 
1 40 MEAT EXTENSIVE 20 
2 89 MEAT INTENSIVE 45 
3 102 MEAT INTENSIVE 51 
4 29 MEAT EXTENSIVE 15 
5 261 MILK INTENSIVE 131 
6 50 BOTH INTENSIVE 25 
7 80 MEAT INTENSIVE 40 
8 23 MEAT INTENSIVE 12 
9 32 MEAT INTENSIVE 16 
10 50 MILK INTENSIVE 25 
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RESULTS 
IFAT RESULTS FROM REFERENCE SERA 
Among the 348 reference sera tested by IFAT, the overall T. gondii apparent prevalence was 
58.6% (204/348); in particular, 121 sera out 244 (49.6%) from Flock 1 and 83 out 104 
(79.8%) from Flock2 were positive for the presence of anti-T. gondii antibodies. According to 
the Rogan and Gladen estimator (TP= AP+ (0.914-1)/0.804 + (0.914 -1); Rogan and Gladen 
1978), the true prevalence was estimated to be 58.4%.  In Table 5, antibody titres of the 83 
positive sera from Flock 1 are summarized. 
DEVELOPMENT OF AN IN-HOUSE INDIRECT ELISA PROTOCOL 
Checkerboard titrations were performed in order to establish optimal dilutions for the 
antigen preparation, serum and HRP-conjugate. The combination of dilutions that achieved 
the maximum spread in activity between negative and high positive samples, with a 
minimized background activity used antigen diluted 1:1000 in bicarbonate buffer (2.6 µg/ml), 
serum sample diluted 1:200 in PBS/0.05%Tween20/1%BSA and HRP-donkey anti-sheep IgG 
diluted 1:5000 in PBS/0.05%Tween20/1%BSA. Since the background signal did not decrease 
beyond an OD value of 0.055, a further washing with 250 µl/well of PBS was included; in this 
way, the background signal decreased to an OD value of 0.04. The incubation time of the 
substrate, monitored by reading of the plates at 650nm, ranged from 5 to 7minutes, in 
relation to the laboratory conditions, i.e. shorter with higher room temperatures (>25°C) and 
longer with cooler temperature (≤23°C). The donkey anti-sheep IgG conjugate showed a 
strong cross-reaction with goat IgG as no great differences in OD values were observed when 
goat positive control were tested with anti-sheep (OD 1.2) or anti-goat conjugate (OD 1.3). 
The optimized in-house indirect ELISA protocol is reported below.  
In-house indirect ELISA protocol.  
Coat a 96-well plate with 100 µl/well of 2.6 µg/ml solubilized T. gondii RH-antigen diluted in 
bicarbonate buffer (Table2) and incubate overnight at 4°C. Wash the plate 4 times with 
washing buffer (250 µl/well PBS/0.05% Tween20), one time with PBS (250 µl/ well) and tap 
dry. Block non specific binding sites by incubation for 1 h at 37°C with 250 µl/well of PBS/1% 
BSA (Table 2) and wash. Dilute sera 1:200 in 1%BSA/PBS/0.05% Tween 20 and add the 
dilutions in duplicate (100 µl/well) to the plate. Incubate the plate for 1h at 37°C and wash; 
add 100 µl/well of 1:5000 diluted (1%BSA/PBS/0.05% Tween 20) HRP-labeled conjugate and 
incubate the plate 1h at 37°C. After washing, reveal the peroxidase activity by adding 100 
µl/well of substrate and incubate the plate at room temperature. Monitor OD value of positive 
control by reading at 650 nm. Stop the reaction by adding 100 µl/well of 2M H2SO4 when OD 
values of the positive control is ≥ 0.6 (5-7 minutes). Leave the plate to equilibrate in the dark 
for 5 minutes and then read at 450 nm by using a spectrophotometer. Include on each plate 
one positive (P1) and one negative (N1) serum control diluted 1:200 next to two serum blank 
samples. In the serum addition step, substitute the analyte with dilution buffer 
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(1%BSA/PBS/0.05% Tween 20) in both blank wells and in the enzyme-conjugate addition 
step, in one blank serum samples substitute the conjugate with dilution buffer 
(1%BSA/PBS/0.05% Tween 20). Correct raw OD-values first for blank measurement, i.e. 
subtract the average OD-value for blank controls on the plate from the OD-values of the sera 
on that plate.  Then, normalize blank-corrected OD values by calculating for each sample 
(ODx) a standardized blank corrected OD value using the formula proposed by Lind et al. 
(1997): 
OD corr = [OD (x) - OD (N1)] x                 / OD (P1) +               
 
where OD (P1) and OD(N1) are the blank-corrected OD values obtained on the actual plate for 
serum P1 and N1 and                 and                are the means OD-values obtained  for the  P1 and 
N1 at the end of the experiment, respectively.  Retest the plate if the CV of duplicates of 
control sera (P1 and N1) is >20%. Retest individual sera if CV of duplicates is > 20% 
(Opsteegh et al. 2010B).  
Standardization of the optimized protocol 
Preliminary evidence of repeatability of the protocol was obtained by evaluating results from 
four replicates of each control sample within each plate (intraplate variation) and between 
plates (interplate variation), in four different occasions. For all control samples, intra and 
interplates coefficients of variation (CV) were <20%, indicating good reproducibility of the 
protocol. CV of all positive controls (P1-P4) were lower (<10%) compared to CV of negative 
controls (N1-N2 <20%). Average OD values trend from each control sample is shown in 
Graph1.   
Graph  1. Average OD values trend from each control sample run in four different occasions   
 
ELISA evaluation by comparison with IFAT 
The logODc-values frequency distribution of the 318 standard sera clearly showed two 
components (Graph 2). Assessment of the ROC curve showed an AUC = 0,968 relative to the 
ELISA (Graph 3); this is very close to an AUC of 1, which indicates a perfect test (Swets 1988). 
The ROC analysis showed an optimal cutoff point at logODc-value -0.292 and at this point the 
estimate of sensitivity and specificity was 91% and 97.9%, respectively. Since these values are 
obtained by comparison with IFAT, they are considered relative values. Using this cut-off 
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point, 166 samples (52.2%) were scored as positive and 152 as negative with the ELISA.  
From the comparison of the two assays, using IFAT as reference, 20 samples gave discordant 
results, i.e. 4 resulted false positive and 16 false negative in ELISA (Table 6). McNemar test 
showed that results obtained by both techniques were significantly different (p<0.000); 
estimated κ value indicated an "almost perfect agreement" between the two tests (κ=0.874).    
Table 5 Contingency table considering IFAT as reference test 
 
ELISA 
IFAT (Reference) 
 POSITIVE NEGATIVE Total 
POSITIVE 162 4 166 
NEGATIVE 16 136 152 
Total 178 140 318 
 
 
 
 
Graph  2 Frequency distribution of ELISA logODc-values of standard sera. The vertical line indicates the 
optimal cut-off value calculated by comparison with IFAT using ROC-curve analysis 
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Graph  3 ROC curve for T. gondii ELISA calculated using IFAT  test as criterion-reference standard  
 
Analysis of mixture distributions 
From the binormal mixture analysis (Graph. 4), the optimal intrinsic cut-off was estimated at 
a logODc-value -0.157 and at this point ELISA sensitivity was estimated at 99.4% and 
specificity at 99.8%. ROC-curve analysis revealed a very good discriminatory power of the 
ELISA (AUC = 0.999).  At this cut-off point, 156 sera (49%) were scored as positive and 162 as 
negative. Considering the ELISA as reference test, IFAT diagnostic performances were 
recalculated in DSe 99.3% and a DSp 85.8 % (Table 7).  Again, McNemar test revealed a 
statistical difference in results obtained with the 2 tests (P=0.000) but κ values showed an 
"almost perfect agreement" (κ=0.849) between them.  
Graph 4. Frequency distribution of observed logODc values in ELISA and fitted normal distributions 
(lines). The vertical line indicates the cut-off point calculated by ROC-curve analysis based on binormal 
mixture model  
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Table 6 Contingency table considering ELISA as reference test 
 
IFAT 
 
ELISA (reference)  
POSITIVE NEGATIVE Total 
POSITIVE 155 23 178 
NEGATIVE 1 139 140 
Total 156 162 318 
  DSe=155/156=99% DSp=139/162=85.8%  
 
SEROLOGICAL ANALYSIS OF SHEEP FROM FORLI-CESENA DISTRICT 
Both overall apparent and true prevalence for T. gondii in sheep from Forli-Cesena district 
was estimated at 41.9% (157/375). All the investigated flocks harbored at least one positive 
animal (100%). The in-flocks prevalence values (both apparent and true) ranged from 4% 
(1/25) to 60.3% (79/131); six flocks had more than 30% seropositive animals (Table 8).  
Seroprevalence increased together with herd size, from 25.4% (15/59) in herds of less than 
50 animals to 53.3% (97/182) in herds with more than 100 animals (p=0.000; χ2=20.1) 
(Table 9). Seroprevalence was higher in dairy sheep (51.9%) than in meat production ones 
(38.7%) or in two-fold aptitude sheep (4%) (p=0.000; χ2=22.03) (Table 10).  
Table 7 In-flocks T. gondii prevalence.  
 Total sheep 
present in 
each flock 
Production 
system 
Management 
system 
N° tested 
sera 
Apparent 
prevalence 
(n°infected animals/ 
total tested) 
1 40 MEAT EXTENSIVE 20 15% (3/20) 
2 89 MEAT INTENSIVE 45 55.6% (25/45) 
3 102 MEAT INTENSIVE 51 35.3% (18/51) 
4 29 MEAT EXTENSIVE 15 46.7% (7/15) 
5 261 MILK INTENSIVE 131 60.3% (79/131) 
6 50 TWO-FOLD 
APTITUDE 
INTENSIVE 25 4% (1/25) 
7 80 MEAT INTENSIVE 39 43.6% (17/39) 
8 23 MEAT INTENSIVE 12 25% (3/12) 
9 32 MEAT INTENSIVE 16 12.5% (2/16) 
10 50 MILK INTENSIVE 25 8 % (2/25) 
 
 
Table 8 Herd size and infection with T. gondii.            Table 9 Type of production and infection with gondii   
HERD 
SIZE 
%T. gondii INFECTED ANIMALS 
(INFECTED/ALL) 
<50 25.4% (15/59) 
50-100 33.6% (45/134) 
>100 53.3% (97/182) 
PRODUCTION 
% T. gondii INFECTED ANIMALS 
(INFECTED/ALL) 
MILK 51.9% (81/156) 
MEAT 38.7%% (75/194) 
TWO-FOLD 
APTITUDE 4% (1/25) 
 
 
72 
 
DISCUSSION 
Since to our knowledge T. gondii prevalence in ovicaprine population of the Emilia-Romagna 
region has never been investigated, the aim of this study was to fill this gap. Furthermore, 
since the 50% of ovicaprine farms are registered for meat production, serological results in 
this category can also give an indication of the possible role of sheep and goat meat in human 
infections.   
Considering the high number of flocks (and relative sera) to test, we decided to first develop 
an indirect ELISA, which is a semi automated serological method that gives rapid,   objective 
results and does not require skilled personnel.  Although several commercial ELISA kits are 
available, the development of an in house ELISA is more economical but also created more 
challenges. The main issue encountered in the development process involved the optimization 
of the washing step;, it was performed by hand, in absence of an automated plate washer. 
Therefore, the excess reactants and the high and/or low-affinity interactions between 
reactants were difficult to remove and to disrupt, respectively, resulting in a high background 
signal in blank serum well (raw OD values ≥0.05). Since there are a variety of reasons for high 
background signal, e.g. instability of reactants, the inclusion of two serum blank samples on 
each plate for testing the stability of the enzyme-conjugate and of the substrate, led us to 
quickly identify the real problem, i.e. the washing step. Following the recommendations of the 
"Troubleshooting ELISA guide" (KPL, 2013), we achieved an effective washing of the plates by 
increasing the number of washing steps at each stage, from 4 to 5, and by using a buffer 
without detergent (PBS only) in the final wash. This way, raw OD values of blank serum wells 
decreased to 0.04. According to the literature, another critical factor that can affect both the 
reactivity and the reproducibility of an ELISA (Jacobson 1998; KPL, 2013) is the temperature 
at which the assay is carried out; in fact even 1°C temperature difference may result in an 
enzyme's change of activity. With regard to this, we noticed that the incubation time of the 
substrate ranged from 5 to 7 minutes in relation to a room temperature < or > 25°C, 
respectively. Thus, to avoid stopping the substrate reaction too late or too soon, we monitored 
the incubation time by reading the plates at 650 nm and we stopped the substrate reaction 
solely when OD value of the positive control at 650 nm were ≥0.6, as reported by the TMB 
Stop Solution datasheet (KPL, Gaithersburg MD, USA). This shrewdness, together with the use 
of pre-warmed reagents, led to a good reproducibility of the assay. The evidence of a strong 
cross-reaction between anti sheep-conjugate and goat IgG was not surprising since between 
these 2 species there is a well-documented interspecies cross-reactivity (Karol et al. 1978). 
Since, in our Country, sheep and goats are often raised together, future serological screening 
will be performed more easily and quickly by using a single enzyme labeled conjugate for both 
species. 
The estimates of the performance characteristics of our indirect ELISA was performed using 
two methods, i.e. by comparison with another serological method, the IFAT, and by a mixture 
distribution analysis. The first is a traditional widely used method, which considers a better-
known diagnostic test as a "gold standard", or as a "standard of comparison", for defining 
performance characteristics of the new test. In our study, IFAT has been first considered as 
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the standard of comparison and the number of infected and uninfected serum samples 
necessary for the validation of the ELISA has been selected on the basis of IFAT results. ROC 
analysis revealed a very good discriminatory power of the ELISA and, according the optimal 
cut-off point, good performance characteristics, i.e. 91% of DSe and 97.9% of DSp.  However, 
since a "gold standard" serological method for the diagnosis of T. gondii in animals is still 
lacking, each test used as the standard of comparison for evaluation of a new test is far from 
perfect as it has its own established levels of false positivity and false negativity which can be 
a source of error in estimates of diagnostic sensitivity (DSe) and specificity (DSp) of the new 
assay.  Furthermore, the estimates of DSe and DSp for the new assay are only relative 
estimates, which might be an under or over estimate (Jacobson 1998; Mainar-Jaime and 
Barberan 2007). An indication of DSe and DSp underestimation can derive when the new 
assay gives a high percentage of false positive or false negative results; in our case, 16 samples 
gave false negative results and 4 tested false positive in the ELISA. Differences in results 
between the two tests were also demonstrated by the McNemar's test (p<0.000). Considering 
that other authors reported low values of DSe (80%) and DSp (91%) for IFAT (Shaapan et al. 
2008; Cenci-Goga et al. 2013), we decided to assess the diagnostic characteristic of the ELISA 
fitting logODc- values in a binormal mixture model, since the binomial distribution of ELISA 
data was assessed previously (Graph 2), followed by a ROC curve analysis based on the 
distribution of the values. The ROC curve analysis confirmed an optimum discriminatory 
power of the ELISA (AUC=0.999) and estimates of ELISA characteristics were surprisingly 
high, i.e. DSe 99.4% and DSe 99.8%. This finding clearly confirms how estimates of diagnostic 
performances can be affected by diagnostic performances of the method used as standard of 
comparison. As suggested by Jacobson (1998), we reversed the roles of the two tests, making 
the ELISA the standard of comparison for IFAT and the relative IFAT DSe and DSp were 99% 
and 85.8%, respectively. We can ascribe the low specificity of the IFAT to the difficult 
interpretation of nonspecific fluorescence that can occur when testing hemolytic or lipid rich 
sera. In fact the main disadvantage of this serological method is the subjective reading of the 
results, since interpretation of a positive sample depends on the number of tachyzoites with 
total peripheral fluorescence per field and on the number of fields observed (Minho et al. 
2004). In our experience, we found it challenging to reach the right discrimination between 
negative sera showing nonspecific fluorescence and positive sera with a low antibody titre 
(≥64 or ≥128). Again, the McNemar's test showed a significant difference in the proportion of 
positive results between the two methods (p<0.000) but the calculated κ value was very high 
either using IFAT or ELISA as standard for the comparison; since the κ value depends on the 
prevalence of the disease in the population analyzed (Mainar-Jaime and Barberan 2007), it is 
not considered an unbiased indicator of agreement between tests (Jacobson, 1998).  
Therefore, we confirm that the analysis of mixture distributions represents a powerful 
approach for an unbiased estimation of seroprevalence, in absence of a serologic-al gold 
standard test, as previously reported (Greiner et al. 1994; Jacobson 1998; Opsteegh et al. 
2010b).  We achieved to develop an easy, good performing serological method that could 
clearly distinguish between seropositive and seronegative sera and that can be used to 
achieve the principal aim of this study, i.e. to obtain preliminary information on the 
prevalence of T. gondii infection in sheep flocks from the Forli-Cesena district, i.e. the district 
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with the highest concentration of sheep. This is the first report of the presence of the parasite 
in this area; therefore, we don't have data for comparison and for evaluating the trend of the 
disease in time.  We found an overall true seroprevalence of 41.9% and all investigated flocks 
harbored at least one seropositive animal (100%). Although these data are surprising and 
noteworthy, they have to be considered as preliminary since only 10 flocks were investigated. 
Very few studies have been conducted in Italy investigating T. gondii seroprevalence in sheep 
and goats (Rinaldi and Scala 2008); despite that, published data are difficult to compare since 
various serological assay were used and investigated animals were kept under different 
management conditions. However, the highest seroprevalence value (49.9%; 937/1876) was 
found by Vesco et al. (2007), analyzing, by a commercial ELISA, sheep sera collected in Sicily. 
Other T. gondii serological surveys have been conducted in Sardinia, Campania and Tuscany 
and the proportion of infected animals were around 30%. In particular, in Sardinia, Masala et 
al. (2003) investigated serum samples from sheep and goats by IFAT, finding a seroprevalence 
values of 28.4% (2048/7194) and 12.3% (302/2445), respectively. In Campania and in 
Tuscany, among investigated sheep, 28.8% (333/1170) (Fusco et al. 2007) and 34% 
(214/630) tested positive by  IFAT, respectively. We found that seroprevalence significantly 
increased with farm size (from 25.4% in flocks <50 animals to 53.3% in flocks) and that dairy 
sheep were more positive than meat producing sheep (p<0.000). Also Vesco et al. (2007) 
reported an increase in seroprevalence in larger flocks, whereas Cenci-Goga et al. (2013) 
found significantly higher seroprevalence values in smaller flocks. In Sicily sheep farm 
management is very uniform with all flocks are permanently kept outside, whereas in 
Tuscany small flocks are generally kept more extensively (Cenci-Goga et al. 2013). In the E-R 
region intensive management is reported to be more widespread (65%; 2161/3331; 
http://www.izs.it/IZS). However, the major parts of intensive managed small-medium size 
flocks usually have access to fenced pastures located in close proximity to the farms (semi-
intensive conditions) whereas farms with higher numbers of sheep tend to be more intensive 
(IZSLER technical group, personal communication). Various risk assessment studies 
demonstrated that extensive, intensive and/or semi-intensive conditions were statistically 
associated with the likelihood of T. gondii infection. Extensively managed flocks because 
animals may have had more exposure to cats in the environment or to contaminated stagnant 
pools (Tenter et al. 2000; Cenci-Goga et al. 2013); intensive or semi-intensive herds because 
farm facilities may provide shelter to various hosts of T. gondii (such as cats and rodents) 
which may be involved in the spread of the infection (Tzanidakis et al. 2012). Since we found 
that dairy sheep were more seropositive than meat producing ones (p<0.000) and we know 
that dairy flocks are usually larger and more intensively managed, we can suppose that 
animals kept under intensive rearing systems are more likely to acquire the infection from T. 
gondii oocysts accumulated in farm facilities. 
Although these are preliminary results that cannot be extended to all regional districts, we 
can affirm that T. gondii infection is widely distributed in sheep reared in Forli-Cesena district 
(41.9% of overall seroprevalence).  Considering that in previous studies seropositive sheep 
have been found to carry tissue cysts (Opsteegh et al. 2010a), the high seroprevalence found 
in meat producing sheep (38.7%) in this study could indicate that mutton may be an 
important source of human infection. In particular in Forli-Cesena district, the most consumed 
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mutton meat is the so called "castrato", i.e. a neutered ram of 5-12 months that is usually 
eaten grilled but not well cooked to maintain its tender texture. Since sheep tested in this 
study are >6 months old, we can make an inference about the risk of consumption of 
undercooked "castrato" meat. In fact, it has been reported that in areas with high 
seroprevalence values, the infection may occur also in young animals due to high levels of 
environmental contamination by oocysts (Vesco et al. 2007).  More detailed information on 
farms management is needed in order to assess risk factors associated with T. gondii infection 
in sheep flocks. In conclusion, when this serological survey will be completed and serum 
samples from all regional districts have been tested, it will possible to draw a detailed risk's 
map for consumers and to design strategies for reducing the prevalence of infection in 
ovicaprine flocks.  
The serological tool developed and proposed by this study, if used in a National Surveillance 
Program could provide reliable epidemiological data on T. gondii infection in small ruminants 
and provide missing information highlighted frequently by EFSA in their scientific reports 
(EFSA, 2007; EFSA, 2014). 
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PREFACE 
The waterborne transmission route of T.gondii to humans via the dissemination of oocysts 
through surface water and its epidemiological impact is now thought to be more significant 
than previously believed (Jones and Dubey 2010; Karanis et al. 2013). 
Detection of T. gondii oocysts in environmental samples (soil, water) is technically difficult 
and rapid and standardized methods for Toxoplasma oocysts separation from water are not 
available. 
Differently, standardized methods for detecting the presence of oocysts and/or cysts of other 
waterborne pathogens, such as Cryptosporidium sp. and Giardia sp., have been available for 
several years (U.S. Environmental Protection Agency, 2001). EPA Method 1623 is a 
performance-based method applicable to the determination of Cryptosporidium in aqueous 
matrices. This method is used in many EU Countries for monitoring of water supplies for the 
presence of Cryptosporidium, which is one of the most widespread protozoa that causes 
waterborne diarrheal disease outbreaks worldwide.  In the UK, Cryptosporidium represents 
the commonest protozoal cause of acute gastroenteritis, with 3000-6000 laboratory 
confirmed cases annually (Bridle et al., 2012). EPA Method 1623 requires filtration, 
immunomagnetic separation of the oocysts from the material captured, and an 
immunofluorescence assay for determination of oocyst concentrations, with confirmation 
through vital dye staining and differential interference contrast microscopy (Fig.1).  
In the absence of commercially available techniques for IMS of T. gondii oocysts, PCR is 
becoming a favored technique for the detection of T. gondii oocysts in water (Kourenti and 
Karanis, 2004, 2006; Schwab and McDevitt, 2003; Sroka et al., 2006; Villena et al., 2004) over 
the conventional mouse bioassay (Isaac-Renton et al., 1998; Villena et al., 2004). Since no 
specific PCR protocols have been developed for detecting T. gondii DNA from water samples, 
PCR protocols for the detection of T. gondii DNA in clinical specimens have been adapted to 
this matrix (Yang et al. 2009; Jones and Dubey 2010).  
The aim of this study was to investigate  the presence of T. gondii DNA in raw and finished 
water samples collected in Scotland. Scottish Water is a statutory corporation that provides 
water and sewerage services in Scotland and that, as expected by the UK monitoring program, 
monitors water supplies for the presence of Cryptosporidium utilizing the EPA method 1623.   
Since T. gondii oocysts (10 to 12 µm in diameter) are larger than Cryptosporidium oocysts (3 
to 5 µm) and they can be recovered following the EPA Method 1623, we decided to collect the 
remainder of raw and finished water samples after the IMS removal of Cryptosporidium 
oocysts by Scottish Water and to detect the presence of T.gondii DNA by PCR methods.  
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Fig. 1 EPA methods1623 
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MATERIALS AND METHODS 
COMPARISON OF DNA ISOLATION METHODS  
Nine samples of 15 ml sterile deionized water (DW) have been seeded in duplicate with a 
known number of  T. gondii oocysts (M4 strain), i.e. 2x 3 samples with 103 oocysts; 2x 3 
samples with 102 oocysts; 2x 3 samples with 10  oocysts).  All samples were centrifuged at 
1,250 x g at 4oC for 10 min in order to obtain a pellet for DNA isolation.   The volume of 15 ml 
was chosen because it simulates the maximum volume of remainder environmental water 
samples after the IMS procedure supplied by Scottish Water.  To aid rupturing Toxoplasma 
oocysts and to increase DNA yields, the pellet (obtained after centrifugation) was subjected to 
five freeze-thaw cycles. 
We tested two commercial kits for DNA isolation, in particular the Wizard ® SV Genomic DNA 
Purification System (Promega) and NucleoSpin ® Tissue kit (Macherey-Nagel).  
The first kit is designed for the isolation of DNA from tissues and cell cultures only, whereas 
the second is designed for a broader variety of starting materials like yeasts, bacteria, viruses 
or stool samples, in addition to tissues and cell cultures. Detailed descriptions of each protocol 
are shown in Table 1. 
The two methods were compared using an ITS1 n-PCR that targets the multi-copy 18S-5·8S 
rRNA internal transcribed spacer (ITS1) region of the parasite. The methodology was carried 
out as reported by (Burrells et al. 2013).  Briefly, each 20 μL reaction contained  
 2μL 10× custom PCRmix – SM0005 (45mM Tris-HCl 11mM (NH4)2SO4, 4·5mM MgCl2, 
0·113 mg mL−1 BSA, 4·4 μM EDTA and 1·0mM dATP, dATC, dGTC, dTTP – ABgene, 
Epsom, Surrey, UK);  
 0·75 units BioTaq (Bioline, London, UK); 
 0·05 μM of forward primer and reverse primers NN1, NN2, first round (Table 2); 
 2 μL DNA. 
The reaction was made to a final volume of 20 μL with DNase/RNase free water.  To improve 
the sensitivity of the technique, each reaction was carried out in triplicate at these cycling 
conditions:  
 5min at 95 °C;  
 35 cycles of 1min at 95 °C, 1min at 55 °C, 1min at 72 °C; 
 A final extension period of 5min at 72 °C. 
To reduce unused primers from the primary PCR, the first round PCR products were diluted 
1:5 with dH2O, 2 μL of the diluted product was used in the second round reaction. The 
conditions for each second round were identical to the first round, however, contained 0·05 
μM in internal forward and reverse primers NP1, NP2 (Table 2).  
Second round PCR products (10 μL) were visualized by gel electrophoresis on 2% (w/v) 
agarose gel, stained with Gel Red (Biotium, Hayward, CA, USA) and visualized under UV light. 
A sample was regarded positive if an amplicon of 227 bp was present in any triplicate 
reaction.  
 
 
81 
 
Multiple negative controls (dH2O) were included in each PCR run as well as DNA extraction 
controls; results were only accepted if these reactions were all negative. 
Table 1 Detailed description of the two DNA extraction methods tested in this study. 
Method 1: 
Wizard ® SV Genomic DNA Purification System 
(Promega) 
Method 2: 
NucleoSpin ® Tissue kit 
(Macherey-Nagel) 
 Spin down sample at 1.250g (2750 rpm) for 
10 min. 
 Resuspend pellet in 1000 µl of Nuclei Lysis 
Solution and transfer in a 2ml tube. 
 Place tube into liquid nitrogen for 10 
seconds. 
 Place in water bath at 50 °C until thawed, 
repeat 5x vortexing between stages. 
 Transfer 400 µl in a new 2ml tube. 
 Add 900 µl of the Nuclei Lysis Solution. 
 Incubate at 56 °C for 1 h and check 
 Cool to room temperature. 
 Add 300µl of the Protein Precipitation 
Solution. 
 Vortex for 20 seconds. 
 Incubate on ice for 5 minutes. 
 Spin at 13000g for 5 minutes. 
 Transfer the supernatant into a fresh 2ml 
tube with 900µl of isopropanol. 
 Mix gently by inversion. 
 Leave overnight at -20°C. 
 Centrifuge at 13000g for 5 min. 
 Remove supernatant. 
 Add 600 µl of  70% ethanol. 
 Centrifuge at 13000 g for 2 minutes (pellet 
visible). 
 Remove supernatant. 
 Centrifuge at 13000 g for 1 minute and 
remove the rest of ethanol with one fine tip. 
 Allow the pellet to dry: it is dry when the 
edges become clear, it takes about 15 
minutes, not more; over-drying will make 
difficult to resuspend the pellet. 
 Add 200µl of dH20 (adjust the volume of 
water; if you want more concentrated DNA 
100 µl of dH20) and dislodge the pellet. 
 Leave the pellet to dissolve overnight at  
4 °C. 
 
 Spin down sample at 1.250g (2750 
rpm) for 10 min and discard 
supernatant. 
 Resuspend the pellet in 400µl of Buffer 
T1 and transfer in a new tube. 
 Place tube into liquid nitrogen for 10 
seconds. 
 Place in water bath at 50 ºC until 
thawed, repeat 5x vortexing between 
stages. 
 Transfer 200 µl in a new 1.5ml tube, 
add 25µl of Proteinase K and vortex. 
 Incubate 1h at 56 °C. 
 Vortex. 
 Add 200 µl of Buffer 3, vortex and 
incubate at 70 °C for 10 min. 
 * If insoluble particles are present, spin 
down the samples at maximum speed 
for 5 min and transfer the supernatant 
in a new 1.5ml tube. Discard the pellet. 
 Add 210 µl of EtOH (100%) and vortex. 
 Place a spin column in a collection tube 
and add the whole sample (610 µl). 
 Centrifuge for 1 min at 11,000g; discard 
the flow and replace the column. 
 Add 500 µl of Buffer BW and centrifuge 
at 11,000 for 1 min. Discard the flow 
and replace the column. 
 Add 600 µl of Buffer B5, centrifuge at 
11,000g for 1 min. Discard the flow and 
replace the column. 
 Centrifuge column at 11,000 g for 1 min 
to dry the membrane (remove the 
residue of ethanol). 
 Place the column into a 1.5 ml tube and 
add 100 µl prewarmed Buffer BE 70 °C. 
 Incubate at room temperature for 
1minute. Centrifuge 1 min at 11,000 g. 
 Transfer the eluted DNA in a new tube 
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Table 2 Oligonucleotide sequences of primers used in the ITS1 n-PCR 
NAME SEQUENCE 5'-3' REFERENCE 
NN1 TCAACCTTTGAATCCAAA (Buxton et al. 2001) 
NN2 CGAGCCAAGACATCCATT  
NP1 GTGATAGTATCGAAAGGTAT (Hurtado et al. 2001) 
NP2 ACTCTCTCTCAAATGTTCCT  
 
EVALUATION OF PCR INHIBITORS IN POOLS OF RAW (RW) AND 
FINISHED WATER (FW) WITH DIFFERENT LEVELS OF TURBIDITY 
Spiked environmental samples of raw (RW) and finished (FW) water have been  analyzed in 
order to find out whether these samples contain PCR inhibitors, which have been found very 
frequently in other studies investigating the presence of T. gondii DNA  in water samples 
(Villena et al., 2004; Aubert and Villena 2009).  For showing whether inhibitors were more 
likely to be present in turbid samples than in clean ones, samples have been pooled into 3 
groups characterized by different turbidity level. The turbidity level (low, medium, high) has 
been evaluated for each sample on the basis of its colour (no colour, yellow, dark brown), its 
density (liquid or muddy) and the presence or absence of debris (Table 3).  
 
Table 3 Evaluation of turbidity level of investigating samples  
 
 
 
 
 
 
 
From each group, a 15 ml sample was seeded in duplicate with 1000, 100 and 10 T. gondii 
oocysts (M4 strain).  All samples were centrifuged at 1,250 x g at 4oC for 10 min to isolate the 
pellet and DNA extraction was performed using Method 2.  
All samples were analyzed by the ITS1 n-PCR described above and by a quantitative real-time 
PCR based on the 529-bp element, in triplicate.  Spiked samples that tested negative in the 
ITS1 n-PCR were considered to be inhibited. 
The real-time PCR targets the highly conserved 529 bp fragment that is repeated 200- to 300-
times in the genome of T .gondii (Homan et al. 2000). The reaction was adapted from 
Opsteegh et al. (2010a). The 529 bp element was amplified using Tox-9F and Toxo-11R, 
forward and reverse primers, and detected by TOX-TP1 probe; the probe was 5 'end labelled 
with 6-FAM and 3' end labelled with Black Hole Quencher (BHQ1).  Table 4 reports the 
oligonucleotide sequence of primers and probes used. 
N° 
SAMPLES 
COLOR 
PRESENCE 
OF DEBRIS 
DENSITY 
LEVEL 
OF TURBIDITY 
GROUP 
15 NO COLOR NO LIQUID LOW 1 
12 YELLOW YES LIQUID MEDIUM 2 
34 BROWN YES MUDDY HIGH 3 
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A competitive internal amplification control (CIAC) was included to enable identification of 
false negative PCR results. This control was kindly provided by the National Institute for 
Public Health and Environment (RIVM, Bilthoven, The Netherlands) where it has been 
developed amplifying a Yersinia pestis  Caf1 DNA construct (Janse et al. 2010) using 
overhanging primers constructed adding the binding sites for Tox-9F and Toxo-11R -primers 
to the 5' and 3’ end of the Y. pestis Caf1 primer sites.  
Once this PCR product arrived in our laboratory, it was re-amplified using a 20 μL reaction 
mixture containing:  
 0.07 μM Tox-9F and Tox-11R primers (see Table 2);  
 0.15 units BioTaq (Bioline, London, UK); 
 2 μL 10× custom PCR mix – SM0005 (Burrells et al. 2013); 
 2 μL DNA. 
The reaction was made to a final volume of 20 μL adding DNase/RNase free water and carried 
out at these cycling conditions: 
 9 min at 95 °C;  
 38 cycles of 30’’ at 95 °C,  30’’ at 58 °C, 45’’ at 72 °C; 
 final extension period of 10 min at 72 °C. 
The amplified product was run on a 1.5% agarose gel, stained with Gel Red (Biotium, 
Hayward, CA, USA) and visualized under UV light.  The 188 bp long product was purified 
(QIAquick Gel Extraction kit, Qiagen, Venlo, The Netherlands) and its concentration 
determined by NanoDrop-1000 spectrophotometer (Thermo Scientific, Waltham, MA). 
In the 529 bp real-time PCR, CIAC was ampliﬁed using the Tox-primers (Table 2) and detected 
by the CIAC-probe, which was 5’ end labeled with JOE and 3’ end labeled with BHQ1. Different 
concentrations of CIAC were tested in combination with different dilutions of T. gondii DNA to 
assess the optimal amount of CIAC to add to the PCR-reaction mixture.  
The addition of 0.0075 fg of CIAC to 20 μL of PCR mix did not inhibit amplification of T. gondii 
DNA and gave a consistently positive CIAC-PCR for T. gondii negative samples.  
Table 4 Oligonucleotide sequences of primers and probed using in the real-time PCR 
NAME SEQUENCE 5'-3' 5'LABEL 3' LABEL 
Tox-9F AGGAGAGATA TCAGGACTGT AG   
Tox-11R GCGTCGTCTC GTCTAGATCG   
ToxTP1 CCGGCTTGGC TGCTTTTCCT 6-FAM BHQ1 
CIAC-probe AGCGTACCAA CAAGTAATTC TGTATCGATG JOE BHQ1 
 
PCR amplification was performed in 96-wells plates using a LightCycler480 II thermal-cycler 
instrument (Roche, Almere, The Netherlands).  The 20 μl reaction mixture consisted of:  
 4 μl 5× concentrated Taqman master mix (Roche); 
 0.7 μM of each primer (Tox-9F and Tox-11R; Table 4); 
 0.05 μM of Tox-TP1 (Table 4); 
 0.2 μM of CIAC-probe (Table 4);  
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 0.0075 fg of CIAC; 
 10 μl of template DNA.  
The reaction mixture was made to final volume with DNase/RNase free water (Roche).  
The PCR protocol consisted of these conditions:  
 initial incubation at 95 °C for 10 min to activate FastStart DNA polymerase.  
 45 amplification cycles that consisted of a denaturation step at 95 °C for 1 s, an 
annealing step at 58 °C for 20 s, and an extension step at 72 °C for 20 s  
 cooled to 40 °C for 5 s. 
 The temperature transition rate was 4.40 °C/s for an increase in temperature and 2.20 °C/s 
for a decrease in temperature. Fluorescence at 530 nm (Tox-TP1) and 560 nm (CIAC-probe) 
was measured at the end of each extension step.  
A 10-fold dilutions series of T. gondii DNA was included in each run for calculation of the 
standard curve. For each sample, the fluorescence by cycle curve was used to calculate the 
fractional cycle number or crossing point (Cp) at which the second derivative was at its 
maximum (LightCycler software, Roche). All samples with a Cp value that show a smooth 
exponential-amplification curve were scored positive, all samples without a Cp value, but with 
a positive CIAC-PCR were scored as negative.  Samples without a Cp value and with a negative 
CIAC-PCR were considered inhibited.  
Inhibited samples were retested by a modified real-time quantitative PCR on 529- bp 
repetitive element where the volume of template DNA was reduced from 10 μl to 2 μl and 8 μg 
of Bovine Serum Albumine (BSA) has been added to the reaction mixture, as reported by 
Villena et al. (2004).  
No variations were made to the cycling conditions. Thus, the new 20 μl reaction mixture 
consisted of:  
 4 μl 5× concentrated Taqman master mix (Roche); 
 0.7 μM of each primer (Tox-9F and Tox-11R); 
 0.05 μM of Tox-TP1; 
 0.2 μM of CIAC-probe;  
 0.0075 fg of CIAC; 
 2 μl of template DNA; 
 8 μg of BSA.  
The reaction mixture was made to final volume with DNase/RNase free water (Roche). 
Samples were scored as positive, negative or inhibited as described above.  
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ENVIRONMENTAL MATCHED SAMPLES OF RW AND FW  
From February to June 2013, 179 matched samples of raw and finished water (358 in total) 
were collected by Scottish Water from 68 water plants located throughout Scotland and were 
analyzed for the presence of T. gondii DNA.  
With “matching samples”, we indicate one sample of raw and one sample of finished water 
collected on the same day from the same water plant before and after the purification process, 
respectively. Prior to DNA extraction, the turbidity level of each sample was evaluated, and 
recorded, as high, medium, low, according to its colour, the presence of debris and its density 
(as described above).  
From each sample, the DNA was extracted using Method 2 and the presence of T. gondii DNA 
was investigated using the original real-time quantitative PCR based on the 529- bp repetitive 
element, adapted from Opsteegh et al. (2010a). Samples were scored as positive, negative or 
inhibited and inhibited samples were retested using the modified real-time quantitative PCR 
protocol as previously in the above section. 
DATA ANALYSIS 
The data were analyzed by χ2 test using SPSS v.17.0 statistical package.  
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Graph 1 Schematization of the analysis of FW and RW environmental samples by real-time PCRs 
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RESULTS AND DISCUSSIONS  
COMPARISON OF DNA ISOLATION METHODS  
Samples of sterile deionized water (DW) were seeded with a known number of purified T. 
gondii oocysts (M4 strain) in order to test the efficiency of two different commercial DNA 
extraction kits. 
DNA extraction from T. gondii oocysts is critical, as the oocyst wall is very robust. Different 
methods have been proposed, including freeze-thawing, grinding with glass beads or 
sonication and lengthy proteinase K digestion (Dumètre & Dardé 2003). However, since there 
is no standard protocol and no optimal conditions have been identified to break open the 
oocyst wall, we chose to resuspend each sample in the lysis buffer supplied from each kit and 
to proceed with 5 freeze-thaw cycles.  
The NucleoSpin R Tissue kit (Macherey-Nagel; Method 2) proved to be more efficient showing 
a PCR success rate of 100% for the detection of 102 and 103 oocysts (Table 5). On the contrary, 
only one sample spiked with 103 oocysts tested positive in n-PCR using the Wizard SV 
Genomic DNA Purification System (Promega; Method 1). The higher efficiency of Method 2 is 
probably due to intrinsic characteristics of the kit as it is designed for isolation of DNA from 
various starting materials (including stool). Furthermore, it utilizes proteinase K digestion 
that has been shown to be very efficient by other authors (Villena et al. 2004; Aubert and 
Villena 2009); nevertheless it ensures appropriate conditions for binding of DNA to the silica 
membrane by addition of large amounts of chaotropic ions (Binding Buffer B3) and ethanol 
(Macherey-Nagel, 2012).  However, even with Method 2, no positive results were obtained for 
DW samples seeded with 10 oocysts. To our knowledge, this is the first time that the The 
NucleoSpin R Tissue kit (Macherey-Nagel) has been used for the DNA extraction from water 
samples. In other studies investigating the presence of T.gondii in water samples, the two 
methods more frequently used were the phenol-chloroform method or QIAamp mini kit 
(Kourenti and Karanis 2004, 2006; Dumétre and Dardè 2007; Jones and Dubey 2010). 
Interestingly, Yang et al. (2009) reported a high efficacy of the FastDNA spin kit for soil in 
extracting Toxoplasma DNA directly from spiked water concentrates.   
The evaluation of the most efficient method for recovering oocysts from experimentally 
spiked water samples is a preliminary step necessary before starting to analyze 
environmental water samples. The concentration of oocysts can be done through various 
procedures, such as filtration, centrifugation and flocculation (Karanis et al., 2013).   
Filtration is utilized by the U.S. EPA Method 1623 and requires the use of specific equipment, 
i.e. capsules (Envirochek TM, Pall Corporation, Ann Arbor, MI) or filters (Filta-Max® foam 
filter) suitable for filtration of large volumes of water (U.S. Environmental Protection Agency, 
2001).  Villena et al. (2004) using Envirochek™ membrane filters obtained PCR success of 
100% (10/10) and 60% (6/10) in recovering 10 and 1 oocyst per litre in spiked DW samples, 
respectively.  
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Flocculation is the concentration of oocysts with the aid of flocculants, e.g. ferric sulfate and 
aluminium sulfate; it is easy to perform, inexpensive and can be used on large volumes of 
water (Kourenti and Karanis 2004, 2006; Karanis et al. 2013). Kourenti et al. (2003) evaluated 
the recovery rate of two flocculation procedures and one centrifugation on 50 ml DW samples 
seeded with 104-105 oocysts; the flocculation was generally more successful than the 
centrifugation, with a recovery rate that approached 100%.   However, filtration is considered 
more robust than chemical flocculation for turbid water processing and for field 
investigations (Dumètre and Dardé 2003).  
We did not focus on testing different methods for concentrating oocysts from experimentally 
infected DW samples because the environmental samples analyzed later in this study had 
already been concentrated by filtration at Scottish Water's laboratories, according to the U.S. 
EPA Mehod 1623. 
As we were more interested in the evaluation of the most efficient DNA extraction method, the 
recovery of the seeded oocysts was performed by the most rapid and easiest method, i.e. the 
centrifugation of the samples. In absence of a visible pellet, this process led to the lose of 
oocysts, in particular in samples seeded with a low number of parasites and this loss affected 
the detection limit of the ITS1 n-PCR.  
Table 5 Comparison of DNA extraction methods by ITS1 n-PCR 
 
 EVALUATION OF PCR INHIBITORS IN SPIKED POOLS OF RAW 
(RW) AND FINISHED WATER (FW) WITH DIFFERENT LEVELS OF 
TURBIDITY 
The presence of PCR inhibitors and their relation to the grade of turbidity of water was 
evaluated by testing spiked environmental samples with different turbidities, using both ITS1 
n-PCR and real-time quantitative PCR based on the 529-bp element, in triplicate.  
The evaluation of the turbidity level was performed by visual inspection of the samples; this is 
a subjective method that can be affected by individual perception, especially for samples with 
N°.OOCYSTS 
/ 15 ml 
OF DW 
NO. OF POSITIVE SAMPLES IN  ITS1 N-PCR / TOTAL TESTED 
(%POSITIVE) 
DNA EXTRACTION METHOD 1 DNA EXTRACTION METHOD 2 
10 0/3 (0%) 0/3 (0%) 
10 0/3 (0%) 0/3 (0%) 
10 0/3 (0%) 0/3 (0%) 
100 0/3 (0%) 3/3 (100%) 
100 0/3 (0%) 3/3 (100%) 
100 0/3 (0%) 3/3 (100%) 
1000 1/3 (33.3%) 3/3 (100%) 
1000 0/3 (0%) 3/3 (100%) 
1000 0/3 (0%) 3/3 (100%) 
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medium turbidity levels. The official instrument for measuring the grade of turbidity of the 
water is the nephelometer which quantifies the turbidity level of water in terms of 
nephelometric turbidity units, but it is not routinely present in bio molecular laboratories.  
For samples showing low and medium turbidity level (group 1 and 2), there was no evidence 
of the presence of PCR inhibitors and both PCR methods (n-PCR and original real-time PCR) 
gave similar results, i.e. all spiked samples tested positive. All the samples with high turbidity 
levels tested positive by ITS1 n-PCR (18/18 replicates), whereas 14/18 replicates tested 
CIAC-PCR negative by the original real-time PCR (Opsteegh et al., 2010a), revealing the 
presence of PCR inhibitors (Table 6).  
Thus, these samples were retested by the modified real-time PCR developed in this study and 
all the replicates (18/18) showed Cp- values and tested CIAC-PCR positive.   
Considering the results obtained with the original real-time PCR (Opsteegh et al., 2010a), 
samples with high turbidity level contained PCR-inhibitors. The presence of PCR- inhibitors in 
water represents a common problem reported in various water studies (Rochelle et al., 1997; 
Villena et al., 2004; Kourenti and Karanis 2006; Aubert and Villena 2009). Inhibitions have 
been ascribed to humic-type materials or other non-characterized substances that co-extract 
with the DNA (Rochelle et al. 1997; Karanis et al. 2013); such substances may interfere with 
restriction endonucleases and polymerase enzyme activity such as Taq DNA polymerase 
(Tebbe and Vahjen 1993; Watson and Blackwell 2000; Tsai and Olson 1992), or lead to non-
specific binding of primers that reduce the sensitivity of detection (Tsai and Olson 1992). It is 
more likely that these substances are present in water with high turbidities (Rochelle et al., 
1997). In order to overcome this problem, it has been suggested that the DNA extracted from 
water with higher turbidities will need extra rounds of purification prior to PCR and various 
methods have been described for this purpose, as preparative agarose gel electrophoresis or 
absorption to glass particles (Rochelle et al. 1997).  To date, the addition of BSA to the 
reaction mix is considered the most effective and easiest strategy for overcoming inhibitions 
and is widely used by researchers working with water samples (Villena et al. 2004; Kourenti 
and Karanis, 2006). The BSA has the ability to prevent the uncoupling of oxidative 
phosphorylation by phenols (Weinbach and Garbus 1966a, b) and prevent inhibition from 
samples that contain plasmin or endogenous protease activity. It also has the capacity to bind 
to lipids by hydrophobic forces and to bind anions (Loomis 1974). The effectiveness of the 
BSA was also confirmed in this study, as it overcame the inhibition problem in 100% of cases.  
Also the reduction of DNA from 10 µl to 2 µl positively affected the outcome because the 
smaller the volume of template added the lower concentration PCR- inhibitors, coextracted 
with the DNA, in the final PCR. 
Although the results obtained by the ITS n-PCR and the real-time PCR were similar, we 
decided to test the environmental RW and FW samples with the 529 bp- real-time PCR. First 
of all, because by using a real-time PCR it is possible to obtain quantitative results, as the 
concentration of DNA present in the sample is calculated according to the standard curve. 
Secondly, the 529 bp-real-time PCR protocol had previously been shown to be highly effective 
in detecting T. gondii DNA in spiked water samples (Yang et al. 2009) and it significantly 
improved the performances of detection of T. gondii in clinical specimens (Switaj et al. 2005; 
Karanis et al. 2013). These authors compared,  three real-time PCR assyas based on the B1 
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gene and a 529 bp for the detection of T. gondii tachyzoites and oocysts in water; all reaction 
mixtures included 2 µl of template and a high concentration of BSA (250 µg/ µl) for 
overcoming inhibitors. The authors reported that the 529-bp PCR method was not only the 
most effective in detecting T. gondii oocysts seeded in concentrates of stream water samples 
but also that it was the most sensitive, with a detection limit of 0.06 to 0.3 tachyzoites/PCR. 
Finally, because the inclusion of a competitive internal amplification control (CIAC) into the 
reaction mix enabled the immediate identification of false negative PCR results; this saved 
performing a second PCR with the addition of spiked T. gondii to the reaction mix or the 
addition of DNA from a mimetic plasmid insert to DNA samples, as reported by Kourenti and 
Karanis (2006) and Villena et al. (2004), respectively.   
 
Table 6 Results of spiked environmental samples with different level of turbidity  
GROUP 
TURBIDITY 
LEVEL 
NO. OF 
OOCYSTS 
/ 15 ml 
N° OF T. gondii 
POSITIVE SAMPLES 
/ TOTAL N°. 
REPLICATES 
N° OF SAMPLES WITH INHIBITION 
/ TOTAL N° REPLICATES 
ITS1 
ORIGINAL 
REAL TIME 
PCR 
ITS 1 
ORIGINAL 
REAL 
TIME PCR 
MODIFIED 
REAL TIME 
PCR 
1 LOW 10 3/3 3/3 0/3 0/3 N.D* 
1 LOW 10 3/3 3/3 0/3 0/3 N.D 
1 LOW 100 3/3 3/3 0/3 0/3 N.D 
1 LOW 100 3/3 3/3 0/3 0/3 N.D 
1 LOW 1000 3/3 3/3 0/3 0/3 N.D 
1 LOW 1000 3/3 3/3 0/3 0/3 N.D 
2 MEDIUM 10 3/3 3/3 0/3 0/3 N.D 
2 MEDIUM 10 3/3 3/3 0/3 0/3 N.D 
2 MEDIUM 100 3/3 3/3 0/3 0/3 N.D 
2 MEDIUM 100 3/3 3/3 0/3 0/3 N.D 
2 MEDIUM 1000 3/3 3/3 0/3 0/3 N.D 
2 MEDIUM 1000 3/3 3/3 0/3 0/3 N.D 
3 HIGH 10 3/3 0/3 0/3 3/3 0/3 
3 HIGH 10 3/3 1/3 0/3 2/3 0/3 
3 HIGH 100 3/3 0/3 0/3 3/3 0/3 
3 HIGH 100 3/3 0/3 0/3 3/3 0/3 
3 HIGH 1000 3/3 3/3 0/3 0/3 0/3 
3 HIGH 1000 3/3 0/3 0/3 3/3 0/3 
*n.d: not done 
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Fig. 2 Geographical distribution of the water plants examined in this study  
 
  
Location of water 
plants with both 
matched RW and 
FW samples resulted 
negative in the real-
time PCR 
 
 
 
 
 
 
 
Location of water 
plants with at least one 
RW or FW sample 
resulted positive in 
the real-time PCR 
 Location of water 
plants with still 
inhibited samples 
 
KEY TO SYMBOLS 
 
 
92 
 
ENVIRONMENTAL MATCHED RAW AND FINISHED WATER 
SAMPLES ANALYSED BY REAL-TIME PCR 
The 358 samples tested in this study were collected from February to June 2013 from 68 
water plants under the Cryptosporidium monitoring plan.  
Since the filtration process was already performed by Scottish Water (U.S. Environmental 
Protection Agency, 2001), we decided to centrifugate the samples, in order to obtain a pellet 
to subject directly to DNA extraction.  DNA was extracted using the The NucleoSpin R Tissue 
kit (Macherey-Nagel; Method 2) and parasite DNA detection was performed by a quantitative 
real-time PCR targeting the highly conserved 529 bp fragment and the rections included a 
competitive internal amplification control (CIAC) (Opsteegh et al.2010a). In case of negative 
CIAC-PCRs, the inhibited samples were retested by the modified real-time PCR proposed in 
this study, which included the addition of BSA to the reaction mix and a decreased volume of 
template. The evaluation of the turbidity level (low, medium, high) of each sample was 
performed by visual inspection, as described above.   
The overall frequency of the turbidity level of the samples is shown in Graph 2. Raw water 
samples showed higher turbidity level than finished water, 65% (118/179) vs 9% (16/179); 
this finding was also reported by Villena et al. (2004), which measured the turbidity level of 
samples using a nephelometer and this concordance validates our method of grading 
turbidity.   
Graph 2 Turbidity level of environmental samples examined in this study.  
 
Fifty (50/358; 13.9%) samples contained PCR inhibitors, i.e. tested CIAC-PCR negative in the 
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significant differences in terms of presence of inhibitors were found between different water 
plants and different months of sampling (p value >0.005) (Fig.3). According to Rochelle et al. 
(1997), this finding confirms that inhibitory substances are more likely to be present in 
untreated water with high turbidities. Nevertheless, the fact that, among inhibited samples, 3 
were matched RW and FW samples indicates that the amount of inhibitors can also depend on 
the water source.   
The 50 inhibited samples were retested by the modified real-time PCR and the reduction of 
the volume of template plus the addition of BSA overcame the inhibitions in the 94% of cases 
but they all tested T. gondii negative. Three samples (6%; 3/50) still tested CIAC-PCR negative 
remaining uninterpretable; all these samples had a high level of turbidity and belonged to two 
water plants located in Mainland, Orkney Islands. This highlights once more that the presence 
of inhibitors in water is strictly related to the substances present in the soil that are washed 
out in the water.  
Only one raw water sample (0.3%), out of the 358 examined, tested T. gondii positive a with a 
Cp-value of 34.32 corresponding to 822 fg of DNA, calculated according to the standard curve. 
However, when the sample was retested one month later, it was T. gondii negative.  
False-positive results may occur either due to laboratory contamination or by detection of 
free DNA. In our experiments, negative controls were included in each examination and were 
all constantly negative. As additional explanation, it is likely that T. gondii DNA was present in 
the sample but in a very low concentration; this will limit the reproducibility of the result. 
This fact could be further enhanced by an inappropriate mixing of the extracted sample prior 
to the collection of the 2 µl of DNA destined for the reaction mix. A continuation of the study 
by another researcher within the group has obtained further T. gondii DNA positive samples 
from the same water treatment plant, giving support that this was a true positive result. 
Considering this positive result as a true positive and comparing this detection rate of 0.3% 
(1/358) with the others published in literature in the last decade, this result is the lowest.  In 
fact, in France, Villena et al. (2004) detected Toxoplasma DNA in 10 samples out the 125 
analyzed (8%): positive samples were underground water (6/10), raw surface water (3/10) 
and one sample of public drinking water. In order to confirm PCR results and to determine the 
infectivity of recovered oocysts, all the samples were also tested by bioassay in mice, but none 
of the T. gondii PCR-positive resulted positive by bioassay. Still in France but few years later, 
Aubert and Villena (2009) detected Toxoplasma in 7.7% (37/482) samples of underground, 
raw surface and public drinking water but again none of the PCR positive samples resulted 
positive by bioassay in mice. The main reason of this failure could be the detection of DNA 
from non-infective oocysts present in the environment or DNA contamination in PCR. Also 
Kourenti and Karanis (2006) did not obtain positive results when they retested their 4 (4/60) 
water samples that tested positive in the first PCR examination; the positive samples 
consisted of: one sample of river water, one of well water, one of tap water and one of sewage 
water.  Sroka et al. 2006 analyzed by PCR a total of 114 drinking water samples collected from 
wells (shallow and deep) and water supplies located on Polish farms; all the Toxoplasma-
positive samples (27.2%; 31/114) were taken from wells and the majority of water samples 
originated from shallow wells. Sotiriadou and Karanis (2008) reported positive samples in 
48% (25/52) of water samples (river, lake and tap waters), collected in Bulgaria and Russia, 
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using a LAMP-specific protocol targeting the TgOWP and B1 Toxoplasma genes; most of 
positive samples were river waters (28.8%; 15/52) but T. gondii DNA was also found in 2 
(2/52; 3.8%) samples of tap water.  Through the same LAMP-protocol, Gallas-Lindermann et 
al. (2013) found 8 (8/95; 8.4%) positive water samples collected from the Lower Rhine area 
in Germany; all the positive samples were influent and effluent samples obtained from 
wastewater treatment plants. Koloren and Demirel (2013) detected, again by LAMP, T. gondii 
DNA in 20 (20/56; 35.7%) river water samples.  
Considering the origin of the T. gondii positive water samples found in these studies, it is not 
surprising that the majority were raw surface water, underground water, river and sewage 
water samples. In fact raw surface water can be easily contaminated by soil after peaks in 
rainfall (Bowie et al. 1997) and also underground water is considered a vulnerable resource 
in relation to its frequent contamination by other waterborne pathogens suchas 
Cryptosporidium and Giardia (Aubert and Villena 2009); the contamination of wastewater 
with Toxoplasma oocysts may be due to the disposal of waste from cat litter boxes into 
toilettes (Jones and Dubey 2010; Gallas-Lindermann et al. 2013).  
The fact that some authors found T. gondii DNA in public drinking water is more surprising, 
but, as reported above, DNA amplification may be due to the detection of dead oocysts 
(Villena et al. 2004; Aubert and Villena 2009) and, in that case, water does not pose a risk for 
consumers. However, as oocysts are highly resistant to the various inactivation procedures 
based on chemical reagents and disinfection processes used by water utilities (Dubey et al., 
1970b, 1998), a PCR positive finding in public drinking water samples should be always 
confirmed by further investigation of the infectivity of the detected oocysts.  To date, mouse 
bioassay is still considered the reference method to detect the viability of Toxoplasma oocysts 
in meat (Opsteegh et al. 2010a) and water (Karanis et al. 2013); this method is not only time 
consuming, as 7 days is required for sporulation before the inoculation and an additional 4 
weeks is required to obtain the immunological results, but it is also expensive (Fayer 2004; 
Shapiro et al. 2010), unavailable in many laboratories (Fayer et al. 2004) and uses many 
animals in order to determine viability.  Furthermore, bioassay results using environmental 
water samples can be disappointing, as reported by various authors (Dubey et al. 1996; Isaac-
Renton et al. 1998; Villena et al. 2004; Aubert and Villena 2009). However, the loss of 
infectivity of oocysts may not be a true representation but could be caused by vigorous 
shaking for consistent elution of oocysts from filters (Simmons et al. 2001), the low 
pathogenicity of Toxoplasma strains or the low infective dose (Karanis et al. 2013). For public 
health purposes, it could be beneficial to develop a quantitative reverse transcription-PCR 
method to differentiate between viable and nonviable oocysts detected in environmental 
samples in order to substitute the mouse bioassays (Villena et al. 2004).  
Based on detection rates of T. gondii DNA in water samples collected in different parts of 
Europe, the scenario that comes to a light is highly heterogeneous. Similarly to what has been 
reported for worldwide seroprevalence values (Tenter et al. 2000), these detection rates are 
difficult to compare because different methods were utilized for the concentration of the 
water samples and different PCRs protocols were used for the detection of T. gondii DNA.  In 
the most recent studies (Sotiriadou and Karanis, 2008; Gallas-Lindermann et al. 2013; 
Koloren and Demirel 2013), a new molecular assay is used for the detection of Toxoplasma in 
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environmental samples, i.e. a loop-mediated isothermal amplification (LAMP); this was first 
developed by Notomi et al. (2000). This method is reported to be highly specific, efficient, 
simple and rapid as the amplification runs under isothermal conditions (Karanis et al. 2013) 
and, by adding a fluorescent metal indicator to the reaction solution, results can be 
determined by visual inspection without the need of specialized equipment (Notomi et al., 
2000; Tomita et al. 2008; Karanis and Ongerth, 2009; Fu et al. 2011). Furthermore, the LAMP 
assay is more sensitive than PCR because inhibitors do not affect the LAMP reaction, as 
described by Bakheit et al. (2008) in fecal samples and by Koloren et al. (2011) in surface 
water samples.  
Despite the detection methods used, differences in detection rates of Toxoplasma in water 
samples are also the result of three combined environmental factors, i.e. oocyst load, oocyst 
survival and oocyst transport (VanWormer et al. 2013). Oocyst load depends on the 
distribution of wild and domestic felids and on the prevalence, the frequency, the duration 
and the quantity of oocysts being shed. The survival of oocysts depends on terrestrial 
conditions (soil chemistry and moisture, air temperature and humidity) and aquatic 
conditions. Finally, the transport and accumulation of oocysts in water is determined by felid 
behavior, terrestrial conditions (watershed, permeability of the substrate), precipitation 
patterns (quantity, intensity, frequency and duration) and aquatic conditions (water 
chemistry, water quality, flow rate) (VanWormer et al. 2013). 
In light of what has been reported until now, some considerations on our results can be 
drawn, as the T. gondii prevalence found in this study is close to 0%.  
First of all, this can reflect a poor recovery of oocysts from concentrated water samples.  We 
performed DNA exctraction directly from concentrated pellet. Although this procedure 
provided good results in spiked water samples, as also reported by Yang et al.(2009), it is 
likely that further experiments are needed to improve the recovery step and to find out if 
these results are realistic.  In order to improve the oocysts recovery rate, some authors used 
sucrose flotation method (Villena et al. 2004; Sroka et al. 2006; Aubert and Villena 2009) or 
purification by discontinuous Sheather’s sugar gradient solution (Kourenti et al. 2003; 
Kourenti ans Karanis 2006; Gallas-Lindemann et al. 2013) reporting to recover 78-100% of 
sporulated or unsporulated T. gondii oocysts from spiked water concentrates; however, the 
recovery was also influenced by the amounts of contaminating debris (Kourenti and Karanis 
2006). In addition, Dumètre and Dardé (2003) demonstrated that recovery rates of oocysts 
from concentrated water samples was affected by the "age" of oocysts, where older oocysts 
are recovered with more difficulty than fresh oocyts due to their fragility and density. The 
turning point will be the developing of a standardized protocolusing Immunomagnetic 
Separation (IMS) techniques together with the commercialization of immunofluorescence 
staining reagents that specifically detect Toxoplasma oocysts from concentrated water 
samples. These techniques are used for Cryptosporidium and Giardia detection in 
environmental samples with good recovery rates (U.S. Environmental Protection Agency,, 
2001; Aubert and Villena 2009).  Preliminary studies on  the IMS  has been performed by 
Dumètre and Dardé in 2005 and 2007. In the first study, the authors used a monoclonal 
antibody directed against the oocysts wall, recovering 45 to 83% of oocysts under 
experimental conditions; in 2007, they tested another monoclonal antibody targeting the 
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sporocyst wall. However, due to cross-reactions with multiple organisms related to 
Toxoplasma, PCR was still necessary to characterize detected sporocysts, so its effectiveness 
in environmental waters remains to be evaluated.  
Additionally, our results can be considered realistic and the prevalence of T. gondii in water 
samples collected between late winter and early summer is really close to 0%. This statement 
can be dawn considering the three factors influencing the level of oocysts environmental 
contamination, i.e. oocysts shedding, surviving and transport.  Scotland is generally not 
affected by the problem of stray cat population either in urbanized areas and in areas where 
water reservoirs are located, i.e. mainly in Central and Southern of Scotland. The exception is 
represented by the Scottish Highlands where the last remaining large predators of Britain, i.e. 
Scottish Wildcats (Felis silvestris grampia), are confined and where there are thought to live at 
least 100,000 feral hybrid cats, results of the mating between Scottish Wildcats and domestic 
cats (www.scottishwildcats.co.uk). In relation to the high predation attitude of the Scottish 
Wildcats, mainly on rabbits and other small to medium size prey species, they are likely to 
become infected and shed T. gondii oocysts. Wild cats, included Felis silvestris, can shed 
oocysts (Jones and Dubey, 2010). It is well known that young cats, and in particular feral 
kittens, may shed higher number of oocysts following primary infection compared to adults 
(Dubey and Beattie 1988). In light of this, we can suppose that kittens of Scottish Wildcats can 
play the key role in T. gondii shedding. In relation to their biology, this hypothetically happens 
when they are around 5 or 6 months of age when they head out independently and start their 
hunting actively (www.scottishwildcats.co.uk). As kittens are born in early spring, the 
supposed shedding period could be dated to between August and September, i.e. after we 
finished analyzing water samples in this study. Furthermore, most rainfall in Scotland is seen 
in September to November (www.weather-and-climate.com) and, as previously reported, 
transport and accumulation of oocysts in water is determined not only by terrestrial 
conditions (watershed, permeability of the substrate), but also by precipitation patterns 
(quantity, intensity, frequency and duration) (VanWormer et al. 2013).  
Evidence that the above speculations are correct and directly relevant for Scottish water 
samples came from a continuation of the study, by scientists at Moredun. They confirmed that 
there was an increase in the detection of T. gondii positive water samples later within the 
year, where 8.2% of samples collected during July to October tested positive for T. gondii DNA. 
Even during this sampling period an increase in the detection rate was observed during 
October, which coincided with an increase in rain fall. This could be further substantiated by 
looking at localised rainfall events in the catchments of specific water treatment plants where 
detection peaks were directly linked to heavy rain fall events (Katzer et al, personal 
communications).  
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